BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Magro C, Mulvey JJ, Berlin D, Nuovo G, Salvatore S, Harp J, Baxter-Stoltzfus A, Laurence J. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases. Transl Res. 2020;220:1-13. [PMID: 32299776 DOI: 10.1016/j.trsl.2020.04.007] [Cited by in Crossref: 979] [Cited by in F6Publishing: 911] [Article Influence: 489.5] [Reference Citation Analysis]
Number Citing Articles
1 Jordan SC. Innate and adaptive immune responses to SARS-CoV-2 in humans: relevance to acquired immunity and vaccine responses. Clin Exp Immunol. 2021;204:310-320. [PMID: 33534923 DOI: 10.1111/cei.13582] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
2 Hausburg MA, Banton KL, Roshon M, Bar-Or D. Clinically distinct COVID-19 cases share notably similar immune response progression: A follow-up analysis. Heliyon 2021;7:e05877. [PMID: 33437888 DOI: 10.1016/j.heliyon.2020.e05877] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Turker IC, Dogan CU, Dirim AB, Guven D, Kutucu OK. Evaluation of early and late COVID-19-induced vascular changes with optical coherence tomography angiography. Can J Ophthalmol 2021:S0008-4182(21)00171-X. [PMID: 34118187 DOI: 10.1016/j.jcjo.2021.05.001] [Reference Citation Analysis]
4 Pombo F, Seabra C, Soares V, Sá AJ, Ferreira I, Mendes M. COVID-19-related Multisystem Inflammatory Syndrome in a Young Adult. Eur J Case Rep Intern Med 2021;8:002520. [PMID: 33987131 DOI: 10.12890/2021_002520] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
5 [DOI: 10.1101/2020.06.08.20125823] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
6 McGregor R, Chauss D, Freiwald T, Yan B, Wang L, Nova-Lamperti E, Zhang Z, Teague H, West EE, Bibby J, Kelly A, Malik A, Freeman AF, Schwartz D, Portilla D, John S, Lavender P, Lionakis MS, Mehta NN, Kemper C, Cooper N, Lombardi G, Laurence A, Kazemian M, Afzali B. An autocrine Vitamin D-driven Th1 shutdown program can be exploited for COVID-19. bioRxiv 2020:2020. [PMID: 32743590 DOI: 10.1101/2020.07.18.210161] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
7 Ogunsakin RE, Ebenezer O, Jordaan MA, Shapi M, Ginindza TG. Mapping Scientific Productivity Trends and Hotspots in Remdesivir Research Publications: A Bibliometric Study from 2016 to 2021. IJERPH 2022;19:8845. [DOI: 10.3390/ijerph19148845] [Reference Citation Analysis]
8 Wang CC, Chao JK, Wang ML, Yang YP, Chien CS, Lai WY, Yang YC, Chang YH, Chou CL, Kao CL. Care for Patients with Stroke During the COVID-19 Pandemic: Physical Therapy and Rehabilitation Suggestions for Preventing Secondary Stroke. J Stroke Cerebrovasc Dis 2020;29:105182. [PMID: 33066878 DOI: 10.1016/j.jstrokecerebrovasdis.2020.105182] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
9 Christie MJ, Irving AT, Forster SC, Marsland BJ, Hansbro PM, Hertzog PJ, Nold-Petry CA, Nold MF. Of bats and men: Immunomodulatory treatment options for COVID-19 guided by the immunopathology of SARS-CoV-2 infection. Sci Immunol 2021;6:eabd0205. [PMID: 34533977 DOI: 10.1126/sciimmunol.abd0205] [Reference Citation Analysis]
10 Varshney R, Bansal N, Khanduri A, Gupta J, Gupta R. Colonic Gangrene: A Sequela of Coronavirus Disease 2019. Cureus 2021;13:e14687. [PMID: 34055531 DOI: 10.7759/cureus.14687] [Reference Citation Analysis]
11 González González F, Cortés Correa C, Peñaranda Contreras E. Cutaneous Manifestations in Patients With COVID-19: Clinical Characteristics and Possible Pathophysiologic Mechanisms. Actas Dermosifiliogr (Engl Ed) 2021;112:314-23. [PMID: 33259815 DOI: 10.1016/j.ad.2020.11.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
12 Araten DJ, Belmont HM, Schaefer-Cutillo J, Iyengar A, Mattoo A, Reddy R. Mild Clinical Course of COVID-19 in 3 Patients Receiving Therapeutic Monoclonal Antibodies Targeting C5 Complement for Hematologic Disorders. Am J Case Rep 2020;21:e927418. [PMID: 32917848 DOI: 10.12659/AJCR.927418] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
13 Ma L, Sahu SK, Cano M, Kuppuswamy V, Bajwa J, McPhatter J, Pine A, Meizlish M, Goshua G, Chang CH, Zhang H, Price C, Bahel P, Rinder H, Lei T, Day A, Reynolds D, Wu X, Schriefer R, Rauseo AM, Goss CW, O'Halloran JA, Presti RM, Kim AH, Gelman AE, Cruz CD, Lee AI, Mudd P, Chun HJ, Atkinson JP, Kulkarni HS. Increased complement activation is a distinctive feature of severe SARS-CoV-2 infection. bioRxiv 2021:2021. [PMID: 33655244 DOI: 10.1101/2021.02.22.432177] [Cited by in Crossref: 7] [Article Influence: 7.0] [Reference Citation Analysis]
14 Srivastava SP, Srivastava R, Chand S, Goodwin JE. Coronavirus Disease (COVID)-19 and Diabetic Kidney Disease. Pharmaceuticals (Basel) 2021;14:751. [PMID: 34451848 DOI: 10.3390/ph14080751] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Thakur M, Evans B, Schindewolf M, Baumgartner I, Döring Y. Neutrophil Extracellular Traps Affecting Cardiovascular Health in Infectious and Inflammatory Diseases. Cells 2021;10:1689. [PMID: 34359859 DOI: 10.3390/cells10071689] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Del Turco S, Vianello A, Ragusa R, Caselli C, Basta G. COVID-19 and cardiovascular consequences: Is the endothelial dysfunction the hardest challenge? Thromb Res 2020;196:143-51. [PMID: 32871306 DOI: 10.1016/j.thromres.2020.08.039] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 14.0] [Reference Citation Analysis]
17 Cacciapuoti F, Cacciapuoti F. Could Low Doses Acetylsalicylic Acid Prevent Thrombotic Complications in COVID-19 Patients? Clin Appl Thromb Hemost 2021;27:10760296211014592. [PMID: 33928791 DOI: 10.1177/10760296211014592] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 El Kady DM, Gomaa EA, Abdella WS, Ashraf Hussien R, Abd ElAziz RH, Khater AGA. Oral manifestations of COVID-19 patients: An online survey of the Egyptian population. Clin Exp Dent Res 2021. [PMID: 33931952 DOI: 10.1002/cre2.429] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Perna A, Passiatore M, Massaro A, Terrinoni A, Bianchi L, Cilli V, D'Orio M, Proietti L, Taccardo G, De Vitis R. Skin manifestations in COVID-19 patients, state of the art. A systematic review. Int J Dermatol 2021;60:547-53. [PMID: 33533036 DOI: 10.1111/ijd.15414] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
20 Maguire G. Better preventing and mitigating the effects of Covid-19. Future Sci OA 2020;6:FSO586. [PMID: 32685190 DOI: 10.2144/fsoa-2020-0051] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
21 Rad F, Dabbagh A, Dorgalaleh A, Biswas A. The Relationship between Inflammatory Cytokines and Coagulopathy in Patients with COVID-19. J Clin Med 2021;10:2020. [PMID: 34065057 DOI: 10.3390/jcm10092020] [Reference Citation Analysis]
22 Subrahmanian S, Borczuk A, Salvatore S, Fung KM, Merrill JT, Laurence J, Ahamed J. Tissue factor upregulation is associated with SARS-CoV-2 in the lungs of COVID-19 patients. J Thromb Haemost 2021;19:2268-74. [PMID: 34236752 DOI: 10.1111/jth.15451] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Agostinis C, Mangogna A, Balduit A, Aghamajidi A, Ricci G, Kishore U, Bulla R. COVID-19, Pre-Eclampsia, and Complement System. Front Immunol 2021;12:775168. [PMID: 34868042 DOI: 10.3389/fimmu.2021.775168] [Reference Citation Analysis]
24 Perico L, Benigni A, Casiraghi F, Ng LFP, Renia L, Remuzzi G. Immunity, endothelial injury and complement-induced coagulopathy in COVID-19. Nat Rev Nephrol. 2021;17:46-64. [PMID: 33077917 DOI: 10.1038/s41581-020-00357-4] [Cited by in Crossref: 85] [Cited by in F6Publishing: 81] [Article Influence: 42.5] [Reference Citation Analysis]
25 Lockhart SM, O'Rahilly S. When Two Pandemics Meet: Why Is Obesity Associated with Increased COVID-19 Mortality? Med (N Y) 2020;1:33-42. [PMID: 32838359 DOI: 10.1016/j.medj.2020.06.005] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 9.5] [Reference Citation Analysis]
26 Razzaq M, Iglesias MJ, Ibrahim-Kosta M, Goumidi L, Soukarieh O, Proust C, Roux M, Suchon P, Boland A, Daiain D, Olaso R, Havervall S, Thalin C, Butler L, Deleuze JF, Odeberg J, Morange PE, Trégouët DA. An artificial neural network approach integrating plasma proteomics and genetic data identifies PLXNA4 as a new susceptibility locus for pulmonary embolism. Sci Rep 2021;11:14015. [PMID: 34234248 DOI: 10.1038/s41598-021-93390-7] [Reference Citation Analysis]
27 Mañón VA, Balandran S, Young S, Wong M, Melville JC. COVID-Associated Avascular Necrosis of the Maxilla - A Rare, New Side Effect of COVID-19. Journal of Oral and Maxillofacial Surgery 2022. [DOI: 10.1016/j.joms.2022.04.015] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Tassiopoulos AK, Mofakham S, Rubano JA, Labropoulos N, Bannazadeh M, Drakos P, Volteas P, Cleri NA, Alkadaa LN, Asencio AA, Oganov A, Hou W, Rutigliano DN, Singer AJ, Vosswinkel J, Talamini M, Mikell CB, Kaushansky K. D-Dimer-Driven Anticoagulation Reduces Mortality in Intubated COVID-19 Patients: A Cohort Study With a Propensity-Matched Analysis. Front Med (Lausanne) 2021;8:631335. [PMID: 33634153 DOI: 10.3389/fmed.2021.631335] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
29 Atzori L, Recalcati S, Ferreli C, Hoenig L, Rongioletti F. COVID-19–related skin manifestations: Update on therapy. Clinics in Dermatology 2020. [DOI: 10.1016/j.clindermatol.2020.12.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Shaw RJ, Bradbury C, Abrams ST, Wang G, Toh CH. COVID-19 and immunothrombosis: emerging understanding and clinical management. Br J Haematol 2021;194:518-29. [PMID: 34114204 DOI: 10.1111/bjh.17664] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
31 Askenase PW. COVID-19 therapy with mesenchymal stromal cells (MSC) and convalescent plasma must consider exosome involvement: Do the exosomes in convalescent plasma antagonize the weak immune antibodies? J Extracell Vesicles 2020;10:e12004. [PMID: 33304473 DOI: 10.1002/jev2.12004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 7.0] [Reference Citation Analysis]
32 Shibeeb S, Ahmad MN. Thrombotic and Hypercoagulability Complications of COVID-19: An Update. J Blood Med 2021;12:785-93. [PMID: 34512059 DOI: 10.2147/JBM.S316014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
33 Seshadri M, Ahamed J, Laurence J. Intervention in COVID-19 linked hypercoaguable states characterized by circuit thrombosis utilizing a direct thrombin inhibitor. Thrombosis Update 2020;1:100009. [DOI: 10.1016/j.tru.2020.100009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
34 Nadeem R, Thomas SJ, Fathima Z, Palathinkal AS, Alkilani YE, Dejan EA, Darwish IMI, Alsubousi AA, Backour AM, Kandeel H, Omar M, Kewan HFYT, Makhlof ME, Kotgire AB. Pattern of anticoagulation prescription for patients with Covid-19 acute respiratory distress syndrome admitted to ICU. Does it impact outcome? Heart Lung 2021;50:1-5. [PMID: 33138975 DOI: 10.1016/j.hrtlng.2020.10.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
35 Casciola-Rosen L, Thiemann DR, Andrade F, Trejo Zambrano MI, Hooper JE, Leonard E, Spangler J, Cox AL, Machamer C, Sauer L, Laeyendecker O, Garibaldi BT, Ray SC, Mecoli C, Christopher-Stine L, Gutierrez-Alamillo L, Yang Q, Hines D, Clarke W, Rothman RE, Pekosz A, Fenstermacher K, Wang Z, Zeger SL, Rosen A. IgM autoantibodies recognizing ACE2 are associated with severe COVID-19. medRxiv 2020:2020. [PMID: 33083808 DOI: 10.1101/2020.10.13.20211664] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 6.5] [Reference Citation Analysis]
36 Prasad A, Prasad M. Single Virus Targeting Multiple Organs: What We Know and Where We Are Heading? Front Med (Lausanne) 2020;7:370. [PMID: 32850890 DOI: 10.3389/fmed.2020.00370] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
37 Soldera D, Soares CF, Girondi JBR, Salum NC, Stein M, Amante LN, Sebold LF, Miranda GM. PREVENÇÃO DE LESÕES POR PRESSÃO NA PRONAÇÃO DE PACIENTES COVID-19: CONSTRUÇÃO DE UMA NARRATIVA GRÁFICA. ESTIMA, Braz J Enterostomal Ther . [DOI: 10.30886/estima.v19.1136_pt] [Reference Citation Analysis]
38 Mondello C, Roccuzzo S, Malfa O, Sapienza D, Gualniera P, Ventura Spagnolo E, Di Nunno N, Salerno M, Pomara C, Asmundo A. Pathological Findings in COVID-19 as a Tool to Define SARS-CoV-2 Pathogenesis. A Systematic Review. Front Pharmacol 2021;12:614586. [PMID: 33867981 DOI: 10.3389/fphar.2021.614586] [Reference Citation Analysis]
39 Arslan MN, Büyük Y, Ziyade N, Elgörmüş N, Şirin G, Çoban İ, Gökşen ME, Daş T, Akçay A. COVID-19 autopsies of Istanbul. Ir J Med Sci 2021. [PMID: 33755916 DOI: 10.1007/s11845-021-02602-6] [Reference Citation Analysis]
40 Castelo-Soccio L, Lara-Corrales I, Paller AS, Bean E, Rangu S, Oboite M, Flohr C, Ahmad RC, Calberg V, Gilliam A, Pope E, Reynolds S, Sibbald C, Shin HT, Berger E, Schaffer J, Siegel MP, Cordoro KM. Acral Changes in pediatric patients during COVID 19 pandemic: Registry report from the COVID 19 response task force of the society of pediatric dermatology (SPD) and pediatric dermatology research alliance (PeDRA). Pediatr Dermatol 2021;38:364-70. [PMID: 33742457 DOI: 10.1111/pde.14566] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
41 Elhadad S, Chapin J, Copertino D, Van Besien K, Ahamed J, Laurence J. MASP2 levels are elevated in thrombotic microangiopathies: association with microvascular endothelial cell injury and suppression by anti-MASP2 antibody narsoplimab. Clin Exp Immunol 2021;203:96-104. [PMID: 32681658 DOI: 10.1111/cei.13497] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
42 Miriam Michaelson N, Malhotra A, Wang Z, Heier L, Tanji K, Wolfe S, Gupta A, MacGowan D. Peripheral neurological complications during COVID-19: A single center experience. J Neurol Sci 2021;434:120118. [PMID: 34971857 DOI: 10.1016/j.jns.2021.120118] [Reference Citation Analysis]
43 Cyprian FS, Suleman M, Abdelhafez I, Doudin A, Masud Danjuma M, Mir FA, Parray A, Yousaf Z, Siddiqui MYA, Abdelmajid A, Mulhim M, Al-Shokri S, Abukhattab M, Shaheen R, Elkord E, Al-Khal AL, Elzouki AN, Girardi G. Complement C5a and Clinical Markers as Predictors of COVID-19 Disease Severity and Mortality in a Multi-Ethnic Population. Front Immunol 2021;12:707159. [PMID: 34966381 DOI: 10.3389/fimmu.2021.707159] [Reference Citation Analysis]
44 Felsenstein S, Reiff AO. A hitchhiker's guide through the COVID-19 galaxy. Clin Immunol 2021;232:108849. [PMID: 34563684 DOI: 10.1016/j.clim.2021.108849] [Reference Citation Analysis]
45 Valdivia-Mazeyra MF, Salas C, Nieves-Alonso JM, Martín-Fragueiro L, Bárcena C, Muñoz-Hernández P, Villar-Zarra K, Martín-López J, Ramasco-Rueda F, Fraga J, Jiménez-Heffernan JA. Increased number of pulmonary megakaryocytes in COVID-19 patients with diffuse alveolar damage: an autopsy study with clinical correlation and review of the literature. Virchows Arch 2021;478:487-96. [PMID: 32915265 DOI: 10.1007/s00428-020-02926-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
46 Goswami J, MacArthur TA, Sridharan M, Pruthi RK, McBane RD 2nd, Witzig TE, Park MS. A Review of Pathophysiology, Clinical Features, and Management Options of COVID-19 Associated Coagulopathy. Shock 2021;55:700-16. [PMID: 33378321 DOI: 10.1097/SHK.0000000000001680] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
47 Emadi-Baygi M, Ehsanifard M, Afrashtehpour N, Norouzi M, Joz-Abbasalian Z. Corona Virus Disease 2019 (COVID-19) as a System-Level Infectious Disease With Distinct Sex Disparities. Front Immunol 2021;12:778913. [PMID: 34912345 DOI: 10.3389/fimmu.2021.778913] [Reference Citation Analysis]
48 Polycarpou A, Grigoriadou S, Klavinskis L, Sacks S. Does the Lectin Complement Pathway Link Kawasaki Disease and SARS-CoV-2? Front Immunol 2020;11:604512. [PMID: 33584675 DOI: 10.3389/fimmu.2020.604512] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
49 Jamal M, Bangash HI, Habiba M, Lei Y, Xie T, Sun J, Wei Z, Hong Z, Shao L, Zhang Q. Immune dysregulation and system pathology in COVID-19. Virulence 2021;12:918-36. [PMID: 33757410 DOI: 10.1080/21505594.2021.1898790] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
50 Okada H, Yoshida S, Hara A, Ogura S, Tomita H. Vascular endothelial injury exacerbates coronavirus disease 2019: The role of endothelial glycocalyx protection. Microcirculation 2021;28:e12654. [PMID: 32791568 DOI: 10.1111/micc.12654] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
51 Sakr Y, Giovini M, Leone M, Pizzilli G, Kortgen A, Bauer M, Tonetti T, Duclos G, Zieleskiewicz L, Buschbeck S, Ranieri VM, Antonucci E. The clinical spectrum of pulmonary thromboembolism in patients with coronavirus disease-2019 (COVID-19) pneumonia: A European case series. J Crit Care 2021;61:39-44. [PMID: 33075608 DOI: 10.1016/j.jcrc.2020.09.021] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
52 Rodriguez-Gonzalez M, Rodríguez-Campoy P, Sánchez-Códez M, Gutiérrez-Rosa I, Castellano-Martinez A, Rodríguez-Benítez A. New onset severe right ventricular failure associated with COVID-19 in a young infant without previous heart disease. Cardiol Young 2020;30:1346-9. [PMID: 32600496 DOI: 10.1017/S1047951120001857] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
53 Zhu A, Chen Z, Wang Y, Zeng Q, Sun J, Zhuang Z, Li F, Zhao J, Zhao J, Zhong N. Immune responses to SARS-CoV-2 infection in Humans and ACE2 humanized mice. Fundamental Research 2021;1:124-30. [DOI: 10.1016/j.fmre.2021.03.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
54 Sharma YP, Agstam S, Yadav A, Gupta A, Gupta A. Cardiovascular manifestations of COVID-19: An evidence-based narrative review. Indian J Med Res 2021;153:7-16. [PMID: 33818464 DOI: 10.4103/ijmr.IJMR_2450_20] [Reference Citation Analysis]
55 Botta C, Indrieri A, Garofalo E, Biamonte F, Bruni A, Pasqua P, Cesario F, Costanzo FS, Longhini F, Mendicino F. COVID-19: High-JAKing of the Inflammatory "Flight" by Ruxolitinib to Avoid the Cytokine Storm. Front Oncol 2020;10:599502. [PMID: 33489899 DOI: 10.3389/fonc.2020.599502] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
56 Han CY, Tarr AM, Gewirtz AN, Kaunzner UW, Roy-Burman P, Cutler TS, MacGowan DJ. Brachial plexopathy as a complication of COVID-19. BMJ Case Rep 2021;14:e237459. [PMID: 33766961 DOI: 10.1136/bcr-2020-237459] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
57 Vizcaychipi MP, Shovlin CL, McCarthy A, Godfrey A, Patel S, Shah PL, Hayes M, Keays RT, Beveridge I, Davies G; Gary Davies on behalf of the ChelWest COVID19 Consortium. Increase in COVID-19 inpatient survival following detection of Thromboembolic and Cytokine storm risk from the point of admission to hospital by a near real time Traffic-light System (TraCe-Tic). Braz J Infect Dis 2020;24:412-21. [PMID: 32857990 DOI: 10.1016/j.bjid.2020.07.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
58 Cryer MJ, Farhan S, Kaufmann CC, Jäger B, Garg A, Krishnan P, Mehran R, Huber K. Prothrombotic Milieu, Thrombotic Events and Prophylactic Anticoagulation in Hospitalized COVID-19 Positive Patients: A Review. Clin Appl Thromb Hemost 2022;28:107602962210743. [DOI: 10.1177/10760296221074353] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
59 Soni B, Kabra R, Singh S. Quantitative Insight into Immunopathology of SARS-CoV-2 Infection. J Interferon Cytokine Res 2021;41:244-57. [PMID: 34280026 DOI: 10.1089/jir.2020.0156] [Reference Citation Analysis]
60 Hajra A, Mathai SV, Ball S, Bandyopadhyay D, Veyseh M, Chakraborty S, Lavie CJ, Aronow WS. Management of Thrombotic Complications in COVID-19: An Update. Drugs 2020;80:1553-62. [PMID: 32803670 DOI: 10.1007/s40265-020-01377-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
61 Jacob G, Aharon A, Brenner B. COVID-19-Associated Hyper-Fibrinolysis: Mechanism and Implementations. Front Physiol 2020;11:596057. [PMID: 33391014 DOI: 10.3389/fphys.2020.596057] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
62 Rocha KO, Zanuncio VV, Freitas BAC, Lima LM. "COVID toes": A meta-analysis of case and observational studies on clinical, histopathological, and laboratory findings. Pediatr Dermatol 2021;38:1143-9. [PMID: 34515379 DOI: 10.1111/pde.14805] [Reference Citation Analysis]
63 Xu R, Feng Z, Wang FS. Mesenchymal stem cell treatment for COVID-19. EBioMedicine 2022;77:103920. [PMID: 35279630 DOI: 10.1016/j.ebiom.2022.103920] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
64 Elsawah HK, Elsokary MA, Elrazzaz MG, Elshafie AH. Hydroxychloroquine for treatment of nonsevere COVID-19 patients: Systematic review and meta-analysis of controlled clinical trials. J Med Virol 2021;93:1265-75. [PMID: 32808712 DOI: 10.1002/jmv.26442] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
65 Abdi A, AlOtaiby S, Badarin FA, Khraibi A, Hamdan H, Nader M. Interaction of SARS-CoV-2 with cardiomyocytes: Insight into the underlying molecular mechanisms of cardiac injury and pharmacotherapy. Biomed Pharmacother 2021;146:112518. [PMID: 34906770 DOI: 10.1016/j.biopha.2021.112518] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
66 Goshua G, Butt A, Lee AI. Immunothrombosis: a COVID-19 concerto. Br J Haematol 2021;194:491-3. [PMID: 34114208 DOI: 10.1111/bjh.17666] [Reference Citation Analysis]
67 Ghareeb DA, Saleh SR, Nofal MS, Kaddah MMY, Hassan SF, Seif IK, El-zahaby SA, Khedr SM, Kenawy MY, Masoud AA, Soudi SA, Sobhy AA, Sery JG, El-wahab MGA, Elmoneam AAA, Al-mahallawi AM, El-demellawy MA. Potential therapeutic and pharmacological strategies for SARS-CoV2. J Pharm Investig 2021;51:281-96. [DOI: 10.1007/s40005-021-00520-4] [Reference Citation Analysis]
68 Bamberger C, Pankow S, Martínez-Bartolomé S, Diedrich J, Park R, Yates J. The Host Interactome of Spike Expands the Tropism of SARS-CoV-2. bioRxiv 2021:2021. [PMID: 33619478 DOI: 10.1101/2021.02.16.431318] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
69 Middleton EA, Zimmerman GA. COVID-19-Associated Acute Respiratory Distress Syndrome: Lessons from Tissues and Cells. Crit Care Clin 2021;37:777-93. [PMID: 34548133 DOI: 10.1016/j.ccc.2021.05.004] [Reference Citation Analysis]
70 Hou YJ, Okuda K, Edwards CE, Martinez DR, Asakura T, Dinnon KH 3rd, Kato T, Lee RE, Yount BL, Mascenik TM, Chen G, Olivier KN, Ghio A, Tse LV, Leist SR, Gralinski LE, Schäfer A, Dang H, Gilmore R, Nakano S, Sun L, Fulcher ML, Livraghi-Butrico A, Nicely NI, Cameron M, Cameron C, Kelvin DJ, de Silva A, Margolis DM, Markmann A, Bartelt L, Zumwalt R, Martinez FJ, Salvatore SP, Borczuk A, Tata PR, Sontake V, Kimple A, Jaspers I, O'Neal WK, Randell SH, Boucher RC, Baric RS. SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract. Cell 2020;182:429-446.e14. [PMID: 32526206 DOI: 10.1016/j.cell.2020.05.042] [Cited by in Crossref: 506] [Cited by in F6Publishing: 464] [Article Influence: 253.0] [Reference Citation Analysis]
71 Raghunandan S, Josephson CD, Verkerke H, Linam WM, Ingram TC, Zerra PE, Arthur CM, Stowell SR, Briones M, Chonat S. Complement Inhibition in Severe COVID-19 Acute Respiratory Distress Syndrome. Front Pediatr 2020;8:616731. [PMID: 33447586 DOI: 10.3389/fped.2020.616731] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
72 Rajan M B, Kumar-M P, Bhardwaj A. The trend of cutaneous lesions during COVID-19 pandemic: lessons from a meta-analysis and systematic review. Int J Dermatol. 2020;59:1358-1370. [PMID: 32936462 DOI: 10.1111/ijd.15154] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
73 Nuovo GJ, Magro C, Shaffer T, Awad H, Suster D, Mikhail S, He B, Michaille JJ, Liechty B, Tili E. Endothelial cell damage is the central part of COVID-19 and a mouse model induced by injection of the S1 subunit of the spike protein. Ann Diagn Pathol 2021;51:151682. [PMID: 33360731 DOI: 10.1016/j.anndiagpath.2020.151682] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
74 Pascoal DB, Araujo IM, Lopes LP, Cruz CMD. Analysis of the Role of Female Hormones During Infection by COVID-19. Rev Bras Ginecol Obstet 2021;43:940-8. [PMID: 34933388 DOI: 10.1055/s-0041-1740208] [Reference Citation Analysis]
75 Nabeh OA, Helaly MM, Menshawey R, Menshawey E, Nasser MMM, Diaa El-Deen AM. Contemporary approach to understand and manage COVID-19-related arrhythmia. Egypt Heart J 2021;73:76. [PMID: 34459992 DOI: 10.1186/s43044-021-00201-5] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
76 Lutchmansingh DD, Knauert MP, Antin-Ozerkis DE, Chupp G, Cohn L, Dela Cruz CS, Ferrante LE, Herzog EL, Koff J, Rochester CL, Ryu C, Singh I, Tickoo M, Winks V, Gulati M, Possick JD. A Clinic Blueprint for Post-Coronavirus Disease 2019 RECOVERY: Learning From the Past, Looking to the Future. Chest 2021;159:949-58. [PMID: 33159907 DOI: 10.1016/j.chest.2020.10.067] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
77 Deraje V, Gujjalanavar RS, Das S, Janardhan R, Rao P. Acute Extremity Gangrene in COVID-19 Patients. Indian J Plast Surg 2021;54:237-9. [DOI: 10.1055/s-0041-1731853] [Reference Citation Analysis]
78 Ahmed-Hassan H, Sisson B, Shukla RK, Wijewantha Y, Funderburg NT, Li Z, Hayes D Jr, Demberg T, Liyanage NPM. Innate Immune Responses to Highly Pathogenic Coronaviruses and Other Significant Respiratory Viral Infections. Front Immunol 2020;11:1979. [PMID: 32973803 DOI: 10.3389/fimmu.2020.01979] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
79 Zhao N, Di B, Xu LL. The NLRP3 inflammasome and COVID-19: Activation, pathogenesis and therapeutic strategies. Cytokine Growth Factor Rev 2021:S1359-6101(21)00054-X. [PMID: 34183243 DOI: 10.1016/j.cytogfr.2021.06.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
80 Bian Y, Le Y, Du H, Chen J, Zhang P, He Z, Wang Y, Yu S, Fang Y, Yu G, Ling J, Feng Y, Wei S, Huang J, Xiao L, Zheng Y, Yu Z, Li S. Efficacy and Safety of Anticoagulation Treatment in COVID-19 Patient Subgroups Identified by Clinical-Based Stratification and Unsupervised Machine Learning: A Matched Cohort Study. Front Med (Lausanne) 2021;8:786414. [PMID: 35004751 DOI: 10.3389/fmed.2021.786414] [Reference Citation Analysis]
81 Revzin MV, Raza S, Warshawsky R, D'Agostino C, Srivastava NC, Bader AS, Malhotra A, Patel RD, Chen K, Kyriakakos C, Pellerito JS. Multisystem Imaging Manifestations of COVID-19, Part 1: Viral Pathogenesis and Pulmonary and Vascular System Complications. Radiographics 2020;40:1574-99. [PMID: 33001783 DOI: 10.1148/rg.2020200149] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 13.0] [Reference Citation Analysis]
82 Polycarpou A, Howard M, Farrar CA, Greenlaw R, Fanelli G, Wallis R, Klavinskis LS, Sacks S. Rationale for targeting complement in COVID-19. EMBO Mol Med 2020;12:e12642. [PMID: 32559343 DOI: 10.15252/emmm.202012642] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 21.0] [Reference Citation Analysis]
83 Dimbath E, Maddipati V, Stahl J, Sewell K, Domire Z, George S, Vahdati A. Implications of microscale lung damage for COVID-19 pulmonary ventilation dynamics: A narrative review. Life Sci 2021;274:119341. [PMID: 33716059 DOI: 10.1016/j.lfs.2021.119341] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
84 Kumar V. Understanding the complexities of SARS-CoV2 infection and its immunology: A road to immune-based therapeutics. Int Immunopharmacol 2020;88:106980. [PMID: 33182073 DOI: 10.1016/j.intimp.2020.106980] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
85 Salva O, Doreski PA, Giler CS, Quinodoz DC, Guzmán LG, Muñoz SE, Carrillo MN, Porta DJ, Ambasch G, Coscia E, Diaz JLT, Bueno GD, Fandi JO, Maldonado MA, Peña Chiappero LE, Fournier F, Pérez HA, Quiroga MA, Sala Mercado JA, Martínez Picco C, Beltrán MA, Argañarás LA, Ríos NM, Kalayan GI, Beltramo DM, García NH. Reversal of SARS-CoV2-Induced Hypoxia by Nebulized Sodium Ibuprofenate in a Compassionate Use Program. Infect Dis Ther 2021;10:2511-24. [PMID: 34460083 DOI: 10.1007/s40121-021-00527-2] [Reference Citation Analysis]
86 Pergola V, Ocagli H, Lorenzoni G, Azzolina D, Leoni L, Mancuso D, Palermo C, Previtero M, Iliceto S, Gregori D, Di Salvo G. Prevalence of Thromboembolic Complications in COVID-19 Infection: A Systematic Review and Meta-Analysis. EMJ. [DOI: 10.33590/emj/20-00237] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
87 Mahajan R, Lipton M, Broglie L, Jain NG, Uy NS. Eculizumab treatment for renal failure in a pediatric patient with COVID-19. J Nephrol 2020;33:1373-6. [PMID: 32981025 DOI: 10.1007/s40620-020-00858-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
88 Colmenero I, Santonja C, Alonso-Riaño M, Noguera-Morel L, Hernández-Martín A, Andina D, Wiesner T, Rodríguez-Peralto JL, Requena L, Torrelo A. SARS-CoV-2 endothelial infection causes COVID-19 chilblains: histopathological, immunohistochemical and ultrastructural study of seven paediatric cases. Br J Dermatol 2020;183:729-37. [PMID: 32562567 DOI: 10.1111/bjd.19327] [Cited by in Crossref: 179] [Cited by in F6Publishing: 158] [Article Influence: 89.5] [Reference Citation Analysis]
89 Ranaldi GT, Villani ER, Franza L. Rationale for ozone-therapy as an adjuvant therapy in COVID-19: a narrative review. Med Gas Res 2020;10:134-8. [PMID: 33004712 DOI: 10.4103/2045-9912.289462] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
90 Wienkamp A, Erpenbeck L, Rossaint J. Platelets in the NETworks interweaving inflammation and thrombosis. Front Immunol 2022;13:953129. [DOI: 10.3389/fimmu.2022.953129] [Reference Citation Analysis]
91 Raina R, Vijayvargiya N, Khooblall A, Melachuri M, Deshpande S, Sharma D, Mathur K, Arora M, Sethi SK, Sandhu S. Pediatric Atypical Hemolytic Uremic Syndrome Advances. Cells 2021;10:3580. [PMID: 34944087 DOI: 10.3390/cells10123580] [Reference Citation Analysis]
92 Jafarpour R, Pashangzadeh S, Dowran R. Host factors: Implications in immunopathogenesis of COVID-19. Pathol Res Pract 2021;228:153647. [PMID: 34749207 DOI: 10.1016/j.prp.2021.153647] [Reference Citation Analysis]
93 Niedźwiedzka-Rystwej P, Majchrzak A, Kurkowska S, Małkowska P, Sierawska O, Hrynkiewicz R, Parczewski M. Immune Signature of COVID-19: In-Depth Reasons and Consequences of the Cytokine Storm. Int J Mol Sci 2022;23:4545. [PMID: 35562935 DOI: 10.3390/ijms23094545] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
94 Lage SL, Rocco JM, Laidlaw E, Rupert A, Galindo F, Kellogg A, Kumar P, Poon R, Wortmann GW, Lisco A, Manion M, Sereti I. Activation of Complement Components on Circulating Blood Monocytes From COVID-19 Patients. Front Immunol 2022;13:815833. [DOI: 10.3389/fimmu.2022.815833] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
95 Hashizume H, Sano Y, Furukawa S, Imokawa S. Eosinophilic granulomatosis with polyangiitis mimicking coronavirus disease 2019: a case report. J Eur Acad Dermatol Venereol 2020;34:e557-9. [PMID: 32495957 DOI: 10.1111/jdv.16705] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
96 Ji P, Chen J, Golding A, Nikolov NP, Saluja B, Ren YR, Sahajwalla CG. Immunomodulatory Therapeutic Proteins in COVID-19: Current Clinical Development and Clinical Pharmacology Considerations. J Clin Pharmacol 2020;60:1275-93. [PMID: 32779201 DOI: 10.1002/jcph.1729] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
97 Muhammad M, Ibrahim SA, Yarube IU, Bello B. A REVIEW ON EMERGING PATHOGENESIS OF COVID-19 AND POINTS OF CONCERN FOR RESEARCH COMMUNITIES IN NIGERIA. Afr J Infect Dis 2021;15:36-43. [PMID: 33889801 DOI: 10.21010/ajid.v15i2.7] [Reference Citation Analysis]
98 Shafqat A, Shafqat S, Salameh SA, Kashir J, Alkattan K, Yaqinuddin A. Mechanistic Insights Into the Immune Pathophysiology of COVID-19; An In-Depth Review. Front Immunol 2022;13:835104. [DOI: 10.3389/fimmu.2022.835104] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
99 Hightower S, Ellis H, Collen J, Ellis J, Grasso I, Roswarski J, Cap AP, Chung K, Prescher L, Kavanaugh M, Brown T, Nau M, Clark P. Correlation of indirect markers of hypercoagulability with thromboelastography in severe coronavirus 2019. Thromb Res 2020;195:69-71. [PMID: 32659463 DOI: 10.1016/j.thromres.2020.07.013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
100 Beura SK, Panigrahi AR, Yadav P, Singh SK. Phytochemicals as Potential Therapeutics for SARS-CoV-2-Induced Cardiovascular Complications: Thrombosis and Platelet Perspective. Front Pharmacol 2021;12:658273. [PMID: 33981235 DOI: 10.3389/fphar.2021.658273] [Reference Citation Analysis]
101 Sapir T, Averch Z, Lerman B, Bodzin A, Fishman Y, Maitra R. COVID-19 and the Immune Response: A Multi-Phasic Approach to the Treatment of COVID-19. IJMS 2022;23:8606. [DOI: 10.3390/ijms23158606] [Reference Citation Analysis]
102 Pan D, Ip A, Zhan S, Wasserman I, Snyder DJ, Agathis AZ, Shamapant N, Yang JY, Pai A, Mazumdar M, Poor H. Pre-hospital antiplatelet medication use on COVID-19 disease severity. Heart Lung 2021;50:618-21. [PMID: 34090177 DOI: 10.1016/j.hrtlng.2021.04.010] [Reference Citation Analysis]
103 Kurtovic L, Beeson JG. Complement Factors in COVID-19 Therapeutics and Vaccines. Trends Immunol 2021;42:94-103. [PMID: 33402318 DOI: 10.1016/j.it.2020.12.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
104 Cooper ID, Crofts CAP, DiNicolantonio JJ, Malhotra A, Elliott B, Kyriakidou Y, Brookler KH. Relationships between hyperinsulinaemia, magnesium, vitamin D, thrombosis and COVID-19: rationale for clinical management. Open Heart. 2020;7. [PMID: 32938758 DOI: 10.1136/openhrt-2020-001356] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
105 Richardson E, García-Bernal D, Calabretta E, Jara R, Palomo M, Baron RM, Yanik G, Fareed J, Vlodavsky I, Iacobelli M, Díaz-Ricart M, Richardson PG, Carlo-Stella C, Moraleda JM. Defibrotide: potential for treating endothelial dysfunction related to viral and post-infectious syndromes. Expert Opin Ther Targets 2021;:1-11. [PMID: 34167431 DOI: 10.1080/14728222.2021.1944101] [Reference Citation Analysis]
106 Gavriilaki E, Ho VT, Schwaeble W, Dudler T, Daha M, Fujita T, Jodele S. Role of the lectin pathway of complement in hematopoietic stem cell transplantation-associated endothelial injury and thrombotic microangiopathy. Exp Hematol Oncol 2021;10:57. [PMID: 34924021 DOI: 10.1186/s40164-021-00249-8] [Reference Citation Analysis]
107 Ghazal S, Litvinov IV, Aljahani N, Jfri A, Netchiporouk E. Cutaneous Manifestations of Coronavirus Disease 2019 (COVID-19) Infection-What Do We Know So Far? J Cutan Med Surg 2020;24:416-7. [PMID: 32391713 DOI: 10.1177/1203475420928375] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
108 Kaya G, Kaya A, Saurat JH. Clinical and Histopathological Features and Potential Pathological Mechanisms of Skin Lesions in COVID-19: Review of the Literature. Dermatopathology (Basel). 2020;7:3-16. [PMID: 32608380 DOI: 10.3390/dermatopathology7010002] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 14.0] [Reference Citation Analysis]
109 Mangalmurti NS, Reilly JP, Cines DB, Meyer NJ, Hunter CA, Vaughan AE. COVID-19-associated Acute Respiratory Distress Syndrome Clarified: A Vascular Endotype? Am J Respir Crit Care Med 2020;202:750-3. [PMID: 32631071 DOI: 10.1164/rccm.202006-2598LE] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
110 Huynh T, Sanchez-Flores X, Yau J, Huang JT. Cutaneous Manifestations of SARS-CoV-2 Infection. Am J Clin Dermatol 2022;23:277-86. [PMID: 35247198 DOI: 10.1007/s40257-022-00675-2] [Reference Citation Analysis]
111 Chang JC. COVID-19 Sepsis: Pathogenesis and Endothelial Molecular Mechanisms Based on "Two-Path Unifying Theory" of Hemostasis and Endotheliopathy-Associated Vascular Microthrombotic Disease, and Proposed Therapeutic Approach with Antimicrothrombotic Therapy. Vasc Health Risk Manag 2021;17:273-98. [PMID: 34103921 DOI: 10.2147/VHRM.S299357] [Reference Citation Analysis]
112 Gavriilaki E, Eftychidis I, Papassotiriou I. Update on endothelial dysfunction in COVID-19: severe disease, long COVID-19 and pediatric characteristics. Journal of Laboratory Medicine 2021;45:293-302. [DOI: 10.1515/labmed-2021-0134] [Reference Citation Analysis]
113 Ahamed J, Laurence J. Long COVID endotheliopathy: hypothesized mechanisms and potential therapeutic approaches. J Clin Invest 2022;132:e161167. [PMID: 35912863 DOI: 10.1172/JCI161167] [Reference Citation Analysis]
114 Gkrouzman E, Barbhaiya M, Erkan D, Lockshin MD. Reality Check on Antiphospholipid Antibodies in COVID‐19–Associated Coagulopathy. Arthritis Rheumatol 2021;73:173-4. [DOI: 10.1002/art.41472] [Cited by in Crossref: 17] [Cited by in F6Publishing: 6] [Article Influence: 8.5] [Reference Citation Analysis]
115 Costanzo L, Failla G, Antignani PL, Fareed J, Gu Y, Pitha J, Aluigi L, Karplus T, Mansilha A. The vascular side of COVID-19 disease. Position paper of the International Union of Angiology. Int Angiol 2020;39:445-51. [PMID: 32892615 DOI: 10.23736/S0392-9590.20.04539-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
116 Nitsure M, Sarangi B, Shankar GH, Reddy VS, Walimbe A, Sharma V, Prayag S. Mechanisms of Hypoxia in COVID-19 Patients: A Pathophysiologic Reflection. Indian J Crit Care Med 2020;24:967-70. [PMID: 33281323 DOI: 10.5005/jp-journals-10071-23547] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
117 Paludan SR, Mogensen TH. Innate immunological pathways in COVID-19 pathogenesis. Sci Immunol 2022;7:eabm5505. [PMID: 34995097 DOI: 10.1126/sciimmunol.abm5505] [Cited by in Crossref: 22] [Cited by in F6Publishing: 13] [Article Influence: 22.0] [Reference Citation Analysis]
118 Singh H, Kaur H, Singh K, Sen CK. Cutaneous Manifestations of COVID-19: A Systematic Review. Adv Wound Care (New Rochelle) 2021;10:51-80. [PMID: 33035150 DOI: 10.1089/wound.2020.1309] [Cited by in Crossref: 40] [Cited by in F6Publishing: 27] [Article Influence: 40.0] [Reference Citation Analysis]
119 Hembram P. An outline of SARS-CoV-2 pathogenesis and the complement cascade of immune system. Bull Natl Res Cent 2021;45:123. [PMID: 34257504 DOI: 10.1186/s42269-021-00582-2] [Reference Citation Analysis]
120 Shahbaz FF, Martins RS, Umair A, Ukrani RD, Jabeen K, Sohail MR, Khan E. A Review of Coronaviruses Associated With Kawasaki Disease: Possible Implications for Pathogenesis of the Multisystem Inflammatory Syndrome Associated With COVID-19. Clin Med Insights Pediatr 2022;16:11795565221075319. [PMID: 35197719 DOI: 10.1177/11795565221075319] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
121 Nathan C. Neutrophils and COVID-19: Nots, NETs, and knots. J Exp Med 2020;217:e20201439. [PMID: 32678431 DOI: 10.1084/jem.20201439] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
122 Safavi F, Nath A. Silencing of immune activation with methotrexate in patients with COVID-19. J Neurol Sci 2020;415:116942. [PMID: 32471659 DOI: 10.1016/j.jns.2020.116942] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
123 Martynov MY, Bogolepova AN, Yasamanova AN. [Endothelial dysfunction in COVID- 19 and cognitive impairment]. Zh Nevrol Psikhiatr Im S S Korsakova 2021;121:93-9. [PMID: 34283537 DOI: 10.17116/jnevro202112106193] [Reference Citation Analysis]
124 Bagheripour MH, Zakeri MA. Acute Mesenteric Ischemia in a COVID-19 Patient: Delay in Referral and Recommendation for Surgery. Case Rep Gastrointest Med 2021;2021:1999931. [PMID: 34777882 DOI: 10.1155/2021/1999931] [Reference Citation Analysis]
125 Zhou Z, Zhou X, Cheng L, Wen L, An T, Gao H, Deng H, Yan Q, Zhang X, Li Y, Liao Y, Chen XZ, Nie B, Cheng J, Deng G, Wang S, Li J, Yin H, Zhang M, Cai L, Zheng L, Li M, Jones B, Chen L, Abdollahi A, Zhou M, Zhou PK, Zhou C. Machine learning algorithms utilizing blood parameters enable early detection of immunethrombotic dysregulation in COVID-19. Clin Transl Med 2021;11:e523. [PMID: 34586734 DOI: 10.1002/ctm2.523] [Reference Citation Analysis]
126 Scheim DE. A Deadly Embrace: Hemagglutination Mediated by SARS-CoV-2 Spike Protein at Its 22 N-Glycosylation Sites, Red Blood Cell Surface Sialoglycoproteins, and Antibody. Int J Mol Sci 2022;23:2558. [PMID: 35269703 DOI: 10.3390/ijms23052558] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
127 D'Marco L, Puchades MJ, Romero-Parra M, Gimenez-Civera E, Soler MJ, Ortiz A, Gorriz JL. Coronavirus disease 2019 in chronic kidney disease. Clin Kidney J 2020;13:297-306. [PMID: 32699615 DOI: 10.1093/ckj/sfaa104] [Cited by in Crossref: 8] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
128 Rodrigues PRS, Alrubayyi A, Pring E, Bart VMT, Jones R, Coveney C, Lu F, Tellier M, Maleki-Toyserkani S, Richter FC, Scourfield DO, Gea-Mallorquí E, Davies LC. Innate immunology in COVID-19-a living review. Part II: dysregulated inflammation drives immunopathology. Oxf Open Immunol 2020;1:iqaa005. [PMID: 34192268 DOI: 10.1093/oxfimm/iqaa005] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
129 McGonagle D, Bridgewood C, Ramanan AV, Meaney JFM, Watad A. COVID-19 vasculitis and novel vasculitis mimics. Lancet Rheumatol 2021;3:e224-33. [PMID: 33521655 DOI: 10.1016/S2665-9913(20)30420-3] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 22.0] [Reference Citation Analysis]
130 Bosch-Amate X, Giavedoni P, Podlipnik S, Andreu-Febrer C, Sanz-Beltran J, Garcia-Herrera A, Alós L, Mascaró JM. Retiform purpura as a dermatological sign of coronavirus disease 2019 (COVID-19) coagulopathy. J Eur Acad Dermatol Venereol 2020;34:e548-9. [PMID: 32491234 DOI: 10.1111/jdv.16689] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 13.0] [Reference Citation Analysis]
131 Ramadan SM, Kasfiki EV, Kelly CW, Ali I. An interesting case of small vessel pathology following coronavirus infection. BMJ Case Rep 2020;13:e237407. [PMID: 32900749 DOI: 10.1136/bcr-2020-237407] [Reference Citation Analysis]
132 Menter T, Haslbauer JD, Nienhold R, Savic S, Hopfer H, Deigendesch N, Frank S, Turek D, Willi N, Pargger H, Bassetti S, Leuppi JD, Cathomas G, Tolnay M, Mertz KD, Tzankov A. Postmortem examination of COVID-19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction. Histopathology. 2020;77:198-209. [PMID: 32364264 DOI: 10.1111/his.14134] [Cited by in Crossref: 493] [Cited by in F6Publishing: 466] [Article Influence: 246.5] [Reference Citation Analysis]
133 Goncharov NV, Vasilyev KA, Kudryavtsev IV, Avdonin PP, Belinskaia DA, Stukova MA, Shamova OV, Avdonin PV. Experimental Search for New Means of Pathogenetic Therapy COVID-19: Inhibitor of H2-Receptors Famotidine Increases the Effect of Oseltamivir on Survival and Immune Status of Mice Infected by A/PR/8/34 (H1N1). J Evol Biochem Phys 2022;58:230-46. [DOI: 10.1134/s0022093022010203] [Reference Citation Analysis]
134 Fogarty H, Townsend L, Ni Cheallaigh C, Bergin C, Martin-Loeches I, Browne P, Bacon CL, Gaule R, Gillett A, Byrne M, Ryan K, O'Connell N, O'Sullivan JM, Conlon N, O'Donnell JS. More on COVID-19 coagulopathy in Caucasian patients. Br J Haematol 2020;189:1060-1. [PMID: 32400024 DOI: 10.1111/bjh.16791] [Cited by in Crossref: 40] [Cited by in F6Publishing: 30] [Article Influence: 20.0] [Reference Citation Analysis]
135 Al-hakeim HK, Al-hamami SA, Almulla AF, Maes M. Increased Serum Thromboxane A2 and Prostacyclin but Lower Complement C3 and C4 Levels in COVID-19: Associations with Chest CT Scan Anomalies and Lowered Peripheral Oxygen Saturation. COVID 2021;1:489-502. [DOI: 10.3390/covid1020042] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
136 Malagoli A, Rossi L, Zanni A, Muto F, Tosetti A, Tondi S. Sustained right ventricular dysfunction in severe COVID-19: The role of disseminated intravascular coagulation. Echocardiography 2022. [PMID: 35277886 DOI: 10.1111/echo.15332] [Reference Citation Analysis]
137 Yan B, Freiwald T, Chauss D, Wang L, West E, Bibby J, Olson M, Kordasti S, Portilla D, Laurence A, Lionakis MS, Kemper C, Afzali B, Kazemian M. SARS-CoV2 drives JAK1/2-dependent local and systemic complement hyper-activation. Res Sq 2020:rs. [PMID: 32702726 DOI: 10.21203/rs.3.rs-33390/v1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 5.5] [Reference Citation Analysis]
138 Suzuki K, Okada H, Tomita H, Sumi K, Kakino Y, Yasuda R, Kitagawa Y, Fukuta T, Miyake T, Yoshida S, Suzuki A, Ogura S. Possible involvement of Syndecan-1 in the state of COVID-19 related to endothelial injury. Thromb J 2021;19:5. [PMID: 33504351 DOI: 10.1186/s12959-021-00258-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
139 Mast AE, Wolberg AS, Gailani D, Garvin MR, Alvarez C, Miller JI, Aronow B, Jacobson D. SARS-CoV-2 suppresses anticoagulant and fibrinolytic gene expression in the lung. Elife 2021;10:e64330. [PMID: 33683204 DOI: 10.7554/eLife.64330] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
140 Serrano M, Espinosa G, Serrano A, Cervera R. Antigens and Antibodies of the Antiphospholipid Syndrome as New Allies in the Pathogenesis of COVID-19 Coagulopathy. Int J Mol Sci 2022;23:4946. [PMID: 35563337 DOI: 10.3390/ijms23094946] [Reference Citation Analysis]
141 Mastellos DC, Pires da Silva BGP, Fonseca BAL, Fonseca NP, Auxiliadora-Martins M, Mastaglio S, Ruggeri A, Sironi M, Radermacher P, Chrysanthopoulou A, Skendros P, Ritis K, Manfra I, Iacobelli S, Huber-Lang M, Nilsson B, Yancopoulou D, Connolly ES, Garlanda C, Ciceri F, Risitano AM, Calado RT, Lambris JD. Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy. Clin Immunol 2020;220:108598. [PMID: 32961333 DOI: 10.1016/j.clim.2020.108598] [Cited by in Crossref: 68] [Cited by in F6Publishing: 66] [Article Influence: 34.0] [Reference Citation Analysis]
142 Sessa F, Salerno M, Pomara C. Autopsy Tool in Unknown Diseases: The Experience with Coronaviruses (SARS-CoV, MERS-CoV, SARS-CoV-2). Medicina (Kaunas) 2021;57:309. [PMID: 33806100 DOI: 10.3390/medicina57040309] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
143 Jayarangaiah A, Kariyanna PT, Chen X, Jayarangaiah A, Kumar A. COVID-19-Associated Coagulopathy: An Exacerbated Immunothrombosis Response. Clin Appl Thromb Hemost 2020;26:1076029620943293. [PMID: 32735131 DOI: 10.1177/1076029620943293] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 12.5] [Reference Citation Analysis]
144 Fishman JA, Roberts MB, Zhang EW, Kumar D, Hirsch HH, Maggiore U. Case 29-2020: A 66-Year-Old Man with Fever and Shortness of Breath after Liver Transplantation. N Engl J Med 2020;383:1168-80. [PMID: 32937051 DOI: 10.1056/NEJMcpc2004982] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
145 Knapp AP, Rehmus W, Chang AY. Skin diseases in displaced populations: a review of contributing factors, challenges, and approaches to care. Int J Dermatol 2020;59:1299-311. [PMID: 32686140 DOI: 10.1111/ijd.15063] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
146 Gandhi B, Jebakumar D, Nickell M, Narayanan M. Thrombotic microangiopathy with multiorgan involvement following COVID-19. Baylor University Medical Center Proceedings 2022;35:204-6. [DOI: 10.1080/08998280.2021.1997054] [Reference Citation Analysis]
147 Jaiswal S, Kumar M, Mandeep, Sunita, Singh Y, Shukla P. Systems Biology Approaches for Therapeutics Development Against COVID-19. Front Cell Infect Microbiol 2020;10:560240. [PMID: 33194800 DOI: 10.3389/fcimb.2020.560240] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
148 Calabrese F, Pezzuto F, Fortarezza F, Boscolo A, Lunardi F, Giraudo C, Cattelan A, Del Vecchio C, Lorenzoni G, Vedovelli L, Sella N, Rossato M, Rea F, Vettor R, Plebani M, Cozzi E, Crisanti A, Navalesi P, Gregori D. Machine learning-based analysis of alveolar and vascular injury in SARS-CoV-2 acute respiratory failure. J Pathol 2021;254:173-84. [PMID: 33626204 DOI: 10.1002/path.5653] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
149 Hammoud H, Bendari A, Bendari T, Bougmiza I. Histopathological Findings in COVID-19 Cases: A Systematic Review. Cureus. [DOI: 10.7759/cureus.25573] [Reference Citation Analysis]
150 Bhatia P, Mohammed S. Severe Hypoxemia in Early COVID-19 Pneumonia. Am J Respir Crit Care Med 2020;202:621-2. [PMID: 32579023 DOI: 10.1164/rccm.202004-1313LE] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
151 Nasonov EL. IMMUNOPATHOLOGY AND IMMUNOPHARMACOTHERAPY OF CORONAVIRUS DISEASE 2019 (COVID-19): FOCUS ON INTERLEUKIN 6. Naučno-praktičeskaâ revmatologiâ 2020;58:245-61. [DOI: 10.14412/1995-4484-2020-245-261] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
152 Chauhan AJ, Wiffen LJ, Brown TP. COVID-19: A collision of complement, coagulation and inflammatory pathways. J Thromb Haemost 2020;18:2110-7. [PMID: 32608159 DOI: 10.1111/jth.14981] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 22.0] [Reference Citation Analysis]
153 Chang H, Rockman CB, Jacobowitz GR, Speranza G, Johnson WS, Horowitz JM, Garg K, Maldonado TS, Sadek M, Barfield ME. Deep vein thrombosis in hospitalized patients with coronavirus disease 2019. J Vasc Surg Venous Lymphat Disord 2021;9:597-604. [PMID: 33039545 DOI: 10.1016/j.jvsv.2020.09.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
154 Kisserli A, Schneider N, Audonnet S, Tabary T, Goury A, Cousson J, Mahmoudi R, Bani-Sadr F, Kanagaratnam L, Jolly D, Cohen JH. Acquired decrease of the C3b/C4b receptor (CR1, CD35) and increased C4d deposits on erythrocytes from ICU COVID-19 patients. Immunobiology 2021;226:152093. [PMID: 34022670 DOI: 10.1016/j.imbio.2021.152093] [Reference Citation Analysis]
155 Kichloo A, Dettloff K, Aljadah M, Albosta M, Jamal S, Singh J, Wani F, Kumar A, Vallabhaneni S, Khan MZ. COVID-19 and Hypercoagulability: A Review. Clin Appl Thromb Hemost 2020;26:1076029620962853. [PMID: 33074732 DOI: 10.1177/1076029620962853] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
156 Conforti C, Dianzani C, Agozzino M, Giuffrida R, Marangi GF, Meo ND, Morariu SH, Persichetti P, Segreto F, Zalaudek I, Neagu N. Cutaneous Manifestations in Confirmed COVID-19 Patients: A Systematic Review. Biology (Basel) 2020;9:E449. [PMID: 33291502 DOI: 10.3390/biology9120449] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
157 Shi K, Liu Y, Zhang Q, Ran CP, Hou J, Zhang Y, Wang XB. Severe Type of COVID-19: Pathogenesis, Warning Indicators and Treatment. Chin J Integr Med 2022;28:3-11. [PMID: 34962616 DOI: 10.1007/s11655-021-3313-x] [Reference Citation Analysis]
158 Parra-Medina R, Herrera S, Mejia J. Systematic Review of Microthrombi in COVID-19 Autopsies. Acta Haematol 2021;144:476-83. [PMID: 33873184 DOI: 10.1159/000515104] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
159 Iba T, Warkentin TE, Thachil J, Levi M, Levy JH. Proposal of the Definition for COVID-19-Associated Coagulopathy. J Clin Med 2021;10:E191. [PMID: 33430431 DOI: 10.3390/jcm10020191] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 14.0] [Reference Citation Analysis]
160 Esenwa C, Cheng NT, Lipsitz E, Hsu K, Zampolin R, Gersten A, Antoniello D, Soetanto A, Kirchoff K, Liberman A, Mabie P, Nisar T, Rahimian D, Brook A, Lee SK, Haranhalli N, Altschul D, Labovitz D. COVID-19-Associated Carotid Atherothrombosis and Stroke. AJNR Am J Neuroradiol. 2020;41:1993-1995. [PMID: 32819896 DOI: 10.3174/ajnr.a6752] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 8.5] [Reference Citation Analysis]
161 Del Nonno F, Frustaci A, Verardo R, Chimenti C, Nicastri E, Antinori A, Petrosillo N, Lalle E, Agrati C, Ippolito G; INMI COVID study group. Virus-Negative Myopericarditis in Human Coronavirus Infection: Report From an Autopsy Series. Circ Heart Fail 2020;:CIRCHEARTFAILURE120007636. [PMID: 33176456 DOI: 10.1161/CIRCHEARTFAILURE.120.007636] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
162 Perrillat A, Foletti JM, Lacagne AS, Guyot L, Graillon N. Facial pressure ulcers in COVID-19 patients undergoing prone positioning: How to prevent an underestimated epidemic? J Stomatol Oral Maxillofac Surg 2020;121:442-4. [PMID: 32565264 DOI: 10.1016/j.jormas.2020.06.008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
163 Chen J, Wang W, Tang Y, Huang XR, Yu X, Lan HY. Inflammatory stress in SARS-COV-2 associated Acute Kidney Injury. Int J Biol Sci 2021;17:1497-506. [PMID: 33907513 DOI: 10.7150/ijbs.58791] [Reference Citation Analysis]
164 Huang SU, O'Sullivan KM. The Expanding Role of Extracellular Traps in Inflammation and Autoimmunity: The New Players in Casting Dark Webs. Int J Mol Sci 2022;23:3793. [PMID: 35409152 DOI: 10.3390/ijms23073793] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
165 Yammine H, Ballast JK, Poulsen N, Arko FR 3rd. Endovascular aortic repair in an asymptomatic COVID-19-positive patient with a symptomatic inflammatory abdominal aortic aneurysm. J Vasc Surg Cases Innov Tech 2020;6:531-3. [PMID: 32904956 DOI: 10.1016/j.jvscit.2020.08.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
166 Conway EM, Pryzdial ELG. Is the COVID-19 thrombotic catastrophe complement-connected? J Thromb Haemost 2020;18:2812-22. [PMID: 32762081 DOI: 10.1111/jth.15050] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 11.0] [Reference Citation Analysis]
167 Kösters K, Schwarzer S, Labuhn A, Rübben A, Yang S, Hessler F, Assaf C. Cutaneous Vasculitis in a Patient With COVID-19. Open Forum Infect Dis 2020;7:ofaa474. [PMID: 33134424 DOI: 10.1093/ofid/ofaa474] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
168 Chang SE, Feng A, Meng W, Apostolidis SA, Mack E, Artandi M, Barman L, Bennett K, Chakraborty S, Chang I, Cheung P, Chinthrajah S, Dhingra S, Do E, Finck A, Gaano A, Geßner R, Giannini HM, Gonzalez J, Greib S, Gündisch M, Hsu AR, Kuo A, Manohar M, Mao R, Neeli I, Neubauer A, Oniyide O, Powell AE, Puri R, Renz H, Schapiro J, Weidenbacher PA, Wittman R, Ahuja N, Chung HR, Jagannathan P, James JA, Kim PS, Meyer NJ, Nadeau KC, Radic M, Robinson WH, Singh U, Wang TT, Wherry EJ, Skevaki C, Luning Prak ET, Utz PJ. New-onset IgG autoantibodies in hospitalized patients with COVID-19. Nat Commun 2021;12:5417. [PMID: 34521836 DOI: 10.1038/s41467-021-25509-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
169 Damiani S, Fiorentino M, De Palma A, Foschini MP, Lazzarotto T, Gabrielli L, Viale PL, Attard L, Riefolo M, D'Errico A. Pathological post-mortem findings in lungs infected with SARS-CoV-2. J Pathol 2021;253:31-40. [PMID: 32930394 DOI: 10.1002/path.5549] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 10.5] [Reference Citation Analysis]
170 Ismayl M, Butt DN, Balakrishna AM, Kousa O, Kabach A. COVID-19 presenting with myocardial infarction with nonobstructive coronary arteries. Baylor University Medical Center Proceedings. [DOI: 10.1080/08998280.2022.2057158] [Reference Citation Analysis]
171 Thakkar S, Arora S, Kumar A, Jaswaney R, Faisaluddin M, Ammad Ud Din M, Shariff M, Barssoum K, Patel HP, Nirav A, Jani C, Patel K, Savani S, DeSimone C, Mulpuru S, Deshmukh A. A Systematic Review of the Cardiovascular Manifestations and Outcomes in the Setting of Coronavirus-19 Disease. Clin Med Insights Cardiol 2020;14:1179546820977196. [PMID: 33312009 DOI: 10.1177/1179546820977196] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
172 Lipton M, Kavanagh CR, Mahajan R, Jain NG, Uy NS, Dogra S, Lin F. Role of pediatric nephrologists in managing adults with AKI due to COVID-19. Pediatr Nephrol 2020;35:2019-22. [PMID: 32588224 DOI: 10.1007/s00467-020-04680-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
173 Klein F, Soriano JC, Anfuso MB, Ruiz V, Perazzo M, Paladini H, Vigliano A, Ossés J, Lowenstein P, Vigliano C, Cáneva J. Transbronchial biopsies' histopathological findings leading to successful late steroid therapy in Covid-19 acute respiratory failure. Virchows Arch 2021. [PMID: 33411031 DOI: 10.1007/s00428-020-02975-6] [Reference Citation Analysis]
174 Ladha MA, Luca N, Constantinescu C, Naert K, Ramien ML. Approach to Chilblains During the COVID-19 Pandemic [Formula: see text]. J Cutan Med Surg 2020;24:504-17. [PMID: 32741218 DOI: 10.1177/1203475420937978] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
175 Che Mohd Nassir CMN, Zolkefley MKI, Ramli MD, Norman HH, Abdul Hamid H, Mustapha M. Neuroinflammation and COVID-19 Ischemic Stroke Recovery—Evolving Evidence for the Mediating Roles of the ACE2/Angiotensin-(1–7)/Mas Receptor Axis and NLRP3 Inflammasome. IJMS 2022;23:3085. [DOI: 10.3390/ijms23063085] [Reference Citation Analysis]
176 Hadique S, Badami V, Sangani R, Forte M, Alexander T, Goswami A, Garrison A, Wen S. Coagulation Studies Are Not Predictive of Hematological Complications of COVID-19 Infection. TH Open 2022;06:e1-9. [DOI: 10.1055/s-0041-1742225] [Reference Citation Analysis]
177 Olsen TG, Shrit MA, Feeser TA, Wargo JJ. COVID Purpura (Toes) Case Series: A Chilblains-Like Vasculopathy. Am J Dermatopathol 2021;43:e47-50. [PMID: 33156022 DOI: 10.1097/DAD.0000000000001829] [Reference Citation Analysis]
178 Semeraro N, Colucci M. The Prothrombotic State Associated with SARS-CoV-2 Infection: Pathophysiological Aspects. Mediterr J Hematol Infect Dis 2021;13:e2021045. [PMID: 34276914 DOI: 10.4084/MJHID.2021.045] [Reference Citation Analysis]
179 Pfister F, Vonbrunn E, Ries T, Jäck HM, Überla K, Lochnit G, Sheriff A, Herrmann M, Büttner-Herold M, Amann K, Daniel C. Complement Activation in Kidneys of Patients With COVID-19. Front Immunol 2020;11:594849. [PMID: 33584662 DOI: 10.3389/fimmu.2020.594849] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
180 Park JF, Banerjee S, Umar S. In the eye of the storm: the right ventricle in COVID-19. Pulm Circ 2020;10:2045894020936660. [PMID: 32655856 DOI: 10.1177/2045894020936660] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
181 De Vito A, Geremia N, Mameli SM, Fiore V, Serra PA, Rocchitta G, Nuvoli S, Spanu A, Lobrano R, Cossu A, Babudieri S, Madeddu G. Epidemiology, Clinical Aspects, Laboratory Diagnosis and Treatment of Rickettsial Diseases in the Mediterranean Area During COVID-19 Pandemic: A Review of the Literature. Mediterr J Hematol Infect Dis 2020;12:e2020056. [PMID: 32952967 DOI: 10.4084/MJHID.2020.056] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
182 Ko CJ, Harigopal M, Damsky W, Gehlhausen JR, Bosenberg M, Patrignelli R, McNiff JM. Perniosis during the COVID-19 pandemic: Negative anti-SARS-CoV-2 immunohistochemistry in six patients and comparison to perniosis before the emergence of SARS-CoV-2. J Cutan Pathol 2020;47:997-1002. [PMID: 32745281 DOI: 10.1111/cup.13830] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
183 Durhan G, Ardalı Düzgün S, Başaran Demirkazık F, Irmak İ, İdilman İ, Gülsün Akpınar M, Akpınar E, Öcal S, Telli G, Topeli A, Arıyürek OM. Visual and software-based quantitative chest CT assessment of COVID-19: correlation with clinical findings. Diagn Interv Radiol 2020;26:557-64. [PMID: 32876569 DOI: 10.5152/dir.2020.20407] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
184 Ashraf M, Sajed S. Acute Stroke in a Young Patient With Coronavirus Disease 2019 in the Presence of Patent Foramen Ovale. Cureus 2020;12:e10233. [PMID: 33042674 DOI: 10.7759/cureus.10233] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
185 Low SW, Swanson KL, McCain JD, Sen A, Kawashima A, Pasha SF. Gastric ischemia and portal vein thrombosis in a COVID-19-infected patient. Endoscopy. 2020;52:E465-E466. [PMID: 32877937 DOI: 10.1055/a-1230-3357] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
186 Bonny V, Maillard A, Mousseaux C, Plaçais L, Richier Q. [COVID-19: Pathogenesis of a multi-faceted disease]. Rev Med Interne 2020;41:375-89. [PMID: 32507520 DOI: 10.1016/j.revmed.2020.05.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
187 Najjar S, Najjar A, Chong DJ, Pramanik BK, Kirsch C, Kuzniecky RI, Pacia SV, Azhar S. Central nervous system complications associated with SARS-CoV-2 infection: integrative concepts of pathophysiology and case reports. J Neuroinflammation 2020;17:231. [PMID: 32758257 DOI: 10.1186/s12974-020-01896-0] [Cited by in Crossref: 60] [Cited by in F6Publishing: 58] [Article Influence: 30.0] [Reference Citation Analysis]
188 Hanff TC, Mohareb AM, Giri J, Cohen JB, Chirinos JA. Thrombosis in COVID-19. Am J Hematol 2020;95:1578-89. [PMID: 32857878 DOI: 10.1002/ajh.25982] [Cited by in Crossref: 99] [Cited by in F6Publishing: 70] [Article Influence: 49.5] [Reference Citation Analysis]
189 Xu Y, Liu S, Zhang Y, Zhi Y. Does hereditary angioedema make COVID-19 worse? World Allergy Organ J 2020;13:100454. [PMID: 32834893 DOI: 10.1016/j.waojou.2020.100454] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
190 Ribeiro Dos Santos Miggiolaro AF, da Silva Motta Junior J, Busatta Vaz de Paula C, Nagashima S, Alessandra Scaranello Malaquias M, Baena Carstens L, N Moreno-Amaral A, Pellegrino Baena C, de Noronha L. Covid-19 cytokine storm in pulmonary tissue: Anatomopathological and immunohistochemical findings. Respir Med Case Rep 2020;31:101292. [PMID: 33200067 DOI: 10.1016/j.rmcr.2020.101292] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
191 Conway R, Konig MF, Graef ER, Webb K, Yazdany J, Kim AHJ. Inflammatory arthritis in patients with COVID-19. Transl Res 2021;232:49-59. [PMID: 33626415 DOI: 10.1016/j.trsl.2021.02.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
192 Atzori L, Ferreli C, Mateeva V, Vassileva S, Rongioletti F. Clinicopathologic features between different viral epidemic outbreaks involving the skin. Clin Dermatol 2021;39:405-17. [PMID: 34517998 DOI: 10.1016/j.clindermatol.2021.04.002] [Reference Citation Analysis]
193 Fang S, Wang H, Lu L, Jia Y, Xia Z. Decreased complement C3 levels are associated with poor prognosis in patients with COVID-19: A retrospective cohort study. Int Immunopharmacol 2020;89:107070. [PMID: 33039965 DOI: 10.1016/j.intimp.2020.107070] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
194 Pourafkari L, Mirza-Aghzadeh-Attari M, Zarrintan A, Mousavi-Aghdas SA. Clinical Experience, Pathophysiology, and Considerations in the Prophylaxis and Treatment of Hypercoagulopathy of COVID-19: A Review Study. Iran J Med Sci 2021;46:1-14. [PMID: 33487787 DOI: 10.30476/ijms.2020.87233.1730] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
195 Bora VR, Patel BM. The Deadly Duo of COVID-19 and Cancer! Front Mol Biosci 2021;8:643004. [PMID: 33912588 DOI: 10.3389/fmolb.2021.643004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
196 Genthon A, Chiarabini T, Baylac P, Valin N, Urbina T, Pacanowski J, Mekinian A, Brissot E, M 'Hammedi-Bouzina F, Lapusan S, Mohty M, Lacombe K, Ingiliz P. Severe COVID-19 infection in a patient with paroxysmal nocturnal hemoglobinuria on eculizumab therapy. Leuk Lymphoma 2021;62:1502-5. [PMID: 33416421 DOI: 10.1080/10428194.2020.1869963] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
197 Signorini C, Pignatti P, Coccini T. How Do Inflammatory Mediators, Immune Response and Air Pollution Contribute to COVID-19 Disease Severity? A Lesson to Learn. Life (Basel) 2021;11:182. [PMID: 33669011 DOI: 10.3390/life11030182] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
198 Biswas S, Thakur V, Kaur P, Khan A, Kulshrestha S, Kumar P. Blood clots in COVID-19 patients: Simplifying the curious mystery. Med Hypotheses 2021;146:110371. [PMID: 33223324 DOI: 10.1016/j.mehy.2020.110371] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
199 Konstantinides SV. Thrombosis and Thromboembolism Related to COVID-19: Increase the Level of Awareness, Lower the Threshold of Suspicion, and Keep Following the Guidelines. JACC Case Rep 2020;2:1388-90. [PMID: 32840252 DOI: 10.1016/j.jaccas.2020.05.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
200 Benger M, Williams O, Siddiqui J, Sztriha L. Intracerebral haemorrhage and COVID-19: Clinical characteristics from a case series. Brain Behav Immun 2020;88:940-4. [PMID: 32525049 DOI: 10.1016/j.bbi.2020.06.005] [Cited by in Crossref: 55] [Cited by in F6Publishing: 42] [Article Influence: 27.5] [Reference Citation Analysis]
201 Gönenli MG, Komesli Z, İncir S, Yalçın Ö, Akay OM. Rotational Thromboelastometry Reveals Distinct Coagulation Profiles for Patients With COVID-19 Depending on Disease Severity. Clin Appl Thromb Hemost 2021;27:10760296211027653. [PMID: 34184563 DOI: 10.1177/10760296211027653] [Reference Citation Analysis]
202 Mansourzadeh MJ, Shamsi A. Concerns About Research Ethics in COVID-19 Publications. Asia Pac J Public Health 2020;32:503-4. [PMID: 32864989 DOI: 10.1177/1010539520956439] [Reference Citation Analysis]
203 Elbeddini A, Gerochi R, Elshahawi A. Evaluation of the prophylaxis and treatment of COVID-associated coagulopathy. J Pharm Policy Pract 2020;13:73. [PMID: 33117545 DOI: 10.1186/s40545-020-00274-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
204 Mehta OP, Bhandari P, Raut A, Kacimi SEO, Huy NT. Coronavirus Disease (COVID-19): Comprehensive Review of Clinical Presentation. Front Public Health 2020;8:582932. [PMID: 33520910 DOI: 10.3389/fpubh.2020.582932] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 12.0] [Reference Citation Analysis]
205 Maxwell AJ, Ding J, You Y, Dong Z, Chehade H, Alvero A, Mor Y, Draghici S, Mor G. Identification of key signaling pathways induced by SARS-CoV2 that underlie thrombosis and vascular injury in COVID-19 patients. J Leukoc Biol 2021;109:35-47. [PMID: 33242368 DOI: 10.1002/JLB.4COVR0920-552RR] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
206 Sashindranath M, Nandurkar HH. Endothelial Dysfunction in the Brain: Setting the Stage for Stroke and Other Cerebrovascular Complications of COVID-19. Stroke 2021;52:1895-904. [PMID: 33794655 DOI: 10.1161/STROKEAHA.120.032711] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
207 Bach I, Surathi P, Montealegre N, Abu-Hadid O, Rubenstein S, Redko S, Gupta S, Hillen M, Patel P, Khandelwal P, Kamel A. Stroke in COVID-19: a single-centre initial experience in a hotspot of the pandemic. Stroke Vasc Neurol 2020;5:331-6. [PMID: 32973116 DOI: 10.1136/svn-2020-000525] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
208 Daneshgaran G, Dubin DP, Gould DJ. Cutaneous Manifestations of COVID-19: An Evidence-Based Review. Am J Clin Dermatol 2020;21:627-39. [PMID: 32865778 DOI: 10.1007/s40257-020-00558-4] [Cited by in Crossref: 75] [Cited by in F6Publishing: 50] [Article Influence: 37.5] [Reference Citation Analysis]
209 Santoro L, Falsetti L, Zaccone V, Nesci A, Tosato M, Giupponi B, Savastano MC, Moroncini G, Gasbarrini A, Landi F, Santoliquido A, On Behalf Of Gemelli Against Covid-Post-Acute Care Study Group. Impaired Endothelial Function in Convalescent Phase of COVID-19: A 3 Month Follow Up Observational Prospective Study. J Clin Med 2022;11:1774. [PMID: 35407382 DOI: 10.3390/jcm11071774] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
210 Martínez-Salazar B, Holwerda M, Stüdle C, Piragyte I, Mercader N, Engelhardt B, Rieben R, Döring Y. COVID-19 and the Vasculature: Current Aspects and Long-Term Consequences. Front Cell Dev Biol 2022;10:824851. [PMID: 35242762 DOI: 10.3389/fcell.2022.824851] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
211 Mazzaccaro D, Giacomazzi F, Giannetta M, Varriale A, Scaramuzzo R, Modafferi A, Malacrida G, Righini P, Marrocco-Trischitta MM, Nano G. Non-Overt Coagulopathy in Non-ICU Patients with Mild to Moderate COVID-19 Pneumonia. J Clin Med 2020;9:E1781. [PMID: 32521707 DOI: 10.3390/jcm9061781] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
212 Pomara C, Li Volti G, Cappello F. The Post-Lockdown Era: What Is Next in Italy? Front Pharmacol 2020;11:1074. [PMID: 32760280 DOI: 10.3389/fphar.2020.01074] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
213 Lhuaire M, Garrido I, Cladière-Nassif V, Dumaine V, Lantieri L. Reconstructive Microsurgery Emergency in a Patient with COVID-19. Plast Reconstr Surg 2020;146:523e-5e. [PMID: 32639424 DOI: 10.1097/PRS.0000000000007266] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
214 Elmas ÖF, Demirbaş A, Özyurt K, Atasoy M, Türsen Ü. Cutaneous manifestations of COVID-19: A review of the published literature. Dermatol Ther 2020;33:e13696. [PMID: 32458546 DOI: 10.1111/dth.13696] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
215 Utebay D, Seeger H, Müller AMS, David S. Complement inhibition for the treatment of COVID-19 triggered thrombotic microangiopathy with cardiac failure: a case report. Eur Heart J Case Rep 2021;5:ytab386. [PMID: 34661055 DOI: 10.1093/ehjcr/ytab386] [Reference Citation Analysis]
216 Takano AM. Pulmonary pathology of infection by SARS-CoV-2, what we have learnt through post-mortem studies and pathophysiological considerations. Proceedings of Singapore Healthcare 2021;30:152-8. [DOI: 10.1177/2010105820960495] [Reference Citation Analysis]
217 Barrantes FJ. The constellation of cholesterol-dependent processes associated with SARS-CoV-2 infection. Progress in Lipid Research 2022. [DOI: 10.1016/j.plipres.2022.101166] [Reference Citation Analysis]
218 Langer F, Kluge S, Klamroth R, Oldenburg J. Coagulopathy in COVID-19 and Its Implication for Safe and Efficacious Thromboprophylaxis. Hamostaseologie 2020;40:264-9. [PMID: 32498097 DOI: 10.1055/a-1178-3551] [Cited by in Crossref: 39] [Cited by in F6Publishing: 27] [Article Influence: 19.5] [Reference Citation Analysis]
219 Patrick MT, Zhang H, Wasikowski R, Prens EP, Weidinger S, Gudjonsson JE, Elder JT, He K, Tsoi LC. Associations between COVID-19 and skin conditions identified through epidemiology and genomic studies. J Allergy Clin Immunol 2021;147:857-869.e7. [PMID: 33485957 DOI: 10.1016/j.jaci.2021.01.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
220 Ascierto PA, Fu B, Wei H. IL-6 modulation for COVID-19: the right patients at the right time? J Immunother Cancer 2021;9:e002285. [PMID: 33837054 DOI: 10.1136/jitc-2020-002285] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
221 Nilsson B, Persson B, Eriksson O, Fromell K, Hultström M, Frithiof R, Lipcsey M, Huber-Lang M, Ekdahl KN. How the Innate Immune System of the Blood Contributes to Systemic Pathology in COVID-19-Induced ARDS and Provides Potential Targets for Treatment. Front Immunol 2022;13:840137. [PMID: 35350780 DOI: 10.3389/fimmu.2022.840137] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
222 Mackman N, Antoniak S, Wolberg AS, Kasthuri R, Key NS. Coagulation Abnormalities and Thrombosis in Patients Infected With SARS-CoV-2 and Other Pandemic Viruses. Arterioscler Thromb Vasc Biol 2020;40:2033-44. [PMID: 32657623 DOI: 10.1161/ATVBAHA.120.314514] [Cited by in Crossref: 47] [Cited by in F6Publishing: 34] [Article Influence: 23.5] [Reference Citation Analysis]
223 Mazzitelli I, Bleichmar L, Ludueña MG, Pisarevsky A, Labato M, Chiaradia V, Finocchieto P, Paulin F, Hormanstorfer M, Baretto MC, Adanza SP, Parodi MN, Ragusa M, Melucci C, Díaz FE, Paletta A, Di Diego F, Ceballos A, Geffner J. Immunoglobulin G Immune Complexes May Contribute to Neutrophil Activation in the Course of Severe Coronavirus Disease 2019. J Infect Dis 2021;224:575-85. [PMID: 34398243 DOI: 10.1093/infdis/jiab174] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
224 Otifi HM, Adiga BK. Endothelial Dysfunction in Covid-19. The American Journal of the Medical Sciences 2022. [DOI: 10.1016/j.amjms.2021.12.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
225 Andina D, Colmenero I, Santonja C, Muñoz de León I, Noguera-Morel L, Hernández-Martín A, Torrelo A. Suspected COVID-19-related reticulated purpura of the soles in an infant. Pediatr Dermatol 2021;38:301-3. [PMID: 33085141 DOI: 10.1111/pde.14409] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
226 Yan B, Freiwald T, Chauss D, Wang L, West E, Mirabelli C, Zhang CJ, Nichols EM, Malik N, Gregory R, Bantscheff M, Ghidelli-Disse S, Kolev M, Frum T, Spence JR, Sexton JZ, Alysandratos KD, Kotton DN, Pittaluga S, Bibby J, Niyonzima N, Olson MR, Kordasti S, Portilla D, Wobus CE, Laurence A, Lionakis MS, Kemper C, Afzali B, Kazemian M. SARS-CoV-2 drives JAK1/2-dependent local complement hyperactivation. Sci Immunol 2021;6:eabg0833. [PMID: 33827897 DOI: 10.1126/sciimmunol.abg0833] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 15.0] [Reference Citation Analysis]
227 Deep A. Effect of adult COVID-19 surge on the provision of kidney replacement therapy in children. Pediatr Nephrol 2020;35:2023-30. [PMID: 32757061 DOI: 10.1007/s00467-020-04723-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
228 Doevelaar AAN, Bachmann M, Hölzer B, Seibert FS, Rohn BJ, Bauer F, Witzke O, Dittmer U, Bachmann M, Yilmaz S, Dittmer R, Schneppenheim S, Babel N, Budde U, Westhoff TH. von Willebrand Factor Multimer Formation Contributes to Immunothrombosis in Coronavirus Disease 2019. Crit Care Med 2021;49:e512-20. [PMID: 33591004 DOI: 10.1097/CCM.0000000000004918] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 12.0] [Reference Citation Analysis]
229 Beketova TV, Blank LM, Lila AM. Covid-19 in a patient with ANCA-associated systemic vasculitis, receiving anti-B cell therapy (rituximab). Naučno-praktičeskaâ revmatologiâ 2020;58:456-62. [DOI: 10.47360/1995-4484-2020-456-462] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
230 Bouck EG, Denorme F, Holle LA, Middelton EA, Blair AM, de Laat B, Schiffman JD, Yost CC, Rondina MT, Wolberg AS, Campbell RA. COVID-19 and Sepsis Are Associated With Different Abnormalities in Plasma Procoagulant and Fibrinolytic Activity. Arterioscler Thromb Vasc Biol 2021;41:401-14. [PMID: 33196292 DOI: 10.1161/ATVBAHA.120.315338] [Cited by in Crossref: 7] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
231 Gencer S, Lacy M, Atzler D, van der Vorst EPC, Döring Y, Weber C. Immunoinflammatory, Thrombohaemostatic, and Cardiovascular Mechanisms in COVID-19. Thromb Haemost 2020;120:1629-41. [PMID: 33124029 DOI: 10.1055/s-0040-1718735] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 9.0] [Reference Citation Analysis]
232 Ferreira AO, Polonini HC, Dijkers ECF. Postulated Adjuvant Therapeutic Strategies for COVID-19. J Pers Med 2020;10:E80. [PMID: 32764275 DOI: 10.3390/jpm10030080] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 6.5] [Reference Citation Analysis]
233 Brosnahan SB, Jonkman AH, Kugler MC, Munger JS, Kaufman DA. COVID-19 and Respiratory System Disorders: Current Knowledge, Future Clinical and Translational Research Questions. Arterioscler Thromb Vasc Biol 2020;40:2586-97. [PMID: 32960072 DOI: 10.1161/ATVBAHA.120.314515] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
234 McClain MT, Constantine FJ, Henao R, Liu Y, Tsalik EL, Burke TW, Steinbrink JM, Petzold E, Nicholson BP, Rolfe R, Kraft BD, Kelly MS, Sempowski GD, Denny TN, Ginsburg GS, Woods CW. Dysregulated transcriptional responses to SARS-CoV-2 in the periphery support novel diagnostic approaches. medRxiv 2020:2020. [PMID: 32743603 DOI: 10.1101/2020.07.20.20155507] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
235 García-Ortega A, Oscullo G, Calvillo P, López-Reyes R, Méndez R, Gómez-Olivas JD, Bekki A, Fonfría C, Trilles-Olaso L, Zaldívar E, Ferrando A, Anguera G, Briones-Gómez A, Reig-Mezquida JP, Feced L, González-Jiménez P, Reyes S, Muñoz-Núñez CF, Carreres A, Gil R, Morata C, Toledo-Pons N, Martí-Bonmati L, Menéndez R, Martínez-García MÁ. Incidence, risk factors, and thrombotic load of pulmonary embolism in patients hospitalized for COVID-19 infection. J Infect 2021;82:261-9. [PMID: 33440207 DOI: 10.1016/j.jinf.2021.01.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
236 Carvelli J, Le Saux A, Bourenne J, Gainnier M, Kaplanski G. Evolution Toward Severe Covid-19 From Biological Monitoring to Therapeutic Considerations. Front Immunol 2020;11:562038. [PMID: 33384683 DOI: 10.3389/fimmu.2020.562038] [Reference Citation Analysis]
237 Costanzo L, Palumbo FP, Ardita G, Antignani PL, Arosio E, Failla G; Italian Society for Vascular Investigation and the Italian Society of Vascular Medicine. Coagulopathy, thromboembolic complications, and the use of heparin in COVID-19 pneumonia. J Vasc Surg Venous Lymphat Disord 2020;8:711-6. [PMID: 32561465 DOI: 10.1016/j.jvsv.2020.05.018] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 9.5] [Reference Citation Analysis]
238 Souchelnytskyi S, Nera A, Souchelnytskyi N. COVID-19 engages clinical markers for the management of cancer and cancer-relevant regulators of cell proliferation, death, migration, and immune response. Sci Rep 2021;11:5228. [PMID: 33664395 DOI: 10.1038/s41598-021-84780-y] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
239 Roca-Ginés J, Torres-Navarro I, Sánchez-Arráez J, Abril-Pérez C, Sabalza-Baztán O, Pardo-Granell S, Martínez I Cózar V, Botella-Estrada R, Évole-Buselli M. Assessment of Acute Acral Lesions in a Case Series of Children and Adolescents During the COVID-19 Pandemic. JAMA Dermatol 2020;156:992-7. [PMID: 32584397 DOI: 10.1001/jamadermatol.2020.2340] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 16.5] [Reference Citation Analysis]
240 Medzikovic L, Cunningham CM, Li M, Amjedi M, Hong J, Ruffenach G, Eghbali M. Sex differences underlying preexisting cardiovascular disease and cardiovascular injury in COVID-19. J Mol Cell Cardiol 2020;148:25-33. [PMID: 32835666 DOI: 10.1016/j.yjmcc.2020.08.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
241 [DOI: 10.1101/2020.08.23.20177824] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
242 Galyfos G, Sianou A, Frountzas M, Vasilios K, Vouros D, Theodoropoulos C, Michalopoulou V, Sigala F, Filis K. Acute limb ischemia among patients with COVID-19 infection. J Vasc Surg 2021:S0741-5214(21)01792-4. [PMID: 34390791 DOI: 10.1016/j.jvs.2021.07.222] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
243 Yilmaz MM, Szabolcs MJ, Geskin LJ, Niedt GW. An Autopsy Review: "COVID Toes". Am J Dermatopathol 2021;43:554-5. [PMID: 33055537 DOI: 10.1097/DAD.0000000000001827] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
244 Zha D, Fu M, Qian Y. Vascular Endothelial Glycocalyx Damage and Potential Targeted Therapy in COVID-19. Cells 2022;11:1972. [PMID: 35741101 DOI: 10.3390/cells11121972] [Reference Citation Analysis]
245 Prendecki M, Clarke C, Medjeral-Thomas N, McAdoo SP, Sandhu E, Peters JE, Thomas DC, Willicombe M, Botto M, Pickering MC. Temporal changes in complement activation in haemodialysis patients with COVID-19 as a predictor of disease progression. Clin Kidney J 2020;13:889-96. [PMID: 33123364 DOI: 10.1093/ckj/sfaa192] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
246 Kim DM, Kim Y, Seo JW, Lee J, Park U, Ha NY, Koh J, Park H, Lee JW, Ro HJ, Yun NR, Kim DY, Yoon SH, Na YS, Moon DS, Lim SC, Kim CM, Jeon K, Kang JG, Jang NY, Jeong H, Kim J, Cheon S, Sohn KM, Moon JY, Kym S, Han SR, Lee MS, Kim HJ, Park WY, Choi JY, Shin HW, Kim HY, Cho CH, Jeon YK, Kim YS, Cho NH. Enhanced eosinophil-mediated inflammation associated with antibody and complement-dependent pneumonic insults in critical COVID-19. Cell Rep 2021;37:109798. [PMID: 34587481 DOI: 10.1016/j.celrep.2021.109798] [Reference Citation Analysis]
247 Ho D, Low R, Tong L, Gupta V, Veeraraghavan A, Agrawal R. COVID-19 and the Ocular Surface: A Review of Transmission and Manifestations. Ocul Immunol Inflamm 2020;28:726-34. [PMID: 32543262 DOI: 10.1080/09273948.2020.1772313] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 14.5] [Reference Citation Analysis]
248 Quinaglia T, Shabani M, Breder I, Silber HA, Lima JAC, Sposito AC. Coronavirus disease-19: The multi-level, multi-faceted vasculopathy. Atherosclerosis 2021;322:39-50. [PMID: 33706082 DOI: 10.1016/j.atherosclerosis.2021.02.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
249 Alam W. Hypercoagulability in COVID-19: A review of the potential mechanisms underlying clotting disorders. SAGE Open Med 2021;9:20503121211002996. [PMID: 33815798 DOI: 10.1177/20503121211002996] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
250 Wang X, Chen X, Tang F, Luo W, Fang J, Qi C, Sun H, Xiao H, Peng X, Shao J. Be aware of acute kidney injury in critically ill children with COVID-19. Pediatr Nephrol 2021;36:163-9. [PMID: 32844290 DOI: 10.1007/s00467-020-04715-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
251 Luo WR, Yu H, Gou JZ, Li XX, Sun Y, Li JX, He JX, Liu L. Histopathologic Findings in the Explant Lungs of a Patient With COVID-19 Treated With Bilateral Orthotopic Lung Transplant. Transplantation 2020;104:e329-31. [PMID: 33122591 DOI: 10.1097/TP.0000000000003412] [Cited by in Crossref: 31] [Cited by in F6Publishing: 12] [Article Influence: 15.5] [Reference Citation Analysis]
252 Moraes ECDS, Martins-gonçalves R, Silva LRD, Mandacaru SC, Melo RM, Azevedo-quintanilha I, Perales J, Bozza FA, Souza TML, Castro-faria-neto HC, Hottz ED, Bozza PT, Trugilho MRO. Proteomic Profile of Procoagulant Extracellular Vesicles Reflects Complement System Activation and Platelet Hyperreactivity of Patients with Severe COVID-19. Front Cell Infect Microbiol 2022;12:926352. [DOI: 10.3389/fcimb.2022.926352] [Reference Citation Analysis]
253 Pezzarossa E, Ungari M, Caresana G, Sagradi F, Cimardi L, Pan A, Testa S, Aguggini S, Varotti E, Tanzi G, Manotti L, Ferrero G, Gusolfino MD, Trombatore M; CreSCO Study Group. Acute Generalized Exanthematous Pustulosis (AGEP) in 12 Patients Treated for SARS-CoV-2 Positive Pneumonia. Am J Dermatopathol 2021;43:342-8. [PMID: 33405402 DOI: 10.1097/DAD.0000000000001819] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
254 Dawudi Y, Federici L, Debus J, Zucman N. Cold agglutinin disease secondary to severe SARS-CoV-2 treated with eculizumab. BMJ Case Rep 2022;15:e242937. [PMID: 35487646 DOI: 10.1136/bcr-2021-242937] [Reference Citation Analysis]
255 Sekhawat V, Green A, Mahadeva U. COVID-19 autopsies: conclusions from international studies. Diagn Histopathol (Oxf). 2021;27:103-107. [PMID: 33312230 DOI: 10.1016/j.mpdhp.2020.11.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
256 Dürvanger Z, Boros E, Nagy ZA, Hegedüs R, Megyeri M, Dobó J, Gál P, Schlosser G, Ángyán AF, Gáspári Z, Perczel A, Harmat V, Mező G, Menyhárd DK, Pál G. Directed Evolution-Driven Increase of Structural Plasticity Is a Prerequisite for Binding the Complement Lectin Pathway Blocking MASP-Inhibitor Peptides. ACS Chem Biol 2022;17:969-86. [PMID: 35378038 DOI: 10.1021/acschembio.2c00114] [Reference Citation Analysis]
257 Steadman E, Fandaros M, Yin W. SARS-CoV-2 and Plasma Hypercoagulability. Cell Mol Bioeng 2021;:1-10. [PMID: 34221178 DOI: 10.1007/s12195-021-00685-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
258 Mina A, van Besien K, Platanias LC. Hematological manifestations of COVID-19. Leuk Lymphoma 2020;61:2790-8. [PMID: 32643489 DOI: 10.1080/10428194.2020.1788017] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
259 Malaquias MAS, Gadotti AC, Motta-Junior JDS, Martins APC, Azevedo MLV, Benevides APK, Cézar-Neto P, Panini do Carmo LA, Zeni RC, Raboni SM, Fonseca AS, Machado-Souza C, Moreno-Amaral AN, de Noronha L. The role of the lectin pathway of the complement system in SARS-CoV-2 lung injury. Transl Res 2021;231:55-63. [PMID: 33221483 DOI: 10.1016/j.trsl.2020.11.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
260 Cecon E, Fernandois D, Renault N, Coelho CFF, Wenzel J, Bedart C, Izabelle C, Gallet S, Le Poder S, Klonjkowski B, Schwaninger M, Prevot V, Dam J, Jockers R. Melatonin drugs inhibit SARS-CoV-2 entry into the brain and virus-induced damage of cerebral small vessels. Cell Mol Life Sci 2022;79:361. [PMID: 35697820 DOI: 10.1007/s00018-022-04390-3] [Reference Citation Analysis]
261 Barker AB, Wagener BM. An Ounce of Prevention May Prevent Hospitalization. Physiol Rev 2020;100:1347-8. [PMID: 32412329 DOI: 10.1152/physrev.00017.2020] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
262 Oshay RR, Chen MYC, Fields BKK, Demirjian NL, Lee RS, Mosallaei D, Gholamrezanezhad A. COVID-19 in pregnancy: a systematic review of chest CT findings and associated clinical features in 427 patients. Clin Imaging 2021;75:75-82. [PMID: 33508754 DOI: 10.1016/j.clinimag.2021.01.004] [Reference Citation Analysis]
263 Berretta AA, Silveira MAD, Cóndor Capcha JM, De Jong D. Propolis and its potential against SARS-CoV-2 infection mechanisms and COVID-19 disease: Running title: Propolis against SARS-CoV-2 infection and COVID-19. Biomed Pharmacother 2020;131:110622. [PMID: 32890967 DOI: 10.1016/j.biopha.2020.110622] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 20.5] [Reference Citation Analysis]
264 Chen W, Pan JY. Anatomical and Pathological Observation and Analysis of SARS and COVID-19: Microthrombosis Is the Main Cause of Death. Biol Proced Online 2021;23:4. [PMID: 33472576 DOI: 10.1186/s12575-021-00142-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 13.0] [Reference Citation Analysis]
265 Kwaan HC, Lindholm PF. The Central Role of Fibrinolytic Response in COVID-19-A Hematologist's Perspective. Int J Mol Sci 2021;22:1283. [PMID: 33525440 DOI: 10.3390/ijms22031283] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
266 Ostrycharz E, Hukowska-szematowicz B. New Insights into the Role of the Complement System in Human Viral Diseases. Biomolecules 2022;12:226. [DOI: 10.3390/biom12020226] [Reference Citation Analysis]
267 Szabolcs M, Sauter JL, Frosina D, Geronimo JA, Hernandez E, Selbs E, Rapkiewicz AV, Rekhtman N, Baine MK, Jäger E, Travis WD, Jungbluth AA. Identification of Immunohistochemical Reagents for In Situ Protein Expression Analysis of Coronavirus-associated Changes in Human Tissues. Appl Immunohistochem Mol Morphol 2021;29:5-12. [PMID: 33086222 DOI: 10.1097/PAI.0000000000000878] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]
268 Gapud EJ, Kronbichler A, Gauckler P, Geetha D. Immunotherapy for ANCA-associated vasculitis during the COVID-19 pandemic. Eur J Rheumatol 2020;7:S121-8. [PMID: 32716836 DOI: 10.5152/eurjrheum.2020.2067] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
269 Messova A, Pivina L, Muzdubayeva Z, Sanbayev D, Urazalina Z, Adams A. COVID-19 and new onset IgA vasculitis: A systematic review of case reports. Journal of Emergency Nursing 2022. [DOI: 10.1016/j.jen.2022.05.002] [Reference Citation Analysis]
270 Ambrosino P, Calcaterra I, Molino A, Moretta P, Lupoli R, Spedicato GA, Papa A, Motta A, Maniscalco M, Di Minno MND. Persistent Endothelial Dysfunction in Post-Acute COVID-19 Syndrome: A Case-Control Study. Biomedicines 2021;9:957. [PMID: 34440161 DOI: 10.3390/biomedicines9080957] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
271 Schmidt C, Weißmüller S, Bohländer F, Germer M, König M, Staus A, Wartenberg-Demand A, Heinz CC, Schüttrumpf J. The Dual Role of a Polyvalent IgM/IgA-Enriched Immunoglobulin Preparation in Activating and Inhibiting the Complement System. Biomedicines 2021;9:817. [PMID: 34356880 DOI: 10.3390/biomedicines9070817] [Reference Citation Analysis]
272 Singh P, Schwartz RA. Disseminated intravascular coagulation: A devastating systemic disorder of special concern with COVID-19. Dermatol Ther 2020;33:e14053. [PMID: 32700813 DOI: 10.1111/dth.14053] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
273 Cárdenas Suri H, Jimomila Bening D. Catastrophic antiphospholipid antibody syndrome and multiple organ dysfunctions in critically ill patients with COVID-19. Expert Rev Respir Med 2020;14:1071-2. [PMID: 32746642 DOI: 10.1080/17476348.2020.1801427] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
274 Zhao D, Zhang S, Igawa T, Frishman W. Use of Nonsteroidal Anti-inflammatory Drugs for COVID-19 Infection: Adjunct Therapy? Cardiology in Review 2020;28:303-7. [DOI: 10.1097/crd.0000000000000340] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
275 Sriram K, Insel PA. Proteinase-activated receptor 1: A target for repurposing in the treatment of COVID-19? Br J Pharmacol 2020;177:4971-4. [PMID: 32639031 DOI: 10.1111/bph.15194] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
276 Anderson MR, Geleris J, Anderson DR, Zucker J, Nobel YR, Freedberg D, Small-Saunders J, Rajagopalan KN, Greendyk R, Chae SR, Natarajan K, Roh D, Edwin E, Gallagher D, Podolanczuk A, Barr RG, Ferrante AW, Baldwin MR. Body Mass Index and Risk for Intubation or Death in SARS-CoV-2 Infection : A Retrospective Cohort Study. Ann Intern Med 2020;173:782-90. [PMID: 32726151 DOI: 10.7326/M20-3214] [Cited by in Crossref: 61] [Cited by in F6Publishing: 42] [Article Influence: 30.5] [Reference Citation Analysis]
277 Obermayer A, Jakob LM, Haslbauer JD, Matter MS, Tzankov A, Stoiber W. Neutrophil Extracellular Traps in Fatal COVID-19-Associated Lung Injury. Dis Markers 2021;2021:5566826. [PMID: 34367376 DOI: 10.1155/2021/5566826] [Reference Citation Analysis]
278 Stassi C, Mondello C, Baldino G, Cardia L, Asmundo A, Ventura Spagnolo E. An Insight into the Role of Postmortem Immunohistochemistry in the Comprehension of the Inflammatory Pathophysiology of COVID-19 Disease and Vaccine-Related Thrombotic Adverse Events: A Narrative Review. Int J Mol Sci 2021;22:12024. [PMID: 34769454 DOI: 10.3390/ijms222112024] [Reference Citation Analysis]
279 Calabrese F, Pezzuto F, Fortarezza F, Hofman P, Kern I, Panizo A, von der Thüsen J, Timofeev S, Gorkiewicz G, Lunardi F. Pulmonary pathology and COVID-19: lessons from autopsy. The experience of European Pulmonary Pathologists. Virchows Arch 2020;477:359-72. [PMID: 32642842 DOI: 10.1007/s00428-020-02886-6] [Cited by in Crossref: 73] [Cited by in F6Publishing: 83] [Article Influence: 36.5] [Reference Citation Analysis]
280 González González F, Cortés Correa C, Peñaranda Contreras E. Cutaneous Manifestations in Patients With COVID-19: Clinical Characteristics and Possible Pathophysiologic Mechanisms. Actas Dermosifiliogr 2021;112:314-23. [PMID: 34012165 DOI: 10.1016/j.adengl.2021.01.024] [Reference Citation Analysis]
281 Rodriguez-Gonzalez M, Castellano-Martinez A, Cascales-Poyatos HM, Perez-Reviriego AA. Cardiovascular impact of COVID-19 with a focus on children: A systematic review. World J Clin Cases 2020; 8(21): 5250-5283 [PMID: 33269260 DOI: 10.12998/wjcc.v8.i21.5250] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 22] [Article Influence: 17.0] [Reference Citation Analysis]
282 Selda-Enriquez G, Fernandez-Nieto D, Burgos-Blasco P, Melian-Olivera A, Fernandez-Guarino M. Skin manifestations overlap in COVID-19 patients: A continuous spectrum? Dermatol Ther 2021;34:e14592. [PMID: 33244877 DOI: 10.1111/dth.14592] [Reference Citation Analysis]
283 Sattler R, Ekanayake LS, Richardson A. A Rare Presentation of Cerebrovascular Accident in a COVID-19 Patient: A Case Report. Cureus 2020;12:e12287. [PMID: 33520495 DOI: 10.7759/cureus.12287] [Reference Citation Analysis]
284 Varghese PM, Tsolaki AG, Yasmin H, Shastri A, Ferluga J, Vatish M, Madan T, Kishore U. Host-pathogen interaction in COVID-19: Pathogenesis, potential therapeutics and vaccination strategies. Immunobiology 2020;225:152008. [PMID: 33130519 DOI: 10.1016/j.imbio.2020.152008] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
285 Rohee-traore A, Kün-darbois J, Boucher S. Masseter muscle pressure injury: first report of a prone position complication in patients with COVID-19. Intensive and Critical Care Nursing 2022. [DOI: 10.1016/j.iccn.2022.103251] [Reference Citation Analysis]
286 Goßlau Y, Warm TD, Hernandez Cancino EF, Braun G, Spring O, Zerwes S, Hyhlik-Dürr A. [Deep Vein Thrombosis in Intensive Care Patients with COVID-19 Infection - Impact of a Standardised Therapeutic Regimen]. Zentralbl Chir 2021;146:605-11. [PMID: 34706375 DOI: 10.1055/a-1630-8163] [Reference Citation Analysis]
287 Lega S, Naviglio S, Volpi S, Tommasini A. Recent Insight into SARS-CoV2 Immunopathology and Rationale for Potential Treatment and Preventive Strategies in COVID-19. Vaccines (Basel) 2020;8:E224. [PMID: 32423059 DOI: 10.3390/vaccines8020224] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 14.0] [Reference Citation Analysis]
288 Maguire G. Stem cells part of the innate and adaptive immune systems as a therapeutic for Covid-19. Commun Integr Biol 2021;14:186-98. [PMID: 34527167 DOI: 10.1080/19420889.2021.1965356] [Reference Citation Analysis]
289 Rongioletti F, Ferreli C, Sena P, Caputo V, Atzori L. Clinicopathologic correlations of COVID-19-related cutaneous manifestations with special emphasis on histopathologic patterns. Clin Dermatol 2021;39:149-62. [PMID: 33972045 DOI: 10.1016/j.clindermatol.2020.12.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
290 Banderas García S, Aragón D, Azarfane B, Trejo F, Garrell-Salat X, Sánchez-Montalvá A, Otero-Romero S, Garcia-Arumi J, Zapata MA. Persistent reduction of retinal microvascular vessel density in patients with moderate and severe COVID-19 disease. BMJ Open Ophthalmol 2022;7:e000867. [PMID: 35039796 DOI: 10.1136/bmjophth-2021-000867] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
291 Dalkıran T, Kandur Y, Kara EM, Dağoğlu B, Taner S, Öncü D. Thrombotic Microangiopathy in a Severe Pediatric Case of COVID-19. Clin Med Insights Pediatr 2021;15:11795565211049897. [PMID: 34707424 DOI: 10.1177/11795565211049897] [Reference Citation Analysis]
292 Pirofski LA, Casadevall A. Pathogenesis of COVID-19 from the Perspective of the Damage-Response Framework. mBio 2020;11:e01175-20. [PMID: 32616514 DOI: 10.1128/mBio.01175-20] [Cited by in Crossref: 27] [Cited by in F6Publishing: 18] [Article Influence: 13.5] [Reference Citation Analysis]
293 Bagherimoghaddam A, Rafatpanah H, Mansouritorghabeh H. Elevated levels of C3 , C4 , and CH50 of the complement system in ICU and non‐ICU patients with COVID ‐19. Health Science Reports 2022;5. [DOI: 10.1002/hsr2.519] [Reference Citation Analysis]
294 Halawa S, Pullamsetti SS, Bangham CRM, Stenmark KR, Dorfmüller P, Frid MG, Butrous G, Morrell NW, de Jesus Perez VA, Stuart DI, O'Gallagher K, Shah AM, Aguib Y, Yacoub MH. Potential long-term effects of SARS-CoV-2 infection on the pulmonary vasculature: a global perspective. Nat Rev Cardiol 2021. [PMID: 34873286 DOI: 10.1038/s41569-021-00640-2] [Reference Citation Analysis]
295 Mirsadraee S, Gorog DA, Mahon CF, Rawal B, Semple TR, Nicol ED, Arachchillage DRJ, Devaraj A, Price S, Desai SR, Ridge CA, Singh S, Padley SPG. Prevalence of Thrombotic Complications in ICU-Treated Patients With Coronavirus Disease 2019 Detected With Systematic CT Scanning. Crit Care Med 2021;49:804-15. [PMID: 33470780 DOI: 10.1097/CCM.0000000000004890] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
296 Zeng HL, Chen D, Yan J, Yang Q, Han QQ, Li SS, Cheng L. Proteomic characteristics of bronchoalveolar lavage fluid in critical COVID-19 patients. FEBS J 2021;288:5190-200. [PMID: 33098359 DOI: 10.1111/febs.15609] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
297 Skevaki C, Fragkou PC, Cheng C, Xie M, Renz H. Laboratory characteristics of patients infected with the novel SARS-CoV-2 virus. J Infect 2020;81:205-12. [PMID: 32579986 DOI: 10.1016/j.jinf.2020.06.039] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 16.5] [Reference Citation Analysis]
298 Campbell CM. The opening salvo of anti-complement therapy against COVID-19. Lancet Rheumatol 2020;2:e729-30. [PMID: 33015642 DOI: 10.1016/S2665-9913(20)30353-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
299 Kyriakoudi A, Pontikis K, Tsaraklis A, Soura E, Vourlakou C, Kossyvakis A, Potamianou E, Kaniaris E, Ioannidou I, Mentis A, Kloukina I, Daganou M, Koutsoukou A. Cutaneous Vasculopathy in a COVID-19 Critically Ill Patient: A Histologic, Immunohistochemical, and Electron Microscopy Study. Case Rep Crit Care 2021;2021:6644853. [PMID: 33859845 DOI: 10.1155/2021/6644853] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
300 Li G, Deng Q, Feng J, Li F, Xiong N, He Q. Clinical Characteristics of Diabetic Patients with COVID-19. J Diabetes Res 2020;2020:1652403. [PMID: 32851093 DOI: 10.1155/2020/1652403] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 8.5] [Reference Citation Analysis]
301 Elyaspour Z, Zibaeenezhad MJ, Razmkhah M, Razeghian-Jahromi I. Is It All About Endothelial Dysfunction and Thrombosis Formation? The Secret of COVID-19. Clin Appl Thromb Hemost 2021;27:10760296211042940. [PMID: 34693754 DOI: 10.1177/10760296211042940] [Reference Citation Analysis]
302 Mulvey JJ, Magro CM, Ma LX, Nuovo GJ, Baergen RN. Analysis of complement deposition and viral RNA in placentas of COVID-19 patients. Ann Diagn Pathol 2020;46:151530. [PMID: 32387855 DOI: 10.1016/j.anndiagpath.2020.151530] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 24.5] [Reference Citation Analysis]
303 Jabri M, El Houda Lamaasab N, Daoudi C, Jabrouni F, Benzekri H, Bouchlarhem A, Oulali N. Purpura as a late complication of covid-19 infection that should not be ignored: Case report and brief review. Ann Med Surg (Lond) 2022;73:103216. [PMID: 35003729 DOI: 10.1016/j.amsu.2021.103216] [Reference Citation Analysis]
304 Lang P, Eichholz T, Bakchoul T, Streiter M, Petrasch M, Bösmüller H, Klein R, Rabsteyn A, Lang AM, Adams C, Klingel K, Gessner M, Rosenberger P, Ruef P, Handgretinger R. Defibrotide for the Treatment of Pediatric Inflammatory Multisystem Syndrome Temporally Associated With Severe Acute Respiratory Syndrome Coronavirus 2 Infection in 2 Pediatric Patients. J Pediatric Infect Dis Soc 2020;9:622-5. [PMID: 32951037 DOI: 10.1093/jpids/piaa117] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
305 Manzo G. COVID-19 as an Immune Complex Hypersensitivity in Antigen Excess Conditions: Theoretical Pathogenetic Process and Suggestions for Potential Therapeutic Interventions. Front Immunol. 2020;11:566000. [PMID: 33193337 DOI: 10.3389/fimmu.2020.566000] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
306 Castro RA, Frishman WH. Thrombotic Complications of COVID-19 Infection: A Review. Cardiol Rev 2021;29:43-7. [PMID: 32947478 DOI: 10.1097/CRD.0000000000000347] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
307 Fernandez-Fernandez B, D'Marco L, Górriz JL, Jacobs-Cachá C, Kanbay M, Luis-Lima S, Porrini E, Sarafidis P, Soler MJ, Ortiz A. Exploring Sodium Glucose Co-Transporter-2 (SGLT2) Inhibitors for Organ Protection in COVID-19. J Clin Med 2020;9:E2030. [PMID: 32605278 DOI: 10.3390/jcm9072030] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
308 Hadid T, Kafri Z, Al-Katib A. Coagulation and anticoagulation in COVID-19. Blood Rev 2021;47:100761. [PMID: 33067035 DOI: 10.1016/j.blre.2020.100761] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 7.5] [Reference Citation Analysis]
309 Cagdas D. Convalescent plasma and hyperimmune globulin therapy in COVID-19. Expert Rev Clin Immunol 2021;17:309-16. [PMID: 33620014 DOI: 10.1080/1744666X.2021.1894927] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
310 Sridharan GK, Vegunta R, Rokkam VRP, Meyyur Aravamudan V, Vegunta R, Khan SR, Ponnada S, Boregowda U, Prudhvi K, Chamarthi G, Mohan BP. Venous Thromboembolism in Hospitalized COVID-19 Patients. Am J Ther 2020;27:e599-610. [PMID: 33156016 DOI: 10.1097/MJT.0000000000001295] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 5.5] [Reference Citation Analysis]
311 Saenz Aguirre A, De la Torre Gomar FJ, Rosés-Gibert P, Gimeno Castillo J, Martinez de Lagrán Alvarez de Arcaya Z, Gonzalez-Perez R. Novel outbreak of acral lesions in times of COVID-19: a description of 74 cases from a tertiary university hospital in Spain. Clin Exp Dermatol 2020;45:1065-7. [PMID: 32421857 DOI: 10.1111/ced.14294] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
312 Clancy CJ, Schwartz IS, Kula B, Nguyen MH. Bacterial Superinfections Among Persons With Coronavirus Disease 2019: A Comprehensive Review of Data From Postmortem Studies. Open Forum Infect Dis 2021;8:ofab065. [PMID: 33732753 DOI: 10.1093/ofid/ofab065] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
313 Gupta K, Gandhi S, Mebane A 3rd, Singh A, Vishnuvardhan N, Patel E. Cancer patients and COVID-19: Mortality, serious complications, biomarkers, and ways forward. Cancer Treat Res Commun 2021;26:100285. [PMID: 33360669 DOI: 10.1016/j.ctarc.2020.100285] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
314 Conway EM, Mackman N, Warren RQ, Wolberg AS, Mosnier LO, Campbell RA, Gralinski LE, Rondina MT, van de Veerdonk FL, Hoffmeister KM, Griffin JH, Nugent D, Moon K, Morrissey JH. Understanding COVID-19-associated coagulopathy. Nat Rev Immunol 2022. [PMID: 35931818 DOI: 10.1038/s41577-022-00762-9] [Reference Citation Analysis]
315 Yu H, Li C, Wang X, Duan J, Yang N, Xie L, Yuan Y, Li S, Bi C, Yang B, Li Y. Techniques and Strategies for Potential Protein Target Discovery and Active Pharmaceutical Molecule Screening in a Pandemic. J Proteome Res 2020;19:4242-58. [PMID: 32957788 DOI: 10.1021/acs.jproteome.0c00372] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
316 Awoniyi A, Rohm Z, Paranjape N, Arinze F. Prolonged Detection of SARS-CoV-2 in a Patient With the Development of New Clinical Symptoms. Infect Dis Clin Pract (Baltim Md) 2021;29:e105-8. [PMID: 34191903 DOI: 10.1097/IPC.0000000000000960] [Reference Citation Analysis]
317 Suchonwanit P, Leerunyakul K, Kositkuljorn C. Diagnostic and prognostic values of cutaneous manifestations in COVID-19. Dermatol Ther 2020;33:e13650. [PMID: 32445279 DOI: 10.1111/dth.13650] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
318 McClain MT, Constantine FJ, Henao R, Liu Y, Tsalik EL, Burke TW, Steinbrink JM, Petzold E, Nicholson BP, Rolfe R, Kraft BD, Kelly MS, Saban DR, Yu C, Shen X, Ko EM, Sempowski GD, Denny TN, Ginsburg GS, Woods CW. Dysregulated transcriptional responses to SARS-CoV-2 in the periphery. Nat Commun 2021;12:1079. [PMID: 33597532 DOI: 10.1038/s41467-021-21289-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
319 Kogan EA, Berezovsky YS, Protsenko DD, Bagdasaryan TR, Gretsov EM, Demura SA, Demyashkin GA, Kalinin DV, Kukleva AD, Kurilina EV, Nekrasova TP, Paramonova NB, Ponomarev AB, Radenska-lopovok SG, Semyonova LA, Tertychny AS. PATHOLOGICAL ANATOMY OF INFECTION CAUSED BY SARS-COV-2. Sud med (Online) 2020;6:8-30. [DOI: 10.19048/2411-8729-2020-6-2-8-30] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 6.5] [Reference Citation Analysis]
320 Grome HN, Threlkeld M, Threlkeld S, Newman C, Martines RB, Reagan-Steiner S, Whitt MA, Gomes-Solecki M, Nair N, Fill MM, Jones TF, Schaffner W, Dunn J. Fatal Multisystem Inflammatory Syndrome in Adult after SARS-CoV-2 Natural Infection and COVID-19 Vaccination. Emerg Infect Dis 2021;27:2914-8. [PMID: 34586059 DOI: 10.3201/eid2711.211612] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
321 Mahmudpour M, Roozbeh J, Keshavarz M, Farrokhi S, Nabipour I. COVID-19 cytokine storm: The anger of inflammation. Cytokine 2020;133:155151. [PMID: 32544563 DOI: 10.1016/j.cyto.2020.155151] [Cited by in Crossref: 138] [Cited by in F6Publishing: 122] [Article Influence: 69.0] [Reference Citation Analysis]
322 Jinno S, Naka I, Nakazawa T. Catastrophic antiphospholipid syndrome complicated with essential thrombocythaemia after COVID-19 vaccination: in search of the underlying mechanism. Rheumatol Adv Pract 2021;5:rkab096. [PMID: 34909568 DOI: 10.1093/rap/rkab096] [Reference Citation Analysis]
323 Trunz LM, Lee P, Lange SM, Pomeranz CL, Needleman L, Ford RW, Karambelkar A, Sundaram B. Imaging approach to COVID-19 associated pulmonary embolism. Int J Clin Pract 2021;:e14340. [PMID: 33966326 DOI: 10.1111/ijcp.14340] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
324 Edwards K, Allison M, Ghuman S. Secondary sclerosing cholangitis in critically ill patients: a rare disease precipitated by severe SARS-CoV-2 infection. BMJ Case Rep 2020;13:e237984. [PMID: 33168538 DOI: 10.1136/bcr-2020-237984] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
325 Margaroli C, Benson P, Sharma NS, Madison MC, Robison SW, Arora N, Ton K, Liang Y, Zhang L, Patel RP, Gaggar A. Spatial mapping of SARS-CoV-2 and H1N1 lung injury identifies differential transcriptional signatures. Cell Rep Med 2021;2:100242. [PMID: 33778787 DOI: 10.1016/j.xcrm.2021.100242] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
326 Price LC, McCabe C, Garfield B, Wort SJ. Thrombosis and COVID-19 pneumonia: the clot thickens! Eur Respir J. 2020;56. [PMID: 32554532 DOI: 10.1183/13993003.01608-2020] [Cited by in Crossref: 63] [Cited by in F6Publishing: 59] [Article Influence: 31.5] [Reference Citation Analysis]
327 Keshavarz P, Rafiee F, Kavandi H, Goudarzi S, Heidari F, Gholamrezanezhad A. Ischemic gastrointestinal complications of COVID-19: a systematic review on imaging presentation. Clin Imaging. 2021;73:86-95. [PMID: 33341452 DOI: 10.1016/j.clinimag.2020.11.054] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
328 Rahmani-Kukia N, Abbasi A. Physiological and Immunological Causes of the Susceptibility of Chronic Inflammatory Patients to COVID-19 Infection: Focus on Diabetes. Front Endocrinol (Lausanne) 2021;12:576412. [PMID: 33746897 DOI: 10.3389/fendo.2021.576412] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
329 Kaidashev I, Shlykova O, Izmailova O, Torubara O, Yushchenko Y, Tyshkovska T, Kyslyi V, Belyaeva A, Maryniak D. Host gene variability and SARS-CoV-2 infection: A review article. Heliyon 2021;7:e07863. [PMID: 34458641 DOI: 10.1016/j.heliyon.2021.e07863] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
330 Gupta R, Gant VA, Williams B, Enver T. Increased Complement Receptor-3 levels in monocytes and granulocytes distinguish COVID-19 patients with pneumonia from those with mild symptoms. Int J Infect Dis 2020;99:381-5. [PMID: 32771640 DOI: 10.1016/j.ijid.2020.08.004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
331 Maniaci A, Iannella G, Vicini C, Pavone P, Nunnari G, Falsaperla R, Di Mauro P, Ferlito S, Cocuzza S. A Case of COVID-19 with Late-Onset Rash and Transient Loss of Taste and Smell in a 15-Year-Old Boy. Am J Case Rep 2020;21:e925813. [PMID: 32814757 DOI: 10.12659/AJCR.925813] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
332 Ferrari F, Martins VM, Teixeira M, Santos RD, Stein R. COVID-19 and Thromboinflammation: Is There a Role for Statins? Clinics (Sao Paulo) 2021;76:e2518. [PMID: 33787678 DOI: 10.6061/clinics/2021/e2518] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
333 Tsantes AE, Frantzeskaki F, Tsantes AG, Rapti E, Rizos M, Kokoris SI, Paramythiotou E, Katsadiotis G, Karali V, Flevari A, Chrysanthopoulou E, Maratou E, Kyriakou E, Gialeraki A, Bonovas S, Dimopoulos G, Tsangaris I, Armaganidis A. The haemostatic profile in critically ill COVID-19 patients receiving therapeutic anticoagulant therapy: An observational study. Medicine (Baltimore) 2020;99:e23365. [PMID: 33217881 DOI: 10.1097/MD.0000000000023365] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
334 Di Franco S, Alfieri A, Petrou S, Damiani G, Passavanti MB, Pace MC, Leone S, Fiore M. Current status of COVID-19 treatment: An opinion review. World J Virol 2020; 9(3): 27-37 [PMID: 33024717 DOI: 10.5501/wjv.v9.i3.27] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
335 Torres-Ruiz J, Absalón-Aguilar A, Nuñez-Aguirre M, Pérez-Fragoso A, Carrillo-Vázquez DA, Maravillas-Montero JL, Mejía-Domínguez NR, Llorente L, Alcalá-Carmona B, Lira-Luna J, Núñez-Álvarez C, Juárez-Vega G, Meza-Sánchez D, Hernández-Gilsoul T, Tapia-Rodríguez M, Gómez-Martín D. Neutrophil Extracellular Traps Contribute to COVID-19 Hyperinflammation and Humoral Autoimmunity. Cells 2021;10:2545. [PMID: 34685525 DOI: 10.3390/cells10102545] [Reference Citation Analysis]
336 Gelincik A, Brockow K, Çelik GE, Doña I, Mayorga C, Romano A, Soyer Ö, Atanaskovic-Markovic M, Barbaud A, Torres MJ. Diagnosis and management of the drug hypersensitivity reactions in Coronavirus disease 19: An EAACI Position Paper. Allergy 2020;75:2775-93. [PMID: 32511784 DOI: 10.1111/all.14439] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 8.5] [Reference Citation Analysis]
337 Cui SN, Tan HY, Fan GC. Immunopathological Roles of Neutrophils in Virus Infection and COVID-19. Shock 2021;56:345-51. [PMID: 33534399 DOI: 10.1097/SHK.0000000000001740] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
338 Gervaise A, Bouzad C, Peroux E, Helissey C. Acute pulmonary embolism in non-hospitalized COVID-19 patients referred to CTPA by emergency department. Eur Radiol 2020;30:6170-7. [PMID: 32518989 DOI: 10.1007/s00330-020-06977-5] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 24.0] [Reference Citation Analysis]
339 Gouveia PADC, Cipriano IC, de Melo MAZ, da Silva HTA, Amorim MAO, de Sá Leitão CC, Guedes MMV, Takano DM, Filgueira NA, Ferraz CE. Exuberant bullous vasculitis associated with SARS-CoV-2 infection. IDCases 2021;23:e01047. [PMID: 33457205 DOI: 10.1016/j.idcr.2021.e01047] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
340 Tomera K, kittah J. Famotidine with Celecoxib Adjuvant Therapy on Hospitalized COVID-19 Patients: A Case Series. SSRN Journal. [DOI: 10.2139/ssrn.3646583] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
341 To KK, Sridhar S, Chiu KH, Hung DL, Li X, Hung IF, Tam AR, Chung TW, Chan JF, Zhang AJ, Cheng VC, Yuen KY. Lessons learned 1 year after SARS-CoV-2 emergence leading to COVID-19 pandemic. Emerg Microbes Infect 2021;10:507-35. [PMID: 33666147 DOI: 10.1080/22221751.2021.1898291] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 17.0] [Reference Citation Analysis]
342 Mazzitelli M, Dastoli S, Mignogna C, Bennardo L, Lio E, Pelle MC, Trecarichi EM, Pereira BI, Nisticò SP, Torti C. Histopathology and immunophenotyping of late onset cutaneous manifestations of COVID-19 in elderly patients: Three case reports. World J Clin Cases 2021; 9(20): 5744-5751 [PMID: 34307634 DOI: 10.12998/wjcc.v9.i20.5744] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
343 Nicosia RF, Ligresti G, Caporarello N, Akilesh S, Ribatti D. COVID-19 Vasculopathy: Mounting Evidence for an Indirect Mechanism of Endothelial Injury. Am J Pathol 2021;191:1374-84. [PMID: 34033751 DOI: 10.1016/j.ajpath.2021.05.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
344 McFadyen JD, Stevens H, Peter K. The Emerging Threat of (Micro)Thrombosis in COVID-19 and Its Therapeutic Implications. Circ Res. 2020;127:571-587. [PMID: 32586214 DOI: 10.1161/circresaha.120.317447] [Cited by in Crossref: 143] [Cited by in F6Publishing: 103] [Article Influence: 71.5] [Reference Citation Analysis]
345 Afzali B, Noris M, Lambrecht BN, Kemper C. The state of complement in COVID-19. Nat Rev Immunol 2021. [PMID: 34912108 DOI: 10.1038/s41577-021-00665-1] [Reference Citation Analysis]
346 Kohansal Vajari M, Shirin M, Pourbagheri-Sigaroodi A, Akbari ME, Abolghasemi H, Bashash D. COVID-19-related coagulopathy: A review of pathophysiology and pharmaceutical management. Cell Biol Int 2021. [PMID: 33945651 DOI: 10.1002/cbin.11623] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
347 Goud PT, Bai D, Abu-Soud HM. A Multiple-Hit Hypothesis Involving Reactive Oxygen Species and Myeloperoxidase Explains Clinical Deterioration and Fatality in COVID-19. Int J Biol Sci 2021;17:62-72. [PMID: 33390833 DOI: 10.7150/ijbs.51811] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 11.0] [Reference Citation Analysis]
348 Gavriilaki E, Sakellari I, Gavriilaki M, Anagnostopoulos A. Thrombocytopenia in COVID-19: pathophysiology matters. Ann Hematol 2021;100:2139-40. [PMID: 32683455 DOI: 10.1007/s00277-020-04183-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
349 Petrilli CM, Jones SA, Yang J, Rajagopalan H, O'Donnell L, Chernyak Y, Tobin KA, Cerfolio RJ, Francois F, Horwitz LI. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ. 2020;369:m1966. [PMID: 32444366 DOI: 10.1136/bmj.m1966] [Cited by in Crossref: 903] [Cited by in F6Publishing: 829] [Article Influence: 451.5] [Reference Citation Analysis]
350 Snell J. SARS-CoV-2 infection and its association with thrombosis and ischemic stroke: a review. Am J Emerg Med 2021;40:188-92. [PMID: 33036853 DOI: 10.1016/j.ajem.2020.09.072] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
351 Mueller AL, McNamara MS, Sinclair DA. Why does COVID-19 disproportionately affect older people? Aging (Albany NY) 2020;12:9959-81. [PMID: 32470948 DOI: 10.18632/aging.103344] [Cited by in Crossref: 190] [Cited by in F6Publishing: 179] [Article Influence: 95.0] [Reference Citation Analysis]
352 Malchrzak W, Mastalerz-Migas A, Sroka Z, Spiegel M. One Year of the COVID-19 Pandemic. What Do We Know and What Is Yet to Come? - The Summarising Review. Int J Public Health 2021;66:1603975. [PMID: 34588946 DOI: 10.3389/ijph.2021.1603975] [Reference Citation Analysis]
353 Vas PRJ, Georgiadis GS, Papanas N. COVID-19 Toes and Other Skin Lesions During the Pandemic: Emerging Entities? Int J Low Extrem Wounds 2021;:15347346211011843. [PMID: 33891517 DOI: 10.1177/15347346211011843] [Reference Citation Analysis]
354 Kumar V. How could we forget immunometabolism in SARS-CoV2 infection or COVID-19? Int Rev Immunol 2021;40:72-107. [PMID: 33155525 DOI: 10.1080/08830185.2020.1840567] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
355 Varela AA, Cheng S, Werren JH. Novel ACE2 protein interactions relevant to COVID-19 predicted by evolutionary rate correlations. PeerJ 2021;9:e12159. [PMID: 34616619 DOI: 10.7717/peerj.12159] [Reference Citation Analysis]
356 Weeks LD, Sylvester KW, Connors JM, Connell NT. Management of therapeutic unfractionated heparin in COVID-19 patients: A retrospective cohort study. Res Pract Thromb Haemost 2021;5:e12521. [PMID: 34013153 DOI: 10.1002/rth2.12521] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
357 Lippi G, Sanchis-Gomar F, Favaloro EJ, Lavie CJ, Henry BM. Coronavirus Disease 2019-Associated Coagulopathy. Mayo Clin Proc 2021;96:203-17. [PMID: 33413819 DOI: 10.1016/j.mayocp.2020.10.031] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 12.5] [Reference Citation Analysis]
358 Bekassy Z, Lopatko Fagerström I, Bader M, Karpman D. Crosstalk between the renin-angiotensin, complement and kallikrein-kinin systems in inflammation. Nat Rev Immunol 2021. [PMID: 34759348 DOI: 10.1038/s41577-021-00634-8] [Reference Citation Analysis]
359 Fan Y, Wang Y, Yu S, Chang J, Yan Y, Wang Y, Bian Y. Natural products provide a new perspective for anti-complement treatment of severe COVID-19: a review. Chin Med 2021;16:67. [PMID: 34321065 DOI: 10.1186/s13020-021-00478-3] [Reference Citation Analysis]
360 Barratt J, Weitz I. Complement Factor D as a Strategic Target for Regulating the Alternative Complement Pathway. Front Immunol 2021;12:712572. [PMID: 34566967 DOI: 10.3389/fimmu.2021.712572] [Reference Citation Analysis]
361 Logette E, Lorin C, Favreau C, Oshurko E, Coggan JS, Casalegno F, Sy MF, Monney C, Bertschy M, Delattre E, Fonta PA, Krepl J, Schmidt S, Keller D, Kerrien S, Scantamburlo E, Kaufmann AK, Markram H. A Machine-Generated View of the Role of Blood Glucose Levels in the Severity of COVID-19. Front Public Health 2021;9:695139. [PMID: 34395368 DOI: 10.3389/fpubh.2021.695139] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
362 Kakarla V, Kaneko N, Nour M, Khatibi K, Elahi F, Liebeskind DS, Hinman JD. Pathophysiologic mechanisms of cerebral endotheliopathy and stroke due to Sars-CoV-2. J Cereb Blood Flow Metab 2021;41:1179-92. [PMID: 33530831 DOI: 10.1177/0271678X20985666] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
363 Zheng W, Wang T, Wu P, Yan Q, Liu C, Wu H, Zhan S, Liu X, Jiang Y, Zhuang H. Host Factor Interaction Networks Identified by Integrative Bioinformatics Analysis Reveals Therapeutic Implications in COPD Patients With COVID-19. Front Pharmacol 2021;12:718874. [PMID: 35002688 DOI: 10.3389/fphar.2021.718874] [Reference Citation Analysis]
364 Nuovo G, Tili E, Suster D, Matys E, Hupp L, Magro C. Strong homology between SARS-CoV-2 envelope protein and a Mycobacterium sp. antigen allows rapid diagnosis of Mycobacterial infections and may provide specific anti-SARS-CoV-2 immunity via the BCG vaccine. Ann Diagn Pathol 2020;48:151600. [PMID: 32805515 DOI: 10.1016/j.anndiagpath.2020.151600] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
365 Giordo R, Paliogiannis P, Mangoni AA, Pintus G. SARS-CoV-2 and endothelial cell interaction in COVID-19: molecular perspectives. Vasc Biol 2021;3:R15-23. [PMID: 33659858 DOI: 10.1530/VB-20-0017] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
366 Rajaiah R, Abhilasha KV, Shekar MA, Vogel SN, Vishwanath BS. Evaluation of mechanisms of action of re-purposed drugs for treatment of COVID-19. Cell Immunol 2020;358:104240. [PMID: 33137649 DOI: 10.1016/j.cellimm.2020.104240] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
367 Izzi-Engbeaya C, Distaso W, Amin A, Yang W, Idowu O, Kenkre JS, Shah RJ, Woin E, Shi C, Alavi N, Bedri H, Brady N, Blackburn S, Leczycka M, Patel S, Sokol E, Toke-Bjolgerud E, Qayum A, Abdel-Malek M, Hope DCD, Oliver NS, Bravis V, Misra S, Tan TM, Hill NE, Salem V. Adverse outcomes in COVID-19 and diabetes: a retrospective cohort study from three London teaching hospitals. BMJ Open Diabetes Res Care 2021;9:e001858. [PMID: 33408084 DOI: 10.1136/bmjdrc-2020-001858] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 25.0] [Reference Citation Analysis]
368 Amin S, Aktar S, Rahman MM, Hassan Chowdhury MM. NLRP3 inflammasome activation in COVID-19: an interlink between risk factors and disease severity. Microbes Infect 2021;:104913. [PMID: 34838941 DOI: 10.1016/j.micinf.2021.104913] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
369 . COVID-19 cutaneous manifestations: simplifying the confusion. Int J Dermatol 2021;60:3-4. [PMID: 33156536 DOI: 10.1111/ijd.15281] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
370 Mortazavi-Jahromi SS, Aslani M. Dysregulated miRNAs network in the critical COVID-19: An important clue for uncontrolled immunothrombosis/thromboinflammation. Int Immunopharmacol 2022;110:109040. [PMID: 35839566 DOI: 10.1016/j.intimp.2022.109040] [Reference Citation Analysis]
371 Lu YF, Pan LY, Zhang WW, Cheng F, Hu SS, Zhang X, Jiang HY. A meta-analysis of the incidence of venous thromboembolic events and impact of anticoagulation on mortality in patients with COVID-19. Int J Infect Dis 2020;100:34-41. [PMID: 32798659 DOI: 10.1016/j.ijid.2020.08.023] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 9.5] [Reference Citation Analysis]
372 Ghale-Noie ZN, Salmaninejad A, Bergquist R, Mollazadeh S, Hoseini B, Sahebkar A. Genetic Aspects and Immune Responses in Covid-19: Important Organ Involvement. Adv Exp Med Biol 2021;1327:3-22. [PMID: 34279825 DOI: 10.1007/978-3-030-71697-4_1] [Reference Citation Analysis]
373 Hashemi A, Madhavan MV, Bikdeli B. Pharmacotherapy for Prevention and Management of Thrombosis in COVID-19. Semin Thromb Hemost 2020;46:789-95. [PMID: 32820478 DOI: 10.1055/s-0040-1714273] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
374 Lakhanpal A, Brahn E. A perspective on modern advances for COVID-19 (SARS-CoV-2) therapeutics. Eur J Rheumatol 2020;7:S102-6. [PMID: 32449669 DOI: 10.5152/eurjrheum.2020.2065] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
375 Stakišaitis D, Kapočius L, Valančiūtė A, Balnytė I, Tamošuitis T, Vaitkevičius A, Sužiedėlis K, Urbonienė D, Tatarūnas V, Kilimaitė E, Gečys D, Lesauskaitė V. SARS-CoV-2 Infection, Sex-Related Differences, and a Possible Personalized Treatment Approach with Valproic Acid: A Review. Biomedicines 2022;10:962. [DOI: 10.3390/biomedicines10050962] [Reference Citation Analysis]
376 Anwar N, Tashfeen S, Akhtar F, Noor A, Khan SA, Omair A. Can disseminated intravascular coagulation scores predict mortality in COVID-19 patients? J Taibah Univ Med Sci 2021;16:596-604. [PMID: 33850513 DOI: 10.1016/j.jtumed.2021.03.002] [Reference Citation Analysis]
377 García-Hernández R, Espigares-López MI, Miralles-Aguiar F, Gámiz-Sánchez R, Arroyo Fernández FJ, Pernia Romero A, Torres LM, Calderón Seoane E; en nombre del GRUPO DE INVESTIGACIÓN CONVEHY®. Immunomodulation using CONVEHY® for COVID-19: from the storm to the cytokine anticyclone. Rev Esp Anestesiol Reanim (Engl Ed) 2021;68:107-12. [PMID: 33455739 DOI: 10.1016/j.redar.2020.08.001] [Reference Citation Analysis]
378 Pavoni V, Gianesello L, Pazzi M, Stera C, Meconi T, Frigieri FC. Venous thromboembolism and bleeding in critically ill COVID-19 patients treated with higher than standard low molecular weight heparin doses and aspirin: A call to action. Thromb Res 2020;196:313-7. [PMID: 32977129 DOI: 10.1016/j.thromres.2020.09.013] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 11.5] [Reference Citation Analysis]
379 Newton-Cheh C, Zlotoff DA, Hung J, Rupasov A, Crowley JC, Funamoto M. Case 24-2020: A 44-Year-Old Woman with Chest Pain, Dyspnea, and Shock. N Engl J Med 2020;383:475-84. [PMID: 32668103 DOI: 10.1056/NEJMcpc2004975] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
380 Raval N, Djougarian A, Lin J. Central retinal vein occlusion in the setting of COVID-19 infection. J Ophthalmic Inflamm Infect 2021;11:10. [PMID: 33824686 DOI: 10.1186/s12348-021-00241-7] [Reference Citation Analysis]
381 Jegatheeswaran V, Chan MWK, Chakrabarti S, Fawcett A, Chen YA. Neuroimaging Findings of Hospitalized Covid-19 Patients: A Canadian Retrospective Observational Study. Can Assoc Radiol J 2021;:8465371211002815. [PMID: 33881958 DOI: 10.1177/08465371211002815] [Reference Citation Analysis]
382 Vinciguerra M, Romiti S, Fattouch K, De Bellis A, Greco E. Atherosclerosis as Pathogenetic Substrate for Sars-Cov2 Cytokine Storm. J Clin Med. 2020;9. [PMID: 32635302 DOI: 10.3390/jcm9072095] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
383 Chong WH, Saha BK. Relationship Between Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the Etiology of Acute Kidney Injury (AKI). Am J Med Sci 2021;361:287-96. [PMID: 33358501 DOI: 10.1016/j.amjms.2020.10.025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
384 Malone RW, Tisdall P, Fremont-Smith P, Liu Y, Huang XP, White KM, Miorin L, Moreno E, Alon A, Delaforge E, Hennecker CD, Wang G, Pottel J, Blair RV, Roy CJ, Smith N, Hall JM, Tomera KM, Shapiro G, Mittermaier A, Kruse AC, García-Sastre A, Roth BL, Glasspool-Malone J, Ricke DO. COVID-19: Famotidine, Histamine, Mast Cells, and Mechanisms. Front Pharmacol 2021;12:633680. [PMID: 33833683 DOI: 10.3389/fphar.2021.633680] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 8.0] [Reference Citation Analysis]
385 Carriazo S, Kanbay M, Ortiz A. Kidney disease and electrolytes in COVID-19: more than meets the eye.Clin Kidney J. 2020;13:274-280. [PMID: 32699613 DOI: 10.1093/ckj/sfaa112] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
386 Gerber GF, Chaturvedi S. How to recognize and manage COVID-19-associated coagulopathy. Hematology Am Soc Hematol Educ Program 2021;2021:614-20. [PMID: 34889412 DOI: 10.1182/hematology.2021000297] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
387 Defendi F, Leroy C, Epaulard O, Clavarino G, Vilotitch A, Le Marechal M, Jacob MC, Raskovalova T, Pernollet M, Le Gouellec A, Bosson JL, Poignard P, Roustit M, Thielens N, Dumestre-Pérard C, Cesbron JY. Complement Alternative and Mannose-Binding Lectin Pathway Activation Is Associated With COVID-19 Mortality. Front Immunol 2021;12:742446. [PMID: 34567008 DOI: 10.3389/fimmu.2021.742446] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
388 Peerschke EI, Valentino A, So RJ, Shulman S, Ravinder. Thromboinflammation Supports Complement Activation in Cancer Patients With COVID-19. Front Immunol 2021;12:716361. [PMID: 34491250 DOI: 10.3389/fimmu.2021.716361] [Reference Citation Analysis]
389 Labarrere CA, Kassab GS. Pattern Recognition Proteins: First Line of Defense Against Coronaviruses. Front Immunol 2021;12:652252. [PMID: 34630377 DOI: 10.3389/fimmu.2021.652252] [Reference Citation Analysis]
390 Willyard C. Coronavirus blood-clot mystery intensifies. Nature 2020;581:250. [PMID: 32393875 DOI: 10.1038/d41586-020-01403-8] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 13.0] [Reference Citation Analysis]
391 Fiel MI, El Jamal SM, Paniz-Mondolfi A, Gordon RE, Reidy J, Bandovic J, Advani R, Kilaru S, Pourmand K, Ward S, Thung SN, Schiano T. Findings of Severe Hepatic Severe Acute Respiratory Syndrome Coronavirus-2 Infection. Cell Mol Gastroenterol Hepatol. 2021;1-8. [PMID: 32992052 DOI: 10.1016/j.jcmgh.2020.09.015] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
392 Garg S, Garg M, Prabhakar N, Malhotra P, Agarwal R. Unraveling the mystery of Covid-19 cytokine storm: From skin to organ systems. Dermatol Ther 2020;33:e13859. [PMID: 32559324 DOI: 10.1111/dth.13859] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 9.0] [Reference Citation Analysis]
393 Ozer KB, Sakin O, Koyuncu K, Cimenoglu B, Demirhan R. Comparison of Laboratory and Radiological Findings of Pregnant and Non-Pregnant Women with Covid-19. Rev Bras Ginecol Obstet 2021;43:200-6. [PMID: 33860503 DOI: 10.1055/s-0041-1726054] [Reference Citation Analysis]
394 Hoevenaar M, Goossens D, Roorda J. Angiotensin-converting enzyme 2, the complement system, the kallikrein-kinin system, type-2 diabetes, interleukin-6, and their interactions regarding the complex COVID-19 pathophysiological crossroads. J Renin Angiotensin Aldosterone Syst 2020;21:1470320320979097. [PMID: 33283602 DOI: 10.1177/1470320320979097] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
395 Fisicaro F, Di Napoli M, Liberto A, Fanella M, Di Stasio F, Pennisi M, Bella R, Lanza G, Mansueto G. Neurological Sequelae in Patients with COVID-19: A Histopathological Perspective. Int J Environ Res Public Health 2021;18:1415. [PMID: 33546463 DOI: 10.3390/ijerph18041415] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 37.0] [Reference Citation Analysis]
396 Lim RK, Kalagara S, Chen KK, Mylonakis E, Kroumpouzos G. DERMATOLOGY IN A MULTIDISCIPLINARY APPROACH WITH INFECTIOUS DISEASE AND OBSTETRIC MEDICINE AGAINST COVID-19. Int J Womens Dermatol 2021. [PMID: 34462725 DOI: 10.1016/j.ijwd.2021.08.008] [Reference Citation Analysis]
397 de Nooijer AH, Grondman I, Janssen NAF, Netea MG, Willems L, van de Veerdonk FL, Giamarellos-Bourboulis EJ, Toonen EJM, Joosten LAB; RCI-COVID-19 study group. Complement Activation in the Disease Course of Coronavirus Disease 2019 and Its Effects on Clinical Outcomes. J Infect Dis 2021;223:214-24. [PMID: 33038254 DOI: 10.1093/infdis/jiaa646] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 18.0] [Reference Citation Analysis]
398 Ramos SG, Rattis BADC, Ottaviani G, Celes MRN, Dias EP. ACE2 Down-Regulation May Act as a Transient Molecular Disease Causing RAAS Dysregulation and Tissue Damage in the Microcirculatory Environment Among COVID-19 Patients. Am J Pathol 2021;191:1154-64. [PMID: 33964216 DOI: 10.1016/j.ajpath.2021.04.010] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
399 Mastaglio S, Ruggeri A, Risitano AM, Angelillo P, Yancopoulou D, Mastellos DC, Huber-Lang M, Piemontese S, Assanelli A, Garlanda C, Lambris JD, Ciceri F. The first case of COVID-19 treated with the complement C3 inhibitor AMY-101. Clin Immunol. 2020;215:108450. [PMID: 32360516 DOI: 10.1016/j.clim.2020.108450] [Cited by in Crossref: 140] [Cited by in F6Publishing: 137] [Article Influence: 70.0] [Reference Citation Analysis]
400 Sagris D, Papanikolaou A, Kvernland A, Korompoki E, Frontera JA, Troxel AB, Gavriatopoulou M, Milionis H, Lip GYH, Michel P, Yaghi S, Ntaios G. COVID-19 and ischemic stroke. Eur J Neurol 2021. [PMID: 34224187 DOI: 10.1111/ene.15008] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
401 Bryce C, Grimes Z, Pujadas E, Ahuja S, Beasley MB, Albrecht R, Hernandez T, Stock A, Zhao Z, AlRasheed MR, Chen J, Li L, Wang D, Corben A, Haines GK 3rd, Westra WH, Umphlett M, Gordon RE, Reidy J, Petersen B, Salem F, Fiel MI, El Jamal SM, Tsankova NM, Houldsworth J, Mussa Z, Veremis B, Sordillo E, Gitman MR, Nowak M, Brody R, Harpaz N, Merad M, Gnjatic S, Liu WC, Schotsaert M, Miorin L, Aydillo Gomez TA, Ramos-Lopez I, Garcia-Sastre A, Donnelly R, Seigler P, Keys C, Cameron J, Moultrie I, Washington KL, Treatman J, Sebra R, Jhang J, Firpo A, Lednicky J, Paniz-Mondolfi A, Cordon-Cardo C, Fowkes ME. Pathophysiology of SARS-CoV-2: the Mount Sinai COVID-19 autopsy experience. Mod Pathol 2021;34:1456-67. [PMID: 33795830 DOI: 10.1038/s41379-021-00793-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 13.0] [Reference Citation Analysis]
402 Hariri LP, North CM, Shih AR, Israel RA, Maley JH, Villalba JA, Vinarsky V, Rubin J, Okin DA, Sclafani A, Alladina JW, Griffith JW, Gillette MA, Raz Y, Richards CJ, Wong AK, Ly A, Hung YP, Chivukula RR, Petri CR, Calhoun TF, Brenner LN, Hibbert KA, Medoff BD, Hardin CC, Stone JR, Mino-Kenudson M. Lung Histopathology in Coronavirus Disease 2019 as Compared With Severe Acute Respiratory Sydrome and H1N1 Influenza: A Systematic Review. Chest. 2021;159:73-84. [PMID: 33038391 DOI: 10.1016/j.chest.2020.09.259] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 17.0] [Reference Citation Analysis]
403 Roy D, Hollingworth M, Kumaria A. A case of malignant cerebral infarction associated with COVID-19 infection. Br J Neurosurg 2021;35:191-4. [PMID: 32755343 DOI: 10.1080/02688697.2020.1779180] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
404 Kamel MH, Yin W, Zavaro C, Francis JM, Chitalia VC. Hyperthrombotic Milieu in COVID-19 Patients. Cells 2020;9:E2392. [PMID: 33142844 DOI: 10.3390/cells9112392] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
405 Ackermann M, Anders HJ, Bilyy R, Bowlin GL, Daniel C, De Lorenzo R, Egeblad M, Henneck T, Hidalgo A, Hoffmann M, Hohberger B, Kanthi Y, Kaplan MJ, Knight JS, Knopf J, Kolaczkowska E, Kubes P, Leppkes M, Mahajan A, Manfredi AA, Maueröder C, Maugeri N, Mitroulis I, Muñoz LE, Narasaraju T, Naschberger E, Neeli I, Ng LG, Radic MZ, Ritis K, Rovere-Querini P, Schapher M, Schauer C, Simon HU, Singh J, Skendros P, Stark K, Stürzl M, van der Vlag J, Vandenabeele P, Vitkov L, von Köckritz-Blickwede M, Yanginlar C, Yousefi S, Zarbock A, Schett G, Herrmann M. Patients with COVID-19: in the dark-NETs of neutrophils. Cell Death Differ 2021. [PMID: 34031543 DOI: 10.1038/s41418-021-00805-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
406 García-Gil MF, Monte Serrano J, Lapeña-Casado A, García García M, Matovelle Ochoa C, Ara-Martín M. Livedo reticularis and acrocyanosis as late manifestations of COVID-19 in two cases with familial aggregation. Potential pathogenic role of complement (C4c). Int J Dermatol 2020;59:1549-51. [PMID: 33040378 DOI: 10.1111/ijd.15233] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
407 Michalski JE, Kurche JS, Schwartz DA. From ARDS to pulmonary fibrosis: the next phase of the COVID-19 pandemic? Transl Res 2021:S1931-5244(21)00243-7. [PMID: 34547499 DOI: 10.1016/j.trsl.2021.09.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
408 Hassan AO, Case JB, Winkler ES, Thackray LB, Kafai NM, Bailey AL, McCune BT, Fox JM, Chen RE, Alsoussi WB, Turner JS, Schmitz AJ, Lei T, Shrihari S, Keeler SP, Fremont DH, Greco S, McCray PB Jr, Perlman S, Holtzman MJ, Ellebedy AH, Diamond MS. A SARS-CoV-2 Infection Model in Mice Demonstrates Protection by Neutralizing Antibodies. Cell 2020;182:744-753.e4. [PMID: 32553273 DOI: 10.1016/j.cell.2020.06.011] [Cited by in Crossref: 264] [Cited by in F6Publishing: 242] [Article Influence: 132.0] [Reference Citation Analysis]
409 Ombrello MJ, Schulert GS. COVID-19 and cytokine storm syndrome: are there lessons from macrophage activation syndrome? Transl Res 2021;232:1-12. [PMID: 33684592 DOI: 10.1016/j.trsl.2021.03.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
410 Schönrich G, Raftery MJ, Samstag Y. Devilishly radical NETwork in COVID-19: Oxidative stress, neutrophil extracellular traps (NETs), and T cell suppression. Adv Biol Regul 2020;77:100741. [PMID: 32773102 DOI: 10.1016/j.jbior.2020.100741] [Cited by in Crossref: 63] [Cited by in F6Publishing: 62] [Article Influence: 31.5] [Reference Citation Analysis]
411 Brumeanu TD, Vir P, Karim AF, Kar S, Benetiene D, Lok M, Greenhouse J, Putmon-Taylor T, Kitajewski C, Chung KK, Pratt KP, Casares SA. Human-Immune-System (HIS) humanized mouse model (DRAGA: HLA-A2.HLA-DR4.Rag1KO.IL-2RγcKO.NOD) for COVID-19. Hum Vaccin Immunother 2022;:1-16. [PMID: 35348437 DOI: 10.1080/21645515.2022.2048622] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
412 Rapkiewicz AV, Mai X, Carsons SE, Pittaluga S, Kleiner DE, Berger JS, Thomas S, Adler NM, Charytan DM, Gasmi B, Hochman JS, Reynolds HR. Megakaryocytes and platelet-fibrin thrombi characterize multi-organ thrombosis at autopsy in COVID-19: A case series. EClinicalMedicine 2020;24:100434. [PMID: 32766543 DOI: 10.1016/j.eclinm.2020.100434] [Cited by in Crossref: 180] [Cited by in F6Publishing: 172] [Article Influence: 90.0] [Reference Citation Analysis]
413 Serra-García L, Bosch-Amate X, Alamon-Reig F, Giavedoni P, Fuertes I, Morgado-Carrasco D, Iglesias P, Puig S, Mascaró JM Jr. Digital ischemia triggered by coronavirus disease 2019 in a patient under cemiplimab treatment. Int J Dermatol 2021;60:e30-2. [PMID: 33040324 DOI: 10.1111/ijd.15239] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
414 Henry BM, Sinkovits G, Szergyuk I, de Oliveira MHS, Lippi G, Benoit JL, Favaloro EJ, Pode-shakked N, Benoit SW, Cooper DS, Müller V, Iványi Z, Gál J, Réti M, Gopcsa L, Reményi P, Szathmáry B, Lakatos B, Szlávik J, Bobek I, Prohászka ZZ, Förhécz Z, Csuka D, Hurler L, Kajdácsi E, Cervenak L, Mező B, Kiszel P, Masszi T, Vályi-nagy I, Prohászka Z. Complement Levels at Admission Reflecting Progression to Severe Acute Kidney Injury (AKI) in Coronavirus Disease 2019 (COVID-19): A Multicenter Prospective Cohort Study. Front Med 2022;9:796109. [DOI: 10.3389/fmed.2022.796109] [Reference Citation Analysis]
415 Abuelgasim E, Dona ACM, Sondh RS, Harky A. Management of urticaria in COVID-19 patients: A systematic review. Dermatol Ther 2021;34:e14328. [PMID: 32986289 DOI: 10.1111/dth.14328] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
416 Fraser DD, Patterson EK, Slessarev M, Gill SE, Martin C, Daley M, Miller MR, Patel MA, Dos Santos CC, Bosma KJ, O'Gorman DB, Cepinskas G. Endothelial Injury and Glycocalyx Degradation in Critically Ill Coronavirus Disease 2019 Patients: Implications for Microvascular Platelet Aggregation. Crit Care Explor 2020;2:e0194. [PMID: 32904031 DOI: 10.1097/CCE.0000000000000194] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 14.0] [Reference Citation Analysis]
417 Valtueña J, Martínez-García G, Ruiz-Sánchez D, Garayar-Cantero M, Dueñas C, Hadi A, Hadi S, Aguado-García Á, Prieto de Paula JM, Manchado-López P. Vascular obliteration because of endothelial and myointimal growth in COVID-19 patients. Int J Dermatol 2021;60:73-80. [PMID: 33179785 DOI: 10.1111/ijd.15300] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
418 Mehata AK, Viswanadh MK, Priya V, Vikas, Muthu MS. Harnessing immunological targets for COVID-19 immunotherapy. Future Virol 2021. [PMID: 34447458 DOI: 10.2217/fvl-2021-0048] [Reference Citation Analysis]
419 Noris M, Benigni A, Remuzzi G. The case of complement activation in COVID-19 multiorgan impact. Kidney Int. 2020;98:314-322. [PMID: 32461141 DOI: 10.1016/j.kint.2020.05.013] [Cited by in Crossref: 116] [Cited by in F6Publishing: 110] [Article Influence: 58.0] [Reference Citation Analysis]
420 Al-Mufti F, Becker C, Kamal H, Alshammari H, Dodson V, Nuoman R, Dakay K, Cooper J, Gulko E, Kaur G, Sahni R, Scurlock C, Mayer SA, Gandhi CD. Acute Cerebrovascular Disorders and Vasculopathies Associated with Significant Mortality in SARS-CoV-2 Patients Admitted to The Intensive Care Unit in The New York Epicenter. J Stroke Cerebrovasc Dis 2021;30:105429. [PMID: 33276301 DOI: 10.1016/j.jstrokecerebrovasdis.2020.105429] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
421 Englert H, Rangaswamy C, Deppermann C, Sperhake JP, Krisp C, Schreier D, Gordon E, Konrath S, Haddad M, Pula G, Mailer RK, Schlüter H, Kluge S, Langer F, Püschel K, Panousis K, Stavrou EX, Maas C, Renné T, Frye M. Defective NET clearance contributes to sustained FXII activation in COVID-19-associated pulmonary thrombo-inflammation. EBioMedicine 2021;67:103382. [PMID: 34000623 DOI: 10.1016/j.ebiom.2021.103382] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
422 Gisondi P, Di Leo S, Bellinato F, Cazzaniga S, Piaserico S, Naldi L. Time of Onset of Selected Skin Lesions Associated with COVID-19: A Systematic Review. Dermatol Ther (Heidelb) 2021;11:695-705. [PMID: 33811315 DOI: 10.1007/s13555-021-00526-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
423 Lo MW, Kemper C, Woodruff TM. COVID-19: Complement, Coagulation, and Collateral Damage. J Immunol 2020;205:1488-95. [PMID: 32699160 DOI: 10.4049/jimmunol.2000644] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 22.0] [Reference Citation Analysis]
424 Knight JS, Kanthi Y. Mechanisms of immunothrombosis and vasculopathy in antiphospholipid syndrome. Semin Immunopathol 2022. [PMID: 35122116 DOI: 10.1007/s00281-022-00916-w] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
425 Kulkarni RB, Lederman Y, Afiari A, Savage JA, Jacob J. Morbilliform Rash: An Uncommon Herald of SARS-CoV-2. Cureus 2020;12:e9321. [PMID: 32850199 DOI: 10.7759/cureus.9321] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
426 Santamarina MG, Boisier D, Contreras R, Baque M, Volpacchio M, Beddings I. COVID-19: a hypothesis regarding the ventilation-perfusion mismatch. Crit Care 2020;24:395. [PMID: 32631389 DOI: 10.1186/s13054-020-03125-9] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 14.5] [Reference Citation Analysis]
427 Mohamed Khosroshahi L, Rokni M, Mokhtari T, Noorbakhsh F. Immunology, immunopathogenesis and immunotherapeutics of COVID-19; an overview. Int Immunopharmacol 2021;93:107364. [PMID: 33486333 DOI: 10.1016/j.intimp.2020.107364] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
428 Evans PC, Rainger GE, Mason JC, Guzik TJ, Osto E, Stamataki Z, Neil D, Hoefer IE, Fragiadaki M, Waltenberger J, Weber C, Bochaton-Piallat ML, Bäck M. Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science. Cardiovasc Res 2020;116:2177-84. [PMID: 32750108 DOI: 10.1093/cvr/cvaa230] [Cited by in Crossref: 89] [Cited by in F6Publishing: 83] [Article Influence: 44.5] [Reference Citation Analysis]
429 Ruggenenti P, Di Marco F, Cortinovis M, Lorini L, Sala S, Novelli L, Raimondi F, Gastoldi S, Galbusera M, Donadelli R, Mele C, Piras R, Noris M, Portalupi V, Cappelletti L, Carrara C, Tomatis F, Bernardi S, Perna A, Peracchi T, Diadei O, Benigni A, Remuzzi G. Eculizumab in patients with severe coronavirus disease 2019 (COVID-19) requiring continuous positive airway pressure ventilator support: Retrospective cohort study. PLoS One 2021;16:e0261113. [PMID: 34928990 DOI: 10.1371/journal.pone.0261113] [Reference Citation Analysis]
430 Fassan M, Collesei A, Angerilli V, Sbaraglia M, Fortarezza F, Pezzuto F, De Gaspari M, Businello G, Moni M, Rizzo S, Traverso G, Colosso V, Taschin E, Lunardi F, Valls AF, Schiavi F, Basso C, Calabrese F, Dei Tos AP. Multi-Design Differential Expression Profiling of COVID-19 Lung Autopsy Specimens Reveals Significantly Deregulated Inflammatory Pathways and SFTPC Impaired Transcription. Cells 2022;11:1011. [DOI: 10.3390/cells11061011] [Reference Citation Analysis]
431 Khandait H, Gandotra G, Sachdeva S, Kramer CA, Nye D, Golamari R, Jain R. COVID-19 and Hematology-What Do We Know So Far? SN Compr Clin Med 2020;:1-6. [PMID: 33134847 DOI: 10.1007/s42399-020-00607-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
432 Sessa F, Bertozzi G, Cipolloni L, Baldari B, Cantatore S, D'Errico S, Di Mizio G, Asmundo A, Castorina S, Salerno M, Pomara C. Clinical-Forensic Autopsy Findings to Defeat COVID-19 Disease: A Literature Review. J Clin Med 2020;9:E2026. [PMID: 32605192 DOI: 10.3390/jcm9072026] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 10.5] [Reference Citation Analysis]
433 Brumeanu TD, Vir P, Karim AF, Kar S, Benetiene D, Lok M, Greenhouse J, Putmon-Taylor T, Kitajewski C, Chung KK, Pratt KP, Casares SA. A Human-Immune-System (HIS) humanized mouse model (DRAGA: HLA-A2. HLA-DR4. Rag1 KO.IL-2Rγc KO. NOD) for COVID-19. bioRxiv 2021:2020. [PMID: 32839773 DOI: 10.1101/2020.08.19.251249] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
434 Rahi MS, Jindal V, Reyes SP, Gunasekaran K, Gupta R, Jaiyesimi I. Hematologic disorders associated with COVID-19: a review. Ann Hematol 2021;100:309-20. [PMID: 33415422 DOI: 10.1007/s00277-020-04366-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
435 Flerlage T, Boyd DF, Meliopoulos V, Thomas PG, Schultz-Cherry S. Influenza virus and SARS-CoV-2: pathogenesis and host responses in the respiratory tract. Nat Rev Microbiol 2021;19:425-41. [PMID: 33824495 DOI: 10.1038/s41579-021-00542-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
436 Poznyak AV, Bezsonov EE, Eid AH, Popkova TV, Nedosugova LV, Starodubova AV, Orekhov AN. ACE2 Is an Adjacent Element of Atherosclerosis and COVID-19 Pathogenesis. Int J Mol Sci 2021;22:4691. [PMID: 33946649 DOI: 10.3390/ijms22094691] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
437 El-Azhary RA, Nowsheen S, Gibson LE, DiCaudo DJ. Disseminated intravascular coagulopathy: a complication of Stevens-Johnson syndrome/toxic epidermal necrolysis. Int J Dermatol 2021;60:185-9. [PMID: 33332598 DOI: 10.1111/ijd.15370] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
438 Van de Walle I, Silence K, Budding K, Van de Ven L, Dijkxhoorn K, de Zeeuw E, Yildiz C, Gabriels S, Percier JM, Wildemann J, Meeldijk J, Simons PJ, Boon L, Cox L, Holgate R, Urbanus R, Otten HG, Leusen JHW, Blanchetot C, de Haard H, Hack CE, Boross P. ARGX-117, a therapeutic complement inhibiting antibody targeting C2. J Allergy Clin Immunol 2021;147:1420-1429.e7. [PMID: 32926878 DOI: 10.1016/j.jaci.2020.08.028] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
439 Marik PE, Iglesias J, Varon J, Kory P. A scoping review of the pathophysiology of COVID-19. Int J Immunopathol Pharmacol 2021;35:20587384211048026. [PMID: 34569339 DOI: 10.1177/20587384211048026] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
440 Vanegas Ramirez A, Efe D, Fischer M. Drug-induced vasculitis in a patient with COVID-19. J Eur Acad Dermatol Venereol 2020;34:e361-2. [PMID: 32378770 DOI: 10.1111/jdv.16588] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
441 Ozcelik N, Ozyurt S, Yilmaz Kara B, Gumus A, Sahin U. The value of the platelet count and platelet indices in differentiation of COVID-19 and influenza pneumonia. J Med Virol 2021;93:2221-6. [PMID: 33135801 DOI: 10.1002/jmv.26645] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
442 Larenas-Linnemann D, Luna-Pech J, Navarrete-Rodríguez EM, Rodríguez-Pérez N, Arias-Cruz A, Blandón-Vijil MV, Del Rio-Navarro BE, Estrada-Cardona A, Onuma-Takane E, Pozo-Beltrán CF, Valencia-Herrera AM, Ortiz-Aldana FI, Toledo-Bahena ME. Cutaneous Manifestations Related to COVID-19 Immune Dysregulation in the Pediatric Age Group. Curr Allergy Asthma Rep 2021;21:13. [PMID: 33630167 DOI: 10.1007/s11882-020-00986-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
443 Rodman J, Ferraz M, Baran A, Zhang B. Optical coherence tomography angiography of retinal vasculature in recovered COVID-19 patients compared to age and ethnic matched controls. Clin Exp Optom 2021;:1-6. [PMID: 34751081 DOI: 10.1080/08164622.2021.1978817] [Reference Citation Analysis]
444 O'Donnell KL, Pinski AN, Clancy CS, Gourdine T, Shifflett K, Fletcher P, Messaoudi I, Marzi A. Pathogenic and transcriptomic differences of emerging SARS-CoV-2 variants in the Syrian golden hamster model. EBioMedicine 2021;73:103675. [PMID: 34758415 DOI: 10.1016/j.ebiom.2021.103675] [Reference Citation Analysis]
445 Yu J, Yuan X, Chen H, Chaturvedi S, Braunstein EM, Brodsky RA. Direct activation of the alternative complement pathway by SARS-CoV-2 spike proteins is blocked by factor D inhibition. Blood 2020;136:2080-9. [PMID: 32877502 DOI: 10.1182/blood.2020008248] [Cited by in Crossref: 80] [Cited by in F6Publishing: 75] [Article Influence: 40.0] [Reference Citation Analysis]
446 Bhat RA, Maqbool S, Rathi A, Ali SM, Hussenbocus YAAM, Wentao X, Qu Y, Zhang Y, Sun Y, Fu HX, Wang LY, Dwivedi A, Bhat JA, Iqbal RS, Islam MM, Tibrewal A, Gao C. The Effects of the SARS-CoV-2 Virus on the Cardiovascular System and Coagulation State Leading to Cardiovascular Diseases: A Narrative Review. Inquiry 2022;59:469580221093442. [PMID: 35613600 DOI: 10.1177/00469580221093442] [Reference Citation Analysis]
447 McBane RD 2nd, Torres Roldan VD, Niven AS, Pruthi RK, Franco PM, Linderbaum JA, Casanegra AI, Oyen LJ, Houghton DE, Marshall AL, Ou NN, Siegel JL, Wysokinski WE, Padrnos LJ, Rivera CE, Flo GL, Shamoun FE, Silvers SM, Nayfeh T, Urtecho M, Shah S, Benkhadra R, Saadi SM, Firwana M, Jawaid T, Amin M, Prokop LJ, Murad MH. Anticoagulation in COVID-19: A Systematic Review, Meta-analysis, and Rapid Guidance From Mayo Clinic. Mayo Clin Proc 2020;95:2467-86. [PMID: 33153635 DOI: 10.1016/j.mayocp.2020.08.030] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 12.5] [Reference Citation Analysis]
448 Wissler Gerdes EO, Vanichkachorn G, Verdoorn BP, Hanson GJ, Joshi AY, Murad MH, Rizza SA, Hurt RT, Tchkonia T, Kirkland JL. Role of senescence in the chronic health consequences of COVID-19. Transl Res 2021:S1931-5244(21)00259-0. [PMID: 34695606 DOI: 10.1016/j.trsl.2021.10.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
449 Sharma A, Matta A, Matta D, Bande D. Non-ST Segment Elevation Myocardial Infarction Secondary to Coronary Multi-Vessel Thrombosis in the Setting of COVID-19. Cureus 2021;13:e19258. [PMID: 34881121 DOI: 10.7759/cureus.19258] [Reference Citation Analysis]
450 Mosleh W, Chen K, Pfau SE, Vashist A. Endotheliitis and Endothelial Dysfunction in Patients with COVID-19: Its Role in Thrombosis and Adverse Outcomes. J Clin Med 2020;9:E1862. [PMID: 32549229 DOI: 10.3390/jcm9061862] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 12.5] [Reference Citation Analysis]
451 Lebeau G, Vagner D, Frumence É, Ah-Pine F, Guillot X, Nobécourt E, Raffray L, Gasque P. Deciphering SARS-CoV-2 Virologic and Immunologic Features. Int J Mol Sci 2020;21:E5932. [PMID: 32824753 DOI: 10.3390/ijms21165932] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
452 Morelli C, Francavilla M, Stabile Ianora AA, Cozzolino M, Gualano A, Stellacci G, Sacco A, Lorusso F, Pedote P, De Ceglie M, Scardapane A. The Multifaceted COVID-19: CT Aspects of Its Atypical Pulmonary and Abdominal Manifestations and Complications in Adults and Children. A Pictorial Review. Microorganisms 2021;9:2037. [PMID: 34683358 DOI: 10.3390/microorganisms9102037] [Reference Citation Analysis]
453 Young S, Narang J, Kumar S, Kwizera E, Malik P, Billings SD, Ko JS, Fernandez AP. Large sacral/buttocks ulcerations in the setting of coagulopathy: A case series establishing the skin as a target organ of significant damage and potential morbidity in patients with severe COVID-19. Int Wound J 2020;17:2033-7. [PMID: 32767632 DOI: 10.1111/iwj.13457] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
454 Sodeifian F, Mushtaq S, Rezaei N. Cutaneous manifestation of COVID-19: What have we learned an year into the pandemic? Actas Dermosifiliogr 2021. [PMID: 34866636 DOI: 10.1016/j.adengl.2021.11.033] [Reference Citation Analysis]
455 Vitaliti G, Giacchi V, Sciacca M, Ruggieri M, Falsaperla R. Thrombotic events in children and adolescent patients with SARS-Cov-2 infection: a systematic review with meta-analysis on incidence and management. Expert Rev Hematol 2022. [PMID: 35757861 DOI: 10.1080/17474086.2022.2094758] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
456 Amigues I, Pearlman AH, Patel A, Reid P, Robinson PC, Sinha R, Kim AH, Youngstein T, Jayatilleke A, Konig M. Coronavirus disease 2019: investigational therapies in the prevention and treatment of hyperinflammation. Expert Rev Clin Immunol 2020;16:1185-204. [PMID: 33146561 DOI: 10.1080/1744666X.2021.1847084] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 6.5] [Reference Citation Analysis]
457 Cohen KR, Anderson D, Ren S, Cook DJ. Contribution of the elevated thrombosis risk of males to the excess male mortality observed in COVID-19: an observational study. BMJ Open 2022;12:e051624. [PMID: 35217534 DOI: 10.1136/bmjopen-2021-051624] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
458 Pillai P, Joseph JP, Fadzillah NHM, Mahmod M. COVID-19 and Major Organ Thromboembolism: Manifestations in Neurovascular and Cardiovascular Systems. J Stroke Cerebrovasc Dis 2021;30:105427. [PMID: 33137615 DOI: 10.1016/j.jstrokecerebrovasdis.2020.105427] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
459 Morrissey SM, Geller AE, Hu X, Tieri D, Ding C, Klaes CK, Cooke EA, Woeste MR, Martin ZC, Chen O, Bush SE, Zhang HG, Cavallazzi R, Clifford SP, Chen J, Ghare S, Barve SS, Cai L, Kong M, Rouchka EC, McLeish KR, Uriarte SM, Watson CT, Huang J, Yan J. A specific low-density neutrophil population correlates with hypercoagulation and disease severity in hospitalized COVID-19 patients. JCI Insight 2021;6:148435. [PMID: 33986193 DOI: 10.1172/jci.insight.148435] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
460 Tomo S, Kumar KP, Roy D, Sankanagoudar S, Purohit P, Yadav D, Banerjee M, Sharma P, Misra S. Complement activation and coagulopathy - an ominous duo in COVID19. Expert Rev Hematol 2021;14:155-73. [PMID: 33480807 DOI: 10.1080/17474086.2021.1875813] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
461 Kumar D, Trivedi N. Disease-drug and drug-drug interaction in COVID-19: Risk and assessment. Biomed Pharmacother 2021;139:111642. [PMID: 33940506 DOI: 10.1016/j.biopha.2021.111642] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
462 Gu SX, Tyagi T, Jain K, Gu VW, Lee SH, Hwa JM, Kwan JM, Krause DS, Lee AI, Halene S, Martin KA, Chun HJ, Hwa J. Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation. Nat Rev Cardiol 2021;18:194-209. [PMID: 33214651 DOI: 10.1038/s41569-020-00469-1] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 24.5] [Reference Citation Analysis]
463 Perico L, Morigi M, Galbusera M, Pezzotta A, Gastoldi S, Imberti B, Perna A, Ruggenenti P, Donadelli R, Benigni A, Remuzzi G. SARS-CoV-2 Spike Protein 1 Activates Microvascular Endothelial Cells and Complement System Leading to Platelet Aggregation. Front Immunol 2022;13:827146. [DOI: 10.3389/fimmu.2022.827146] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
464 Osuchowski MF, Aletti F, Cavaillon JM, Flohé SB, Giamarellos-Bourboulis EJ, Huber-Lang M, Relja B, Skirecki T, Szabó A, Maegele M. SARS-CoV-2/COVID-19: Evolving Reality, Global Response, Knowledge Gaps, and Opportunities. Shock 2020;54:416-37. [PMID: 32433217 DOI: 10.1097/SHK.0000000000001565] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 7.5] [Reference Citation Analysis]
465 Gallman AE, Fassett MS. Cutaneous Pathology of COVID-19 as a Window into Immunologic Mechanisms of Disease. Dermatol Clin 2021;39:533-43. [PMID: 34556243 DOI: 10.1016/j.det.2021.05.008] [Reference Citation Analysis]
466 Maincent C, Perrin C, Chironi G, Baqué-Juston M, Berthier F, Paulmier B, Hugonnet F, Dittlot C, Farhad RL, Renvoise J, Serrano B, Nataf V, Mocquot F, Keita-Perse O, Claessens YE, Faraggi M. Microvascular injuries, secondary edema, and inconsistencies in lung vascularization between affected and nonaffected pulmonary segments of non-critically ill hospitalized COVID-19 patients presenting with clinical deterioration. Ther Adv Respir Dis 2022;16:17534666221096040. [PMID: 35485327 DOI: 10.1177/17534666221096040] [Reference Citation Analysis]
467 Java A, Apicelli AJ, Liszewski MK, Coler-Reilly A, Atkinson JP, Kim AH, Kulkarni HS. The complement system in COVID-19: friend and foe? JCI Insight 2020;5:140711. [PMID: 32554923 DOI: 10.1172/jci.insight.140711] [Cited by in Crossref: 100] [Cited by in F6Publishing: 87] [Article Influence: 50.0] [Reference Citation Analysis]
468 Ahmad F, Kannan M, Ansari AW. Role of SARS-CoV-2 -induced cytokines and growth factors in coagulopathy and thromboembolism. Cytokine Growth Factor Rev 2021:S1359-6101(21)00079-4. [PMID: 34750061 DOI: 10.1016/j.cytogfr.2021.10.007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
469 Scozzi D, Cano M, Ma L, Zhou D, Zhu JH, O'Halloran JA, Goss C, Rauseo AM, Liu Z, Peritore V, Rocco M, Ricci A, Amodeo R, Aimati L, Ibrahim M, Hachem R, Kreisel D, Mudd PA, Kulkarni HS, Gelman AE. Circulating Mitochondrial DNA is an Early Indicator of Severe Illness and Mortality from COVID-19. bioRxiv 2020:2020. [PMID: 32766574 DOI: 10.1101/2020.07.30.227553] [Cited by in Crossref: 5] [Article Influence: 2.5] [Reference Citation Analysis]
470 King RAN, Climacosa FMM, Santos BMM, Caoili SEC. A Human Erythrocyte-based Haemolysis Assay for the Evaluation of Human Complement Activity. Altern Lab Anim 2020;48:127-35. [PMID: 33006498 DOI: 10.1177/0261192920953170] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
471 Song WC, FitzGerald GA. COVID-19, microangiopathy, hemostatic activation, and complement. J Clin Invest 2020;130:3950-3. [PMID: 32459663 DOI: 10.1172/JCI140183] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 12.0] [Reference Citation Analysis]
472 Chouaki Benmansour N, Carvelli J, Vivier É. [Involvement of the complement cascade in severe forms of COVID-19]. Med Sci (Paris) 2021;37:333-41. [PMID: 33835019 DOI: 10.1051/medsci/2021021] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
473 Pannone G, Caponio VCA, De Stefano IS, Ramunno MA, Meccariello M, Agostinone A, Pedicillo MC, Troiano G, Zhurakivska K, Cassano T, Bizzoca ME, Papagerakis S, Buonaguro FM, Advani S, Muzio LL. Lung histopathological findings in COVID-19 disease - a systematic review. Infect Agent Cancer 2021;16:34. [PMID: 34001199 DOI: 10.1186/s13027-021-00369-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
474 Junaid A, van Duinen V, Stam W, Dólleman S, Yang W, de Rijke Y, Endeman H, van Kooten C, Mashaghi A, de Boer H, van Gils J, Hankemeier T, van Zonneveld AJ. A Microfluidics-Based Screening Tool to Assess the Impact of Blood Plasma Factors on Microvascular Integrity. Adv Biol (Weinh) 2021;5:e2100954. [PMID: 34590440 DOI: 10.1002/adbi.202100954] [Reference Citation Analysis]
475 Blasco M, Guillén-Olmos E, Diaz-Ricart M, Palomo M. Complement Mediated Endothelial Damage in Thrombotic Microangiopathies. Front Med (Lausanne) 2022;9:811504. [PMID: 35547236 DOI: 10.3389/fmed.2022.811504] [Reference Citation Analysis]
476 van Dam PA, Huizing M, Mestach G, Dierckxsens S, Tjalma W, Trinh XB, Papadimitriou K, Altintas S, Vermorken J, Vulsteke C, Janssens A, Berneman Z, Prenen H, Meuris L, Vanden Berghe W, Smits E, Peeters M. SARS-CoV-2 and cancer: Are they really partners in crime? Cancer Treat Rev 2020;89:102068. [PMID: 32731090 DOI: 10.1016/j.ctrv.2020.102068] [Cited by in Crossref: 32] [Cited by in F6Publishing: 21] [Article Influence: 16.0] [Reference Citation Analysis]
477 Scimeca M, Urbano N, Bonfiglio R, Montanaro M, Bonanno E, Schillaci O, Mauriello A. Imaging Diagnostics and Pathology in SARS-CoV-2-Related Diseases. Int J Mol Sci 2020;21:E6960. [PMID: 32971906 DOI: 10.3390/ijms21186960] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
478 Chakraborty J, Banerjee I, Vaishya R, Ghosh S. Bioengineered in Vitro Tissue Models to Study SARS-CoV-2 Pathogenesis and Therapeutic Validation.ACS Biomater Sci Eng. 2020;6:6540. [PMID: 33320635 DOI: 10.1021/acsbiomaterials.0c01226] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
479 Mawhirt SL, Frankel D, Diaz AM. Cutaneous Manifestations in Adult Patients with COVID-19 and Dermatologic Conditions Related to the COVID-19 Pandemic in Health Care Workers. Curr Allergy Asthma Rep 2020;20:75. [PMID: 33047260 DOI: 10.1007/s11882-020-00974-w] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
480 Messina F, Giombini E, Montaldo C, Sharma AA, Zoccoli A, Sekaly RP, Locatelli F, Zumla A, Maeurer M, Capobianchi MR, Lauria FN, Ippolito G. Looking for pathways related to COVID-19: confirmation of pathogenic mechanisms by SARS-CoV-2-host interactome. Cell Death Dis 2021;12:788. [PMID: 34385425 DOI: 10.1038/s41419-021-03881-8] [Reference Citation Analysis]
481 Gauchel N, Krauel K, Hamad MA, Bode C, Duerschmied D. Thromboinflammation as a Driver of Venous Thromboembolism. Hamostaseologie 2021;41:428-32. [PMID: 34942655 DOI: 10.1055/a-1661-0257] [Reference Citation Analysis]
482 García-Cervera C, Giner-Galvañ V, Wikman-Jorgensen P, Laureiro J, Rubio-Rivas M, Gurjian Arena A, Arnalich-Fernandez F, Beato Pérez JL, Vargas Núñez JA, González Igual JJ, Díez-Manglano J, Méndez Bailón M, García Blanco MJ, Freire Castro SJ, Aranda Lobo J, Manzano L, Magallanes Gamboa JO, Arribas Pérez L, González Moraleja J, Calderón Hernaiz R, García Alegría J, González Noya A, Gómez Huelgas R, Lumbreras Bermejo C, Antón Santos JM; SEMI-COVID-19 Network. Estimation of Admission D-dimer Cut-off Value to Predict Venous Thrombotic Events in Hospitalized COVID-19 Patients: Analysis of the SEMI-COVID-19 Registry. J Gen Intern Med 2021. [PMID: 34287774 DOI: 10.1007/s11606-021-07017-8] [Reference Citation Analysis]
483 Świerzko AS, Cedzyński M. The Influence of the Lectin Pathway of Complement Activation on Infections of the Respiratory System. Front Immunol 2020;11:585243. [PMID: 33193407 DOI: 10.3389/fimmu.2020.585243] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
484 Beaudoin CA, Jamasb AR, Alsulami AF, Copoiu L, van Tonder AJ, Hala S, Bannerman BP, Thomas SE, Vedithi SC, Torres PHM, Blundell TL. Predicted structural mimicry of spike receptor-binding motifs from highly pathogenic human coronaviruses. Comput Struct Biotechnol J 2021. [PMID: 34234921 DOI: 10.1016/j.csbj.2021.06.041] [Reference Citation Analysis]
485 Parchure P, Joshi H, Dharmarajan K, Freeman R, Reich DL, Mazumdar M, Timsina P, Kia A. Development and validation of a machine learning-based prediction model for near-term in-hospital mortality among patients with COVID-19. BMJ Support Palliat Care 2020:bmjspcare-2020-002602. [PMID: 32963059 DOI: 10.1136/bmjspcare-2020-002602] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
486 Sattur SS, Sattur IS. COVID-19 Infection: Impact on Hair. Indian J Plast Surg 2021;54:521-6. [PMID: 34984095 DOI: 10.1055/s-0041-1740289] [Reference Citation Analysis]
487 Fodor A, Tiperciuc B, Login C, Orasan OH, Lazar AL, Buchman C, Hanghicel P, Sitar-Taut A, Suharoschi R, Vulturar R, Cozma A. Endothelial Dysfunction, Inflammation, and Oxidative Stress in COVID-19-Mechanisms and Therapeutic Targets. Oxid Med Cell Longev 2021;2021:8671713. [PMID: 34457119 DOI: 10.1155/2021/8671713] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
488 Muscogiuri G, Pugliese G, Barrea L, Savastano S, Colao A. Commentary: Obesity: The "Achilles heel" for COVID-19? Metabolism 2020;108:154251. [PMID: 32353356 DOI: 10.1016/j.metabol.2020.154251] [Cited by in Crossref: 128] [Cited by in F6Publishing: 105] [Article Influence: 64.0] [Reference Citation Analysis]
489 Laurence J, Mulvey JJ, Seshadri M, Racanelli A, Harp J, Schenck EJ, Zappetti D, Horn EM, Magro CM. Anti-complement C5 therapy with eculizumab in three cases of critical COVID-19. Clin Immunol 2020;219:108555. [PMID: 32771488 DOI: 10.1016/j.clim.2020.108555] [Cited by in Crossref: 46] [Cited by in F6Publishing: 37] [Article Influence: 23.0] [Reference Citation Analysis]
490 Soldera D, Soares CF, Girondi JBR, Salum NC, Stein M, Amante LN, Sebold LF, Miranda GM. PREVENTION OF PRESSURE INJURIES IN THE PRONATION OF COVID-19 PATIENTS: CONSTRUCTION OF A GRAPHIC NARRATIVE. ESTIMA, Braz J Enterostomal Ther . [DOI: 10.30886/estima.v19.1136_in] [Reference Citation Analysis]
491 . Scientific and Clinical Abstracts From WOCNext® 2021: An Online Event ♦ June 24-26, 2021. J Wound Ostomy Continence Nurs 2021;48:S1-S49. [PMID: 34002732 DOI: 10.1097/WON.0000000000000772] [Reference Citation Analysis]
492 Ikonne EU, Ikpeazu VO, Ugbogu OC, Emmanuel O, Nwakuche IP, Iweala EJ, Ugbogu EA. A review on the clinical trials of repurposing therapeutic drugs, mechanisms and preventive measures against SARS-CoV-2. Drug Metab Pers Ther 2021. [PMID: 33818026 DOI: 10.1515/dmpt-2020-0184] [Reference Citation Analysis]
493 Ad’hiah AH, Abdullah MH, Alsudani MY, Shnawa RMS, Al-sa’ady AJR, Allami RH, Misha’al KI, Jassim IA, Taqi EA. Association between ABO blood groups and susceptibility to COVID-19: profile of age and gender in Iraqi patients. Egypt J Med Hum Genet 2020;21. [DOI: 10.1186/s43042-020-00115-y] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
494 Annane D, Heming N, Grimaldi-Bensouda L, Frémeaux-Bacchi V, Vigan M, Roux AL, Marchal A, Michelon H, Rottman M, Moine P; Garches COVID 19 Collaborative Group. Eculizumab as an emergency treatment for adult patients with severe COVID-19 in the intensive care unit: A proof-of-concept study. EClinicalMedicine 2020;28:100590. [PMID: 33173853 DOI: 10.1016/j.eclinm.2020.100590] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 19.0] [Reference Citation Analysis]
495 Angeles Montero-Fernandez M, Pardo-Garcia R. Histopathology features of the lung in COVID-19 patients. Diagn Histopathol (Oxf) 2021;27:123-7. [PMID: 33312229 DOI: 10.1016/j.mpdhp.2020.11.009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
496 Zinellu A, Mangoni AA. Serum Complement C3 and C4 and COVID-19 Severity and Mortality: A Systematic Review and Meta-Analysis With Meta-Regression. Front Immunol 2021;12:696085. [PMID: 34163491 DOI: 10.3389/fimmu.2021.696085] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
497 Knight AC, Montgomery SA, Fletcher CA, Baxter VK. Mouse Models for the Study of SARS-CoV-2 Infection. Comp Med 2021;71:383-97. [PMID: 34610856 DOI: 10.30802/AALAS-CM-21-000031] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
498 Juhász MF, Ocskay K, Kiss S, Hegyi P, Párniczky A. Insufficient etiological workup of COVID-19-associated acute pancreatitis: A systematic review. World J Gastroenterol 2020; 26(40): 6270-6278 [PMID: 33177799 DOI: 10.3748/wjg.v26.i40.6270] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
499 Cugno M, Meroni PL, Gualtierotti R, Griffini S, Grovetti E, Torri A, Lonati P, Grossi C, Borghi MO, Novembrino C, Boscolo M, Uceda Renteria SC, Valenti L, Lamorte G, Manunta M, Prati D, Pesenti A, Blasi F, Costantino G, Gori A, Bandera A, Tedesco F, Peyvandi F. Complement activation and endothelial perturbation parallel COVID-19 severity and activity. J Autoimmun 2021;116:102560. [PMID: 33139116 DOI: 10.1016/j.jaut.2020.102560] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 15.0] [Reference Citation Analysis]
500 Castro P, Palomo M, Moreno-Castaño AB, Fernández S, Torramadé-Moix S, Pascual G, Martinez-Sanchez J, Richardson E, Téllez A, Nicolas JM, Carreras E, Richardson PG, Badimon JJ, Escolar G, Diaz-Ricart M. Is the Endothelium the Missing Link in the Pathophysiology and Treatment of COVID-19 Complications? Cardiovasc Drugs Ther 2021. [PMID: 34097193 DOI: 10.1007/s10557-021-07207-w] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
501 Buckland MS, Galloway JB, Fhogartaigh CN, Meredith L, Provine NM, Bloor S, Ogbe A, Zelek WM, Smielewska A, Yakovleva A, Mann T, Bergamaschi L, Turner L, Mescia F, Toonen EJM, Hackstein CP, Akther HD, Vieira VA, Ceron-Gutierrez L, Periselneris J, Kiani-Alikhan S, Grigoriadou S, Vaghela D, Lear SE, Török ME, Hamilton WL, Stockton J, Quick J, Nelson P, Hunter M, Coulter TI, Devlin L, Bradley JR, Smith KGC, Ouwehand WH, Estcourt L, Harvala H, Roberts DJ, Wilkinson IB, Screaton N, Loman N, Doffinger R, Lyons PA, Morgan BP, Goodfellow IG, Klenerman P, Lehner PJ, Matheson NJ, Thaventhiran JED; CITIID-NIHR COVID-19 BioResource Collaboration., MRC-Toxicology Unit COVID-19 Consortium. Treatment of COVID-19 with remdesivir in the absence of humoral immunity: a case report. Nat Commun 2020;11:6385. [PMID: 33318491 DOI: 10.1038/s41467-020-19761-2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 26] [Article Influence: 10.0] [Reference Citation Analysis]
502 Odilov A, Volkov A, Abdullaev A, Gasanova T, Lipina T, Babichenko I. COVID-19: Multiorgan Dissemination of SARS-CoV-2 Is Driven by Pulmonary Factors. Viruses 2021;14:39. [PMID: 35062243 DOI: 10.3390/v14010039] [Reference Citation Analysis]
503 Quintana-Castanedo L, Feito-Rodríguez M, Fernández-Alcalde C, Granados-Fernández M, Montero-Vega D, Mayor-Ibarguren A, de Lucas-Laguna R. Concurrent chilblains and retinal vasculitis in a child with COVID-19. J Eur Acad Dermatol Venereol 2020;34:e764-6. [PMID: 32618041 DOI: 10.1111/jdv.16801] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
504 Stark K, Massberg S. Interplay between inflammation and thrombosis in cardiovascular pathology. Nat Rev Cardiol 2021;18:666-82. [PMID: 33958774 DOI: 10.1038/s41569-021-00552-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
505 Bose P, Sunita P, Pattanayak SP. Molecular Insights into the Crosstalk Between Immune Inflammation Nexus and SARS-CoV-2 Virus. Curr Microbiol 2021;78:3813-28. [PMID: 34550435 DOI: 10.1007/s00284-021-02657-9] [Reference Citation Analysis]
506 Wang L, Gao Y, Zhang ZJ, Pan CK, Wang Y, Zhu YC, Qi YP, Xie FJ, Du X, Li NN, Chen PF, Yue CS, Wu JH, Wang XT, Tang YJ, Lai QQ, Kang K. Comparison of demographic features and laboratory parameters between COVID-19 deceased patients and surviving severe and critically ill cases. World J Clin Cases 2022; 10(23): 8161-8169 [DOI: 10.12998/wjcc.v10.i23.8161] [Reference Citation Analysis]
507 Palazzuoli A, Giustozzi M, Ruocco G, Tramonte F, Gronda E, Agnelli G. Thromboembolic Complications in Covid-19: From Clinical Scenario to Laboratory Evidence. Life (Basel) 2021;11:395. [PMID: 33925334 DOI: 10.3390/life11050395] [Reference Citation Analysis]
508 Majumdar S, Verma R, Saha A, Bhattacharyya P, Maji P, Surjit M, Kundu M, Basu J, Saha S. Perspectives About Modulating Host Immune System in Targeting SARS-CoV-2 in India. Front Genet 2021;12:637362. [PMID: 33664772 DOI: 10.3389/fgene.2021.637362] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
509 Ionescu F, Jaiyesimi I, Petrescu I, Lawler PR, Castillo E, Munoz-Maldonado Y, Imam Z, Narasimhan M, Abbas AE, Konde A, Nair GB. Association of anticoagulation dose and survival in hospitalized COVID-19 patients: A retrospective propensity score-weighted analysis. Eur J Haematol 2021;106:165-74. [PMID: 33043484 DOI: 10.1111/ejh.13533] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 9.5] [Reference Citation Analysis]
510 Yokoi S, Iwata Y, Tanaka Y, Sugiura K. COVID-19-associated livedo and purpura: clinical and histopathological findings. Eur J Dermatol 2021. [PMID: 34405810 DOI: 10.1684/ejd.2021.4084] [Reference Citation Analysis]
511 Russo V, Cardillo G, Viggiano GV, Mangiacapra S, Cavalli A, Fontanella A, Agrusta F, Bellizzi A, Amitrano M, Iannuzzo M, Sacco C, Lodigiani C, Castaldo G, Di Micco P. Thromboprofilaxys With Fondaparinux vs. Enoxaparin in Hospitalized COVID-19 Patients: A Multicenter Italian Observational Study. Front Med (Lausanne) 2020;7:569567. [PMID: 33330530 DOI: 10.3389/fmed.2020.569567] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
512 Sadeghzadeh-Bazargan A, Rezai M, Najar Nobari N, Mozafarpoor S, Goodarzi A. Skin manifestations as potential symptoms of diffuse vascular injury in critical COVID-19 patients. J Cutan Pathol 2021. [PMID: 33978234 DOI: 10.1111/cup.14059] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
513 Malone RW, Tisdall P, Fremont-Smith P, Liu Y, Huang XP, White KM, Miorin L, Olmo EMD, Alon A, Delaforge E, Hennecker CD, Wang G, Pottel J, Smith N, Hall JM, Shapiro G, Mittermaier A, Kruse AC, García-Sastre A, Roth BL, Glasspool-Malone J, Ricke DO. COVID-19: Famotidine, Histamine, Mast Cells, and Mechanisms. Res Sq 2020:rs. [PMID: 32702719 DOI: 10.21203/rs.3.rs-30934/v2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
514 Jung F, Krüger-Genge A, Franke RP, Hufert F, Küpper JH. COVID-19 and the endothelium. Clin Hemorheol Microcirc 2020;75:7-11. [PMID: 32568187 DOI: 10.3233/CH-209007] [Cited by in Crossref: 35] [Cited by in F6Publishing: 17] [Article Influence: 17.5] [Reference Citation Analysis]
515 Zamani Rarani F, Zamani Rarani M, Hamblin MR, Rashidi B, Hashemian SMR, Mirzaei H. Comprehensive overview of COVID-19-related respiratory failure: focus on cellular interactions. Cell Mol Biol Lett 2022;27:63. [PMID: 35907817 DOI: 10.1186/s11658-022-00363-3] [Reference Citation Analysis]
516 Abourida Y, Rebahi H, Chichou H, Fenane H, Msougar Y, Fakhri A, Hazmiri FE, Ismail A, Rais H, Soraa N, Samkaoui MA. What Open-Lung Biopsy Teaches Us about ARDS in COVID-19 Patients: Mechanisms, Pathology, and Therapeutic Implications. Biomed Res Int 2020;2020:2909673. [PMID: 33376717 DOI: 10.1155/2020/2909673] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
517 Wu T, Zuo Z, Yang D, Luo X, Jiang L, Xia Z, Xiao X, Liu J, Ye M, Deng M. Venous thromboembolic events in patients with COVID-19: a systematic review and meta-analysis. Age Ageing 2021;50:284-93. [PMID: 33201226 DOI: 10.1093/ageing/afaa259] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 12.0] [Reference Citation Analysis]
518 Ong E, Castro-Dominguez Y, Brennan J, Oen-Hsiao J. COVID-19 complicated by ST-segment elevation myocardial infarction in a 29-year-old patient. Catheter Cardiovasc Interv 2021;97:267-71. [PMID: 32672402 DOI: 10.1002/ccd.29102] [Reference Citation Analysis]
519 Stahel PF, Barnum SR. Complement Inhibition in Coronavirus Disease (COVID)-19: A Neglected Therapeutic Option. Front Immunol 2020;11:1661. [PMID: 32733489 DOI: 10.3389/fimmu.2020.01661] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 9.5] [Reference Citation Analysis]
520 Bunprakob S, Hemachudha P, Ruchisrisarod C, Supharatpariyakorn T, Hemachudha T. IP-10 and complement activation as friend or foe in COVID-19. Int J Immunopathol Pharmacol 2022;36:039463202210962. [DOI: 10.1177/03946320221096202] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
521 Heinz C, Miesbach W, Herrmann E, Sonntagbauer M, Raimann FJ, Zacharowski K, Weber CF, Adam EH. Greater Fibrinolysis Resistance but No Greater Platelet Aggregation in Critically Ill COVID-19 Patients. Anesthesiology 2021;134:457-67. [PMID: 33417674 DOI: 10.1097/ALN.0000000000003685] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
522 Soldati G, Giannasi G, Smargiassi A, Inchingolo R, Demi L. Contrast-Enhanced Ultrasound in Patients With COVID-19: Pneumonia, Acute Respiratory Distress Syndrome, or Something Else? J Ultrasound Med 2020;39:2483-9. [PMID: 32395910 DOI: 10.1002/jum.15338] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 9.5] [Reference Citation Analysis]
523 Gando S, Wada T. Thromboplasminflammation in COVID-19 Coagulopathy: Three Viewpoints for Diagnostic and Therapeutic Strategies. Front Immunol 2021;12:649122. [PMID: 34177896 DOI: 10.3389/fimmu.2021.649122] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
524 Lupu L, Palmer A, Huber-Lang M. Inflammation, Thrombosis, and Destruction: The Three-Headed Cerberus of Trauma- and SARS-CoV-2-Induced ARDS. Front Immunol. 2020;11:584514. [PMID: 33101314 DOI: 10.3389/fimmu.2020.584514] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
525 Rajan A, Thirunavukkarasu GK, Lockey RF, Kolliputi N. Is the mechanism of COVID-19 coagulopathy still a rabbit's hole? J Cell Commun Signal 2021. [PMID: 34076828 DOI: 10.1007/s12079-021-00613-7] [Reference Citation Analysis]
526 Aggarwal A, Cohen E, Figueira M, Sabharwal V, Herlihy JM, Bronwen C, Barnett ED, Pelton SI, Camelo IY. Multisystem Inflammatory Syndrome in an Adult With COVID-19-A Trial of Anakinra: A Case Report. Infect Dis Clin Pract (Baltim Md) 2021;29:e420-3. [PMID: 34803350 DOI: 10.1097/IPC.0000000000001028] [Reference Citation Analysis]
527 Musumeci ML, Nasca MR, Micali G. COVID-19: The Italian experience. Clin Dermatol 2021;39:418-23. [PMID: 34517999 DOI: 10.1016/j.clindermatol.2021.01.013] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
528 Mohammed Y, Goodlett DR, Cheng MP, Vinh DC, Lee TC, Mcgeer A, Sweet D, Tran K, Lee T, Murthy S, Boyd JH, Singer J, Walley KR, Patrick DM, Quan C, Ismail S, Amar L, Pal A, Bassawon R, Fesdekjian L, Gou K, Lamontagne F, Marshall J, Haljan G, Fowler R, Winston BW, Russell JA; ARBs CORONA I. Longitudinal Plasma Proteomics Analysis Reveals Novel Candidate Biomarkers in Acute COVID-19. J Proteome Res 2022. [PMID: 35143212 DOI: 10.1021/acs.jproteome.1c00863] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
529 Salerno M, Sessa F, Piscopo A, Montana A, Torrisi M, Patanè F, Murabito P, Volti GL, Pomara C. No Autopsies on COVID-19 Deaths: A Missed Opportunity and the Lockdown of Science. J Clin Med 2020;9:E1472. [PMID: 32422983 DOI: 10.3390/jcm9051472] [Cited by in Crossref: 49] [Cited by in F6Publishing: 39] [Article Influence: 24.5] [Reference Citation Analysis]
530 Ghareeb DA, Saleh SR, Nofal MS, Kaddah MMY, Hassan SF, Seif IK, El-Zahaby SA, Khedr SM, Kenawy MY, Masoud AA, Soudi SA, Sobhy AA, Sery JG, El-Wahab MGA, Elmoneam AAA, Al-Mahallawi AM, El-Demellawy MA. Potential therapeutic and pharmacological strategies for SARS-CoV2. J Pharm Investig 2021;:1-16. [PMID: 33688448 DOI: 10.1007/s40005-021-00520-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
531 Wang X, Gkrouzman E, Andrade DCO, Andreoli L, Barbhaiya M, Belmont HM, Branch DW, de Jesús GR, Efthymiou M, Ríos-Garcés R, Gerosa M, El Hasbani G, Knight J, Meroni PL, Pazzola G, Petri M, Rand J, Salmon J, Tektonidou M, Tincani A, Uthman IW, Zuily S, Zuo Y, Lockshin M, Cohen H, Erkan D; APS ACTION. COVID-19 and antiphospholipid antibodies: A position statement and management guidance from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION). Lupus 2021;:9612033211062523. [PMID: 34915764 DOI: 10.1177/09612033211062523] [Reference Citation Analysis]
532 Mohamed IZB, Balson L, Madathil S. Massive bilateral stroke in a COVID-19 patient. BMJ Case Rep 2020;13:e236254. [PMID: 32816935 DOI: 10.1136/bcr-2020-236254] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
533 Wang X, Sahu KK, Cerny J. Coagulopathy, endothelial dysfunction, thrombotic microangiopathy and complement activation: potential role of complement system inhibition in COVID-19. J Thromb Thrombolysis 2021;51:657-62. [PMID: 33063256 DOI: 10.1007/s11239-020-02297-z] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
534 Pike A, Muus P, Munir T, Mitchell L, Arnold L, Riley K, Houghton N, Forrest B, Gachev J, Hillmen P, Griffin M. COVID-19 infection in patients on anti-complement therapy: The Leeds National Paroxysmal Nocturnal Haemoglobinuria service experience. Br J Haematol 2020;191:e1-4. [PMID: 32945525 DOI: 10.1111/bjh.17097] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
535 Gavriilaki E, Brodsky RA. Severe COVID‐19 infection and thrombotic microangiopathy: success does not come easily. Br J Haematol 2020;189. [DOI: 10.1111/bjh.16783] [Cited by in Crossref: 95] [Cited by in F6Publishing: 84] [Article Influence: 47.5] [Reference Citation Analysis]
536 Durazo FA, Nicholas AA, Mahaffey JJ, Sova S, Evans JJ, Trivella JP, Loy V, Kim J, Zimmerman MA, Hong JC. Post-Covid-19 Cholangiopathy-A New Indication for Liver Transplantation: A Case Report. Transplant Proc 2021;53:1132-7. [PMID: 33846012 DOI: 10.1016/j.transproceed.2021.03.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
537 Ailioaie LM, Ailioaie C, Litscher G. Implications of SARS-CoV-2 Infection in Systemic Juvenile Idiopathic Arthritis. Int J Mol Sci 2022;23:4268. [PMID: 35457086 DOI: 10.3390/ijms23084268] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
538 Mohta A, Mohta A, Nai RS, Arora A, Jain SK, Mohta A, Mehta RD, Ghiya BC, Prasad V, Khokhar R, Toteja R, Bha Rgava G. An Observational Study of Mucocutaneous Manifestations among SARS-CoV-2 Patients from Three COVID-19 Dedicated Tertiary Care Centers. Indian Dermatol Online J 2021;12:687-95. [PMID: 34667754 DOI: 10.4103/idoj.IDOJ_127_21] [Reference Citation Analysis]
539 Mizurini DM, Hottz ED, Bozza PT, Monteiro RQ. Fundamentals in Covid-19-Associated Thrombosis: Molecular and Cellular Aspects. Front Cardiovasc Med 2021;8:785738. [PMID: 34977191 DOI: 10.3389/fcvm.2021.785738] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
540 Sahay S, Farber HW. Management of hospitalized patients with pulmonary arterial hypertension and COVID-19 infection. Pulm Circ 2020;10:2045894020933480. [PMID: 32595934 DOI: 10.1177/2045894020933480] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
541 Giryes S, Bragazzi NL, Bridgewood C, De Marco G, McGonagle D. COVID-19 Vasculitis and vasculopathy-Distinct immunopathology emerging from the close juxtaposition of Type II Pneumocytes and Pulmonary Endothelial Cells. Semin Immunopathol 2022. [PMID: 35412072 DOI: 10.1007/s00281-022-00928-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
542 Burks SM, Rosas-Hernandez H, Alejandro Ramirez-Lee M, Cuevas E, Talpos JC. Can SARS-CoV-2 infect the central nervous system via the olfactory bulb or the blood-brain barrier? Brain Behav Immun 2021;95:7-14. [PMID: 33412255 DOI: 10.1016/j.bbi.2020.12.031] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
543 Lämmle B, Rossmann H. Invited commentary to: ADAMTS13 deficiency is associated with abnormal distribution of von Willebrand factor multimers in patients with COVID-19 by Tiffany Pascreau et al. Letter to the Editors-in-Chief, Thrombosis Research. Thromb Res 2021;204:141-2. [PMID: 33678420 DOI: 10.1016/j.thromres.2021.02.030] [Reference Citation Analysis]
544 Gustafson D, Raju S, Wu R, Ching C, Veitch S, Rathnakumar K, Boudreau E, Howe KL, Fish JE. Overcoming Barriers: The Endothelium As a Linchpin of Coronavirus Disease 2019 Pathogenesis? Arterioscler Thromb Vasc Biol 2020;40:1818-29. [PMID: 32510978 DOI: 10.1161/ATVBAHA.120.314558] [Cited by in Crossref: 33] [Cited by in F6Publishing: 18] [Article Influence: 16.5] [Reference Citation Analysis]
545 Dalamaga M, Christodoulatos GS, Karampela I, Vallianou N, Apovian CM. Understanding the Co-Epidemic of Obesity and COVID-19: Current Evidence, Comparison with Previous Epidemics, Mechanisms, and Preventive and Therapeutic Perspectives. Curr Obes Rep 2021. [PMID: 33909265 DOI: 10.1007/s13679-021-00436-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
546 Ogawa M, Doo FX, Somwaru AS, Roudenko A, Kamath A, Friedman B. Peripheral arterial occlusion due to COVID-19: CT angiography findings of nine patients. Clin Imaging 2021;73:43-7. [PMID: 33307372 DOI: 10.1016/j.clinimag.2020.11.023] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
547 Ai J, Hong W, Wu M, Wei X. Pulmonary vascular system: A vulnerable target for COVID-19. MedComm (2020) 2021. [PMID: 34909758 DOI: 10.1002/mco2.94] [Reference Citation Analysis]
548 Noris M. The case of complement inhibitors. Adv Biol Regul 2021;81:100822. [PMID: 34454870 DOI: 10.1016/j.jbior.2021.100822] [Reference Citation Analysis]
549 Kumari B, Hajela K, Ali A, Sharma AK, Yadav RK, Ranjan A, Nair R, Bharti S, Dipankar S, Singh PK, Sharma S. Evaluation of C4b as an adjunct marker in symptomatic RT-PCR negative Covid-19 cases. Indian J Clin Biochem 2022;:1-8. [PMID: 35756690 DOI: 10.1007/s12291-022-01033-z] [Reference Citation Analysis]
550 Papait A, Cargnoni A, Sheleg M, Silini AR, Kunis G, Ofir R, Parolini O. Perinatal Cells: A Promising COVID-19 Therapy? Front Bioeng Biotechnol 2020;8:619980. [PMID: 33520970 DOI: 10.3389/fbioe.2020.619980] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
551 Brandão MGSA, Barros LM, de Aquino Mendonça J, de Oliveira AR, de Araújo TM, Veras VS. Clinical and histopathological findings of cutaneous manifestations of COVID-19 patients. Dermatol Ther 2020;33:e13926. [PMID: 32779817 DOI: 10.1111/dth.13926] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
552 Boix-Vilanova J, Gracia-Darder I, Saus C, Ramos D, Llull A, Santonja C, Del Pozo LJ, Martín-Santiago A. Grover-like skin eruption: another cutaneous manifestation in a COVID-19 patient. Int J Dermatol 2020;59:1290-2. [PMID: 32880914 DOI: 10.1111/ijd.15104] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
553 Sanghvi AR. COVID-19: An overview for dermatologists. Int J Dermatol 2020;59:1437-49. [PMID: 33107038 DOI: 10.1111/ijd.15257] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 4.5] [Reference Citation Analysis]
554 Carissimo G, Xu W, Kwok I, Abdad MY, Chan YH, Fong SW, Puan KJ, Lee CY, Yeo NK, Amrun SN, Chee RS, How W, Chan S, Fan BE, Andiappan AK, Lee B, Rötzschke O, Young BE, Leo YS, Lye DC, Renia L, Ng LG, Larbi A, Ng LF. Whole blood immunophenotyping uncovers immature neutrophil-to-VD2 T-cell ratio as an early marker for severe COVID-19. Nat Commun 2020;11:5243. [PMID: 33067472 DOI: 10.1038/s41467-020-19080-6] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 21.0] [Reference Citation Analysis]
555 Vaughan CJ, Cronin H, Ryan PM, Caplice NM. Obesity and COVID-19: A Virchow's Triad for the 21st Century. Thromb Haemost 2020;120:1590-3. [PMID: 32679596 DOI: 10.1055/s-0040-1714216] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
556 Fernandez-Nieto D, Ortega-Quijano D, Jimenez-Cauhe J, Burgos-Blasco P, de Perosanz-Lobo D, Suarez-Valle A, Cortes-Cuevas JL, Carretero I, Garcia-Del Real C, Fernandez-Guarino M. Clinical and histological characterization of vesicular COVID-19 rashes: a prospective study in a tertiary care hospital. Clin Exp Dermatol 2020;45:872-5. [PMID: 32384180 DOI: 10.1111/ced.14277] [Cited by in Crossref: 53] [Cited by in F6Publishing: 39] [Article Influence: 26.5] [Reference Citation Analysis]
557 Veldtman GR, Pirisi M, Storti E, Roomi A, Fadl-Elmula FEM, Vriz O, Bokhari S, Ammash N, Salam Y, Liu GZ, Spinelli S, Barbieri G, Hashmi S. Management principles in patients with COVID-19: perspectives from a growing global experience with emphasis on cardiovascular surveillance. Open Heart 2020;7:e001357. [PMID: 33168640 DOI: 10.1136/openhrt-2020-001357] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
558 Weichmann F, Rohdewald P. Projected supportive effects of Pycnogenol in patients suffering from multi-dimensional health impairments after a SARS-CoV2 infection. Int J Antimicrob Agents 2020;56:106191. [PMID: 33045354 DOI: 10.1016/j.ijantimicag.2020.106191] [Reference Citation Analysis]
559 Sadegh Beigee F, Pourabdollah Toutkaboni M, Khalili N, Nadji SA, Dorudinia A, Rezaei M, Askari E, Farzanegan B, Marjani M, Rafiezadeh A. Diffuse alveolar damage and thrombotic microangiopathy are the main histopathological findings in lung tissue biopsy samples of COVID-19 patients. Pathol Res Pract 2020;216:153228. [PMID: 32979740 DOI: 10.1016/j.prp.2020.153228] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
560 Farinazzo E, Dianzani C, Zalaudek I, Conforti C, Grabbe S, Goldust M. Synthesis of the Data on COVID-19 Skin Manifestations: Underlying Mechanisms and Potential Outcomes. Clin Cosmet Investig Dermatol 2021;14:991-7. [PMID: 34385830 DOI: 10.2147/CCID.S325552] [Reference Citation Analysis]
561 Cadd M, Nunn M. An A-E assessment of post-ICU COVID-19 recovery. J Intensive Care 2021;9:29. [PMID: 33743819 DOI: 10.1186/s40560-021-00544-w] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
562 Quenzer F, Smyres C, Tabarez N, Singh S, LaFree A, Tomaszewski C, Hayden SR. Large Cerebellar Stroke in a Young COVID-19-Positive Patient: Case Report. J Emerg Med 2021;61:29-36. [PMID: 33863570 DOI: 10.1016/j.jemermed.2021.02.004] [Reference Citation Analysis]
563 Spence JD, de Freitas GR, Pettigrew LC, Ay H, Liebeskind DS, Kase CS, Del Brutto OH, Hankey GJ, Venketasubramanian N. Mechanisms of Stroke in COVID-19. Cerebrovasc Dis 2020;49:451-8. [PMID: 32690850 DOI: 10.1159/000509581] [Cited by in Crossref: 47] [Cited by in F6Publishing: 34] [Article Influence: 23.5] [Reference Citation Analysis]
564 Bhayana R, Som A, Li MD, Carey DE, Anderson MA, Blake MA, Catalano O, Gee MS, Hahn PF, Harisinghani M, Kilcoyne A, Lee SI, Mojtahed A, Pandharipande PV, Pierce TT, Rosman DA, Saini S, Samir AE, Simeone JF, Gervais DA, Velmahos G, Misdraji J, Kambadakone A. Abdominal Imaging Findings in COVID-19: Preliminary Observations. Radiology. 2020;297:E207-E215. [PMID: 32391742 DOI: 10.1148/radiol.2020201908] [Cited by in Crossref: 121] [Cited by in F6Publishing: 110] [Article Influence: 60.5] [Reference Citation Analysis]
565 Loh JT, Zhang B, Teo JKH, Lai RC, Choo ABH, Lam KP, Lim SK. Mechanism for the attenuation of neutrophil and complement hyperactivity by MSC exosomes. Cytotherapy 2022:S1465-3249(22)00018-4. [PMID: 35177337 DOI: 10.1016/j.jcyt.2021.12.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
566 Fahmy OH, Daas FM, Salunkhe V, Petrey JL, Cosar EF, Ramirez J, Akca O. Is Microthrombosis the Main Pathology in Coronavirus Disease 2019 Severity?-A Systematic Review of the Postmortem Pathologic Findings. Crit Care Explor 2021;3:e0427. [PMID: 34036278 DOI: 10.1097/CCE.0000000000000427] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
567 Ismail Z, Salabei JK, Stanger G, Asnake ZT, Frimer L, Smock A. Third-Degree Heart Block Associated With Saddle Pulmonary Embolism: A Rare Sequelae of COVID-19-Induced Hypercoagulable State. Cureus 2021;13:e16246. [PMID: 34381643 DOI: 10.7759/cureus.16246] [Reference Citation Analysis]
568 Cuschieri S, Grech S. COVID-19 and diabetes: The why, the what and the how. J Diabetes Complications 2020;34:107637. [PMID: 32456846 DOI: 10.1016/j.jdiacomp.2020.107637] [Cited by in Crossref: 37] [Cited by in F6Publishing: 29] [Article Influence: 18.5] [Reference Citation Analysis]
569 Kolilekas L, Loverdos K, Giannakaki S, Vlassi L, Levounets A, Zervas E, Gaga M. Can steroids reverse the severe COVID-19 induced "cytokine storm"? J Med Virol 2020;92:2866-9. [PMID: 32530507 DOI: 10.1002/jmv.26165] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 12.5] [Reference Citation Analysis]
570 Sarkar M, Madabhavi IV, Quy PN, Govindagoudar MB. COVID-19 and coagulopathy. Clin Respir J 2021. [PMID: 34399021 DOI: 10.1111/crj.13438] [Reference Citation Analysis]
571 Ali L, Naeem M, Canibano B, John A, Iqrar A. Bilateral Acute Optic Perineuritis Associated With COVID-19 in a Patient With Seronegative Myelin Oligodendrocyte Glycoprotein (MOG) Antibody. Cureus 2021;13:e18234. [PMID: 34712522 DOI: 10.7759/cureus.18234] [Reference Citation Analysis]
572 Ghosh R, Roy D, Mandal A, Pal SK, Chandra Swaika B, Naga D, Pandit A, Ray BK, Benito-León J. Cerebral venous thrombosis in COVID-19. Diabetes Metab Syndr 2021;15:1039-45. [PMID: 34015627 DOI: 10.1016/j.dsx.2021.04.026] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 12.0] [Reference Citation Analysis]
573 Shin CH, Kim KH, Jeeva S, Kang SM. Towards Goals to Refine Prophylactic and Therapeutic Strategies Against COVID-19 Linked to Aging and Metabolic Syndrome. Cells 2021;10:1412. [PMID: 34204163 DOI: 10.3390/cells10061412] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
574 Li J, Liu B. The roles and potential therapeutic implications of C5a in the pathogenesis of COVID-19-associated coagulopathy. Cytokine Growth Factor Rev 2021;58:75-81. [PMID: 33558131 DOI: 10.1016/j.cytogfr.2020.12.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
575 Saini G, Swahn MH, Aneja R. Disentangling the Coronavirus Disease 2019 Health Disparities in African Americans: Biological, Environmental, and Social Factors. Open Forum Infect Dis 2021;8:ofab064. [PMID: 33732752 DOI: 10.1093/ofid/ofab064] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
576 Vespignani H, Colas D, Lavin BS, Soufflet C, Maillard L, Pourcher V, Paccoud O, Medjebar S, Frouin PY. Report on Electroencephalographic Findings in Critically Ill Patients with COVID-19. Ann Neurol 2020;88:626-30. [PMID: 32533727 DOI: 10.1002/ana.25814] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 15.0] [Reference Citation Analysis]
577 Idilman IS, Telli Dizman G, Ardali Duzgun S, Irmak I, Karcaaltincaba M, Inkaya AC, Demirkazik F, Durhan G, Gulsun Akpinar M, Ariyurek OM, Akpinar E, Rello J, Akova M, Akata D. Lung and kidney perfusion deficits diagnosed by dual-energy computed tomography in patients with COVID-19-related systemic microangiopathy. Eur Radiol 2021;31:1090-9. [PMID: 32860146 DOI: 10.1007/s00330-020-07155-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 4.5] [Reference Citation Analysis]
578 Frydman GH, Boyer EW, Nazarian RM, Van Cott EM, Piazza G. Coagulation Status and Venous Thromboembolism Risk in African Americans: A Potential Risk Factor in COVID-19. Clin Appl Thromb Hemost 2020;26:1076029620943671. [PMID: 32702995 DOI: 10.1177/1076029620943671] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
579 Joshi K, Fabes J, Melikian C, Spiro M. Thromboelastography demonstrates progressive hypercoagulability in COVID-19 patients admitted to ICU with respiratory failure. Journal of the Intensive Care Society. [DOI: 10.1177/17511437211026787] [Reference Citation Analysis]
580 Kountouri A, Korakas E, Ikonomidis I, Raptis A, Tentolouris N, Dimitriadis G, Lambadiari V. Type 1 Diabetes Mellitus in the SARS-CoV-2 Pandemic: Oxidative Stress as a Major Pathophysiological Mechanism Linked to Adverse Clinical Outcomes. Antioxidants (Basel) 2021;10:752. [PMID: 34065123 DOI: 10.3390/antiox10050752] [Reference Citation Analysis]
581 Zirpe KG, Bamne SN. Compass in COVID-19 Illness: Disseminated Intravascular Coagulation/Sepsis-induced Coagulopathy Scoring in Predicting Severity. Indian J Crit Care Med 2021;25:1333-4. [PMID: 35027787 DOI: 10.5005/jp-journals-10071-24061] [Reference Citation Analysis]
582 Funk CD, Ardakani A. A Novel Strategy to Mitigate the Hyperinflammatory Response to COVID-19 by Targeting Leukotrienes. Front Pharmacol 2020;11:1214. [PMID: 32848802 DOI: 10.3389/fphar.2020.01214] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 8.0] [Reference Citation Analysis]
583 Bumiller-Bini V, de Freitas Oliveira-Toré C, Carvalho TM, Kretzschmar GC, Gonçalves LB, Alencar NM, Gasparetto Filho MA, Beltrame MH, Winter Boldt AB. MASPs at the crossroad between the complement and the coagulation cascades - the case for COVID-19. Genet Mol Biol 2021;44:e20200199. [PMID: 33729332 DOI: 10.1590/1678-4685-GMB-2020-0199] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
584 Tiwari NR, Phatak S, Sharma VR, Agarwal SK. COVID-19 and thrombotic microangiopathies. Thromb Res 2021;202:191-8. [PMID: 33894421 DOI: 10.1016/j.thromres.2021.04.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
585 Wengerter SP, Wengerter KR, Masoudpoor H, Sagarwala A, Karim O, Rao N, Gillen J, Choi HM, Bernik T, Schwartz ML. Acute aortoiliac and infrainguinal arterial thrombotic events in four patients diagnosed with the novel coronavirus 2019. J Vasc Surg Cases Innov Tech 2020;6:698-702. [PMID: 33102991 DOI: 10.1016/j.jvscit.2020.09.011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
586 Kim MY, Cheong H, Kim HS; Working Group for Standard Autopsy Guideline for COVID-19 from The Korean Society for Legal Medicine. Proposal of the Autopsy Guideline for Infectious Diseases: Preparation for the Post-COVID-19 Era (abridged translation). J Korean Med Sci 2020;35:e310. [PMID: 32830471 DOI: 10.3346/jkms.2020.35.e310] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
587 Bhandari S, Solanki R, Jindal A, Rankawat G, Pathak D, Bagarhatta M, Singh A. Demystifying COVID-19 lung pathology: A clinicopathological study of postmortem core needle biopsy. Lung India 2021;38:343-9. [PMID: 34259173 DOI: 10.4103/lungindia.lungindia_919_20] [Reference Citation Analysis]
588 Najar Nobari N, Seirafianpour F, Dodangeh M, Sadeghzadeh-Bazargan A, Behrangi E, Mozafarpoor S, Goodarzi A. A systematic review of the histopathologic survey on skin biopsies in patients with Corona Virus Disease 2019 (COVID-19) who developed virus or drug-related mucocutaneous manifestations. Exp Dermatol 2021;30:1233-53. [PMID: 33977531 DOI: 10.1111/exd.14384] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
589 Roy K, Agarwal S, Banerjee R, Paul MK, Purbey PK. COVID-19 and gut immunomodulation. World J Gastroenterol 2021; 27(46): 7925-7942 [DOI: 10.3748/wjg.v27.i46.7925] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
590 Chen Y, Guo L, Jiao Y, Fan F, Liu J, Chen M, Yuan H, Lin L, Wang Y. Imaging features of COVID-19: What we can learn from SARS and MERS (Review). Exp Ther Med 2021;21:356. [PMID: 33732329 DOI: 10.3892/etm.2021.9787] [Reference Citation Analysis]
591 Kumar R, Lee MH, Mickael C, Kassa B, Pasha Q, Tuder R, Graham B. Pathophysiology and potential future therapeutic targets using preclinical models of COVID-19. ERJ Open Res 2020;6:00405-2020. [PMID: 33313306 DOI: 10.1183/23120541.00405-2020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
592 Belcher JD, Nguyen J, Chen C, Abdulla F, Conglin R, Ivy ZK, Cummings J, Dudler T, Vercellotti GM. MASP-2 and MASP-3 inhibitors block complement activation, inflammation, and microvascular stasis in a murine model of vaso-occlusion in sickle cell disease. Transl Res 2022:S1931-5244(22)00152-9. [PMID: 35878790 DOI: 10.1016/j.trsl.2022.06.018] [Reference Citation Analysis]
593 Wang CC, Chao JK, Chang YH, Chou CL, Kao CL. Care for patients with musculoskeletal pain during the COVID-19 pandemic: Physical therapy and rehabilitation suggestions for pain management. J Chin Med Assoc 2020;83:822-4. [PMID: 32618600 DOI: 10.1097/JCMA.0000000000000376] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
594 Veleri S. Neurotropism of SARS-CoV-2 and neurological diseases of the central nervous system in COVID-19 patients. Exp Brain Res 2021. [PMID: 34694467 DOI: 10.1007/s00221-021-06244-z] [Reference Citation Analysis]
595 Kumar A, Narayan RK, Kumari C, Faiq MA, Kulandhasamy M, Kant K, Pareek V. SARS-CoV-2 cell entry receptor ACE2 mediated endothelial dysfunction leads to vascular thrombosis in COVID-19 patients. Med Hypotheses 2020;145:110320. [PMID: 33032170 DOI: 10.1016/j.mehy.2020.110320] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 9.5] [Reference Citation Analysis]
596 Mezache L, Nuovo GJ, Suster D, Tili E, Awad H, Radwański PB, Veeraraghavan R. Histologic, viral, and molecular correlates of heart disease in fatal COVID-19. Annals of Diagnostic Pathology 2022. [DOI: 10.1016/j.anndiagpath.2022.151983] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
597 Dillon K, Hook C, Coupland Z, Avery P, Taylor H, Lockyer A. Pre-hospital lowest recorded oxygen saturation independently predicts death in patients with COVID-19. Br Paramed J 2020;5:59-65. [PMID: 33456398 DOI: 10.29045/14784726.2020.09.5.3.59] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
598 Afra TP, Nampoothiri RV, Razmi T M, Hafi NAB. Linking hydroxychloroquine to hemolysis in a 'suspected' glucose-6-phosphate dehydrogenase deficient patient with COVID-19 infection - a critical appraisal. Eur J Intern Med 2020;80:101-2. [PMID: 32651040 DOI: 10.1016/j.ejim.2020.07.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
599 Russo C, Morello G, Malaguarnera R, Piro S, Furno DL, Malaguarnera L. Candidate genes of SARS-CoV-2 gender susceptibility. Sci Rep 2021;11:21968. [PMID: 34753980 DOI: 10.1038/s41598-021-01131-7] [Reference Citation Analysis]
600 Ribes A, Vardon-Bounes F, Mémier V, Poette M, Au-Duong J, Garcia C, Minville V, Sié P, Bura-Rivière A, Voisin S, Payrastre B. Thromboembolic events and Covid-19. Adv Biol Regul 2020;77:100735. [PMID: 32773098 DOI: 10.1016/j.jbior.2020.100735] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 10.5] [Reference Citation Analysis]
601 Drenovska K, Schmidt E, Vassileva S. Covid-19 pandemic and the skin. Int J Dermatol 2020;59:1312-9. [PMID: 32954488 DOI: 10.1111/ijd.15189] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
602 Kim AHJ, Wu X, Atkinson JP. The beneficial and pathogenic roles of complement in COVID-19. Cleve Clin J Med 2020. [PMID: 33115882 DOI: 10.3949/ccjm.87a.ccc065] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
603 Bae S, Kim SR, Kim MN, Shim WJ, Park SM. Impact of cardiovascular disease and risk factors on fatal outcomes in patients with COVID-19 according to age: a systematic review and meta-analysis. Heart 2021;107:373-80. [PMID: 33334865 DOI: 10.1136/heartjnl-2020-317901] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 18.0] [Reference Citation Analysis]
604 Fatone MC. COVID-19: A Great Mime or a Trigger Event of Autoimmune Manifestations? Curr Rheumatol Rev 2021;17:7-16. [PMID: 33019935 DOI: 10.2174/1573397116666201005122603] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
605 Sonkaya AR, Öztrk B, Karadaş Ö. Cerebral hemodynamic alterations in patients with Covid-19. Turk J Med Sci 2021;51:435-9. [PMID: 33021761 DOI: 10.3906/sag-2006-203] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
606 Esposito A, Palmisano A, Toselli M, Vignale D, Cereda A, Rancoita PMV, Leone R, Nicoletti V, Gnasso C, Monello A, Biagi A, Turchio P, Landoni G, Gallone G, Monti G, Casella G, Iannopollo G, Nannini T, Patelli G, Di Mare L, Loffi M, Sergio P, Ippolito D, Sironi S, Pontone G, Andreini D, Mancini EM, Di Serio C, De Cobelli F, Ciceri F, Zangrillo A, Colombo A, Tacchetti C, Giannini F. Chest CT-derived pulmonary artery enlargement at the admission predicts overall survival in COVID-19 patients: insight from 1461 consecutive patients in Italy. Eur Radiol 2021;31:4031-41. [PMID: 33355697 DOI: 10.1007/s00330-020-07622-x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 9.0] [Reference Citation Analysis]
607 Caputo V, Schroeder J, Rongioletti F. A generalized purpuric eruption with histopathologic features of leucocytoclastic vasculitis in a patient severely ill with COVID-19. J Eur Acad Dermatol Venereol 2020;34:e579-81. [PMID: 32531119 DOI: 10.1111/jdv.16737] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 9.0] [Reference Citation Analysis]
608 Bonaventura A, Vecchié A, Dagna L, Martinod K, Dixon DL, Van Tassell BW, Dentali F, Montecucco F, Massberg S, Levi M, Abbate A. Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19. Nat Rev Immunol 2021;21:319-29. [PMID: 33824483 DOI: 10.1038/s41577-021-00536-9] [Cited by in Crossref: 33] [Cited by in F6Publishing: 40] [Article Influence: 33.0] [Reference Citation Analysis]
609 Caramaschi S, Kapp ME, Miller SE, Eisenberg R, Johnson J, Epperly G, Maiorana A, Silvestri G, Giannico GA. Histopathological findings and clinicopathologic correlation in COVID-19: a systematic review. Mod Pathol 2021;34:1614-33. [PMID: 34031537 DOI: 10.1038/s41379-021-00814-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
610 Nienhold R, Ciani Y, Koelzer VH, Tzankov A, Haslbauer JD, Menter T, Schwab N, Henkel M, Frank A, Zsikla V, Willi N, Kempf W, Hoyler T, Barbareschi M, Moch H, Tolnay M, Cathomas G, Demichelis F, Junt T, Mertz KD. Two distinct immunopathological profiles in autopsy lungs of COVID-19.Nat Commun. 2020;11:5086. [PMID: 33033248 DOI: 10.1038/s41467-020-18854-2] [Cited by in Crossref: 74] [Cited by in F6Publishing: 79] [Article Influence: 37.0] [Reference Citation Analysis]
611 Gottlieb M, Long B. Dermatologic manifestations and complications of COVID-19. Am J Emerg Med 2020;38:1715-21. [PMID: 32731141 DOI: 10.1016/j.ajem.2020.06.011] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 10.0] [Reference Citation Analysis]
612 Nappi F, Giacinto O, Ellouze O, Nenna A, Avtaar Singh SS, Chello M, Bouzguenda A, Copie X. Association between COVID-19 Diagnosis and Coronary Artery Thrombosis: A Narrative Review. Biomedicines 2022;10:702. [DOI: 10.3390/biomedicines10030702] [Reference Citation Analysis]
613 Moreno G, Carbonell R, Bodí M, Rodríguez A. [Systematic review of the prognostic utility of D-dimer, disseminated intravascular coagulation, and anticoagulant therapy in COVID-19 critically ill patients]. Med Intensiva (Engl Ed) 2021;45:42-55. [PMID: 32646669 DOI: 10.1016/j.medin.2020.06.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
614 Natarajan H, Crowley AR, Butler SE, Xu S, Weiner JA, Bloch EM, Littlefield K, Wieland-Alter W, Connor RI, Wright PF, Benner SE, Bonny TS, Laeyendecker O, Sullivan D, Shoham S, Quinn TC, Larman HB, Casadevall A, Pekosz A, Redd AD, Tobian AAR, Ackerman ME. Markers of Polyfunctional SARS-CoV-2 Antibodies in Convalescent Plasma. mBio 2021;12:e00765-21. [PMID: 33879585 DOI: 10.1128/mBio.00765-21] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
615 Devaux CA, Camoin-Jau L, Mege JL, Raoult D. Can hydroxychloroquine be protective against COVID-19-associated thrombotic events ? J Microbiol Immunol Infect 2021;54:37-45. [PMID: 33500211 DOI: 10.1016/j.jmii.2020.12.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
616 Gauchel N, Rieder M, Krauel K, Goller I, Jeserich M, Salzer U, Venhoff AC, Baldus N, Pollmeier L, Wirth L, Kern W, Rieg S, Busch HJ, Hofmann M, Bode C, Duerschmied D, Lother A, Heger LA. Complement system component dysregulation is a distinctive feature of COVID-19 disease: a prospective and comparative analysis of patients admitted to the emergency department for suspected COVID-19 disease. J Thromb Thrombolysis 2021. [PMID: 34904186 DOI: 10.1007/s11239-021-02617-x] [Reference Citation Analysis]
617 Moore JP, Klasse PJ. COVID-19 Vaccines: "Warp Speed" Needs Mind Melds, Not Warped Minds. J Virol 2020;94:e01083-20. [PMID: 32591466 DOI: 10.1128/JVI.01083-20] [Cited by in Crossref: 47] [Cited by in F6Publishing: 33] [Article Influence: 23.5] [Reference Citation Analysis]
618 Galván-casas C, Ochoa-bermúdez J, Muñoz-ordoñez S, Tovar-cock Á, Meizoso T. Prominent Cutaneous Manifestation of COVID-19: A Case Report. EMJ. [DOI: 10.33590/emj/20-00247] [Reference Citation Analysis]
619 Lange K, Matthies M, Firouzi-memarpuri P, Homey B. COVID-19 und Hautmanifestationen: Übersicht der aktuellen Literatur im Rückblick auf die bisherige Pandemie. Hautarzt. [DOI: 10.1007/s00105-022-04961-2] [Reference Citation Analysis]
620 Kaushik A, Parsad D, Kumaran MS. Urticaria in the times of COVID-19. Dermatol Ther 2020;33:e13817. [PMID: 32531079 DOI: 10.1111/dth.13817] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
621 Hazeldine J, Lord JM. Neutrophils and COVID-19: Active Participants and Rational Therapeutic Targets. Front Immunol 2021;12:680134. [PMID: 34149717 DOI: 10.3389/fimmu.2021.680134] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
622 Aggarwal M, Dass J, Mahapatra M. Hemostatic Abnormalities in COVID-19: An Update. Indian J Hematol Blood Transfus 2020;:1-11. [PMID: 32837053 DOI: 10.1007/s12288-020-01328-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
623 Lancet EA, Gonzalez D, Alexandrou NA, Zabar B, Lai PH, Hall CB, Braun J, Zeig-Owens R, Isaacs D, Ben-Eli D, Reisman N, Kaufman B, Asaeda G, Weiden MD, Nolan A, Teo H, Wei E, Natsui S, Philippou C, Prezant DJ. Prehospital hypoxemia, measured by pulse oximetry, predicts hospital outcomes during the New York City COVID-19 pandemic. J Am Coll Emerg Physicians Open 2021;2:e12407. [PMID: 33748809 DOI: 10.1002/emp2.12407] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
624 Chouaki Benmansour N, Carvelli J, Vivier E. Complement cascade in severe forms of COVID-19: Recent advances in therapy. Eur J Immunol 2021;51:1652-9. [PMID: 33738806 DOI: 10.1002/eji.202048959] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
625 Martín-Martín J, Martín-Cazorla F, Suárez J, Rubio L, Las-Heras SM. Comorbidities and autopsy findings of COVID-19 deaths and their association with time to death: a systematic review and meta-analysis. Curr Med Res Opin 2022;:1-22. [PMID: 35254193 DOI: 10.1080/03007995.2022.2050110] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
626 Chandel A, Patolia S, Looby M, Bade N, Khangoora V, King CS. Association of D-dimer and Fibrinogen With Hypercoagulability in COVID-19 Requiring Extracorporeal Membrane Oxygenation. J Intensive Care Med 2021;36:689-95. [PMID: 33641491 DOI: 10.1177/0885066621997039] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
627 Jering KS, McGrath MM, Mc Causland FR, Claggett B, Cunningham JW, Solomon SD. Excess mortality in solid organ transplant recipients hospitalized with COVID-19: A large-scale comparison of SOT recipients hospitalized with or without COVID-19. Clin Transplant 2021;:e14492. [PMID: 34558116 DOI: 10.1111/ctr.14492] [Reference Citation Analysis]
628 Ali YM, Lynch NJ, Khatri P, Bamigbola IE, Chan ACY, Yabuki M, Demopulos GA, Heeney JL, Pai S, Baxendale H, Schwaeble WJ. Secondary Complement Deficiency Impairs Anti-Microbial Immunity to Klebsiella pneumoniae and Staphylococcus aureus During Severe Acute COVID-19. Front Immunol 2022;13:841759. [PMID: 35572551 DOI: 10.3389/fimmu.2022.841759] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
629 Zanza C, Racca F, Longhitano Y, Piccioni A, Franceschi F, Artico M, Abenavoli L, Maiese A, Passaro G, Volonnino G, La Russa R. Risk Management and Treatment of Coagulation Disorders Related to COVID-19 Infection. Int J Environ Res Public Health 2021;18:1268. [PMID: 33572570 DOI: 10.3390/ijerph18031268] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
630 De Michele S, Sun Y, Yilmaz MM, Katsyv I, Salvatore M, Dzierba AL, Marboe CC, Brodie D, Patel NM, Garcia CK, Saqi A. Forty Postmortem Examinations in COVID-19 Patients. Am J Clin Pathol 2020;154:748-60. [PMID: 32876680 DOI: 10.1093/ajcp/aqaa156] [Cited by in Crossref: 58] [Cited by in F6Publishing: 47] [Article Influence: 29.0] [Reference Citation Analysis]
631 Cipolloni L, Sessa F, Bertozzi G, Baldari B, Cantatore S, Testi R, D'Errico S, Di Mizio G, Asmundo A, Castorina S, Salerno M, Pomara C. Preliminary Post-Mortem COVID-19 Evidence of Endothelial Injury and Factor VIII Hyperexpression. Diagnostics (Basel) 2020;10:E575. [PMID: 32784826 DOI: 10.3390/diagnostics10080575] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 13.0] [Reference Citation Analysis]
632 Li D, Wang Q, Jia C, Lv Z, Yang J. An Overview of Neurological and Psychiatric Complications During Post-COVID Period: A Narrative Review. JIR 2022;Volume 15:4199-215. [DOI: 10.2147/jir.s375494] [Reference Citation Analysis]
633 Chand S, Rrapi R, Lo JA, Song S, Gabel CK, Desai N, Hoang MP, Kroshinsky D. Purpuric ulcers associated with COVID-19: A case series. JAAD Case Rep 2021;11:13-9. [PMID: 33558846 DOI: 10.1016/j.jdcr.2021.01.019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
634 Raviraj KG, Shobhana SS. Findings and inferences from full autopsies, minimally invasive autopsies and biopsy studies in patients who died as a result of COVID19 - A systematic review. Forensic Sci Med Pathol 2022. [PMID: 35817946 DOI: 10.1007/s12024-022-00494-1] [Reference Citation Analysis]
635 Li S, Wang J, Yan Y, Zhang Z, Gong W, Nie S. Clinical Characterization and Possible Pathological Mechanism of Acute Myocardial Injury in COVID-19. Front Cardiovasc Med 2022;9:862571. [PMID: 35387441 DOI: 10.3389/fcvm.2022.862571] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
636 Morris SB, Schwartz NG, Patel P, Abbo L, Beauchamps L, Balan S, Lee EH, Paneth-Pollak R, Geevarughese A, Lash MK, Dorsinville MS, Ballen V, Eiras DP, Newton-Cheh C, Smith E, Robinson S, Stogsdill P, Lim S, Fox SE, Richardson G, Hand J, Oliver NT, Kofman A, Bryant B, Ende Z, Datta D, Belay E, Godfred-Cato S. Case Series of Multisystem Inflammatory Syndrome in Adults Associated with SARS-CoV-2 Infection - United Kingdom and United States, March-August 2020. MMWR Morb Mortal Wkly Rep 2020;69:1450-6. [PMID: 33031361 DOI: 10.15585/mmwr.mm6940e1] [Cited by in Crossref: 122] [Cited by in F6Publishing: 124] [Article Influence: 61.0] [Reference Citation Analysis]
637 McBride JD, Narang J, Simonds R, Agrawal S, Rodriguez ER, Tan CD, Baldwin WM, Dvorina N, Krywanczyk AR, Fernandez AP. Development of sacral/buttock retiform purpura as an ominous presenting sign of COVID-19 and clinical and histopathologic evolution during severe disease course. J Cutan Pathol 2021;48:1166-72. [PMID: 33931901 DOI: 10.1111/cup.14038] [Reference Citation Analysis]
638 Charitos P, Heijnen IAFM, Egli A, Bassetti S, Trendelenburg M, Osthoff M. Functional Activity of the Complement System in Hospitalized COVID-19 Patients: A Prospective Cohort Study. Front Immunol 2021;12:765330. [PMID: 34777382 DOI: 10.3389/fimmu.2021.765330] [Reference Citation Analysis]
639 Lim EHT, van Amstel RBE, de Boer VV, van Vught LA, de Bruin S, Brouwer MC, Vlaar APJ, van de Beek D. Complement activation in COVID-19 and targeted therapeutic options: A scoping review. Blood Reviews 2022. [DOI: 10.1016/j.blre.2022.100995] [Reference Citation Analysis]
640 Aid M, Busman-Sahay K, Vidal SJ, Maliga Z, Bondoc S, Starke C, Terry M, Jacobson CA, Wrijil L, Ducat S, Brook OR, Miller AD, Porto M, Pellegrini KL, Pino M, Hoang TN, Chandrashekar A, Patel S, Stephenson K, Bosinger SE, Andersen H, Lewis MG, Hecht JL, Sorger PK, Martinot AJ, Estes JD, Barouch DH. Vascular Disease and Thrombosis in SARS-CoV-2-Infected Rhesus Macaques. Cell 2020;183:1354-1366.e13. [PMID: 33065030 DOI: 10.1016/j.cell.2020.10.005] [Cited by in Crossref: 44] [Cited by in F6Publishing: 53] [Article Influence: 22.0] [Reference Citation Analysis]
641 Nieto-Benito LM, Hernández de la Torre-Ruiz E, Balaguer-Franch I, Rosell-Díaz ÁM, Mateos-Mayo A, Herrero-Sanchez A, Lacasta-Plasín C, García-Piqueras P, Barchino-Ortiz L, Bergón-Sendín M, Pulido-Pérez A, Baniandrés-Rodríguez O, Rodriguez-Lomba E, Molina-Lopez I, Suárez-Fernandez R. Histopathological findings in COVID-19-induced cutaneous lesions. Clinicopathological correlation of SARS-CoV-19 dermatologic patterns: review of the literature. Australas J Dermatol 2021;62:e98-e101. [PMID: 32920868 DOI: 10.1111/ajd.13442] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
642 Macor P, Durigutto P, Mangogna A, Bussani R, De Maso L, D'Errico S, Zanon M, Pozzi N, Meroni PL, Tedesco F. Multiple-Organ Complement Deposition on Vascular Endothelium in COVID-19 Patients. Biomedicines 2021;9:1003. [PMID: 34440207 DOI: 10.3390/biomedicines9081003] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
643 Lin F, Ichim TE, Pingle S, Jones LD, Kesari S, Ashili S. Mesenchymal stem cells as living anti-inflammatory therapy for COVID-19 related acute respiratory distress syndrome. World J Stem Cells 2020; 12(10): 1067-1079 [PMID: 33178392 DOI: 10.4252/wjsc.v12.i10.1067] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 8.0] [Reference Citation Analysis]
644 Ionescu F, Grasso-Knight G, Castillo E, Naeem E, Petrescu I, Imam Z, Patel VK, Narasimhan M, Nair GB. Therapeutic Anticoagulation Delays Death in COVID-19 Patients: Cross-Sectional Analysis of a Prospective Cohort. TH Open 2020;4:e263-70. [PMID: 32995704 DOI: 10.1055/s-0040-1716721] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
645 Fiacchini G, Tricò D, Ribechini A, Forfori F, Brogi E, Lucchi M, Berrettini S, Bertini P, Guarracino F, Bruschini L. Evaluation of the Incidence and Potential Mechanisms of Tracheal Complications in Patients With COVID-19. JAMA Otolaryngol Head Neck Surg 2021;147:70-6. [PMID: 33211087 DOI: 10.1001/jamaoto.2020.4148] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 12.0] [Reference Citation Analysis]
646 Fernandez-Ruiz R, Paredes JL, Niewold TB. COVID-19 in patients with systemic lupus erythematosus: lessons learned from the inflammatory disease. Transl Res 2021;232:13-36. [PMID: 33352298 DOI: 10.1016/j.trsl.2020.12.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
647 Mondal S, Quintili AL, Karamchandani K, Bose S. Thromboembolic disease in COVID-19 patients: A brief narrative review. J Intensive Care 2020;8:70. [PMID: 32939266 DOI: 10.1186/s40560-020-00483-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
648 Baeck M, Herman A. COVID toes: where do we stand with the current evidence? Int J Infect Dis 2021;102:53-5. [PMID: 33075530 DOI: 10.1016/j.ijid.2020.10.021] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
649 Funk CD, Laferrière C, Ardakani A. A Snapshot of the Global Race for Vaccines Targeting SARS-CoV-2 and the COVID-19 Pandemic. Front Pharmacol 2020;11:937. [PMID: 32636754 DOI: 10.3389/fphar.2020.00937] [Cited by in Crossref: 78] [Cited by in F6Publishing: 60] [Article Influence: 39.0] [Reference Citation Analysis]
650 Sultan S, Acharya Y. Antimalarial and cytotoxic drugs on COVID-19 and the cardiovascular burden: Literature review and lessons to be learned. Vascular 2021;29:220-7. [PMID: 32691699 DOI: 10.1177/1708538120941635] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
651 Perdrizet G, Hightower LE. On barring the vascular gateway against severe COVID-19 disease. Cell Stress Chaperones 2020;25:721-3. [PMID: 32458383 DOI: 10.1007/s12192-020-01122-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
652 Frazer JS, Tyrynis Everden AJ. Emerging patterns of hypercoagulability associated with critical COVID-19: A review. Trends in Anaesthesia and Critical Care 2020;34:4-13. [DOI: 10.1016/j.tacc.2020.07.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
653 Choudhary S, Sharma K, Singh PK. Von Willebrand factor: A key glycoprotein involved in thrombo-inflammatory complications of COVID-19. Chem Biol Interact 2021;348:109657. [PMID: 34516971 DOI: 10.1016/j.cbi.2021.109657] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
654 Skendros P, Mitsios A, Chrysanthopoulou A, Mastellos DC, Metallidis S, Rafailidis P, Ntinopoulou M, Sertaridou E, Tsironidou V, Tsigalou C, Tektonidou M, Konstantinidis T, Papagoras C, Mitroulis I, Germanidis G, Lambris JD, Ritis K. Complement and tissue factor-enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis. J Clin Invest 2020;130:6151-7. [PMID: 32759504 DOI: 10.1172/JCI141374] [Cited by in Crossref: 148] [Cited by in F6Publishing: 113] [Article Influence: 74.0] [Reference Citation Analysis]
655 Shah S, Akhade K, Ganguly S, Nanda R, Mohapatra E, Goel AK. Cutaneous manifestations associated with COVID-19 in children: A systematic review. J Family Med Prim Care 2021;10:93-101. [PMID: 34017709 DOI: 10.4103/jfmpc.jfmpc_1389_20] [Reference Citation Analysis]
656 Amruta N, Engler-Chiurazzi EB, Murray-Brown IC, Gressett TE, Biose IJ, Chastain WH, Befeler JB, Bix G. In Vivo protection from SARS-CoV-2 infection by ATN-161 in k18-hACE2 transgenic mice. Life Sci 2021;284:119881. [PMID: 34389403 DOI: 10.1016/j.lfs.2021.119881] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
657 Mirabelli M, Chiefari E, Puccio L, Foti DP, Brunetti A. Potential Benefits and Harms of Novel Antidiabetic Drugs During COVID-19 Crisis. Int J Environ Res Public Health 2020;17:E3664. [PMID: 32456064 DOI: 10.3390/ijerph17103664] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 10.5] [Reference Citation Analysis]
658 Sadoughi F, Maleki Dana P, Hallajzadeh J, Asemi Z, Mansournia MA, Yousefi B. Coagulopathy: Another side effect of coronavirus infection. J Cardiovasc Thorac Res 2021;13:15-22. [PMID: 33815697 DOI: 10.34172/jcvtr.2020.59] [Reference Citation Analysis]
659 Chang SE, Feng A, Meng W, Apostolidis SA, Mack E, Artandi M, Barman L, Bennett K, Chakraborty S, Chang I, Cheung P, Chinthrajah S, Dhingra S, Do E, Finck A, Gaano A, Geßner R, Giannini HM, Gonzalez J, Greib S, Gündisch M, Hsu AR, Kuo A, Manohar M, Mao R, Neeli I, Neubauer A, Oniyide O, Powell AE, Puri R, Renz H, Schapiro JM, Weidenbacher PA, Wittman R, Ahuja N, Chung HR, Jagannathan P, James J, Kim PS, Meyer NJ, Nadeau K, Radic M, Robinson WH, Singh U, Wang TT, Wherry EJ, Skevaki C, Prak ETL, Utz PJ. New-Onset IgG Autoantibodies in Hospitalized Patients with COVID-19. medRxiv 2021:2021. [PMID: 33532787 DOI: 10.1101/2021.01.27.21250559] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 12.0] [Reference Citation Analysis]
660 Ionescu M, Stoian AP, Rizzo M, Serban D, Nuzzo D, Mazilu L, Suceveanu AI, Dascalu AM, Parepa IR. The Role of Endothelium in COVID-19. Int J Mol Sci 2021;22:11920. [PMID: 34769350 DOI: 10.3390/ijms222111920] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
661 Do MH, Stewart CR, Harp J. Cutaneous Manifestations of COVID-19 in the Inpatient Setting. Dermatol Clin 2021;39:521-32. [PMID: 34556242 DOI: 10.1016/j.det.2021.05.011] [Reference Citation Analysis]
662 Freeman EE, McMahon DE, Lipoff JB, Rosenbach M, Kovarik C, Takeshita J, French LE, Thiers BH, Hruza GJ, Fox LP; American Academy of Dermatology Ad Hoc Task Force on COVID-19. Pernio-like skin lesions associated with COVID-19: A case series of 318 patients from 8 countries. J Am Acad Dermatol 2020;83:486-92. [PMID: 32479979 DOI: 10.1016/j.jaad.2020.05.109] [Cited by in Crossref: 80] [Cited by in F6Publishing: 69] [Article Influence: 40.0] [Reference Citation Analysis]
663 Kaur H. Dermatological Manifestations of COVID-19: A Brief Review. Annals of the National Academy of Medical Sciences (India) 2021;57:03-7. [DOI: 10.1055/s-0040-1716938] [Reference Citation Analysis]
664 Chen Z, John Wherry E. T cell responses in patients with COVID-19. Nat Rev Immunol. 2020;20:529-536. [PMID: 32728222 DOI: 10.1038/s41577-020-0402-6] [Cited by in Crossref: 282] [Cited by in F6Publishing: 243] [Article Influence: 141.0] [Reference Citation Analysis]
665 Colonna C, Monzani NA, Rocchi A, Gianotti R, Boggio F, Gelmetti C. Chilblain-like lesions in children following suspected COVID-19 infection. Pediatr Dermatol 2020;37:437-40. [PMID: 32374033 DOI: 10.1111/pde.14210] [Cited by in Crossref: 55] [Cited by in F6Publishing: 54] [Article Influence: 27.5] [Reference Citation Analysis]
666 Ogata AF, Maley AM, Wu C, Gilboa T, Norman M, Lazarovits R, Mao CP, Newton G, Chang M, Nguyen K, Kamkaew M, Zhu Q, Gibson TE, Ryan ET, Charles RC, Marasco WA, Walt DR. Ultra-Sensitive Serial Profiling of SARS-CoV-2 Antigens and Antibodies in Plasma to Understand Disease Progression in COVID-19 Patients with Severe Disease. Clin Chem 2020;66:1562-72. [PMID: 32897389 DOI: 10.1093/clinchem/hvaa213] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 27.0] [Reference Citation Analysis]
667 Regev T, Antebi M, Eytan D, Shachor-Meyouhas Y, Ilivitzki A, Aviel YB, Ben-Ari J. Pediatric Inflammatory Multisystem Syndrome With Central Nervous System Involvement and Hypocomplementemia Following SARS-COV-2 Infection. Pediatr Infect Dis J 2020;39:e206-7. [PMID: 32639461 DOI: 10.1097/INF.0000000000002804] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
668 Jain A, Jafri F, Manglani R, Al-Mufti F, Aronow WS, Chandy D. Stroke in critical COVID-19 patients: a cautionary tale from the frontlines. Arch Med Sci Atheroscler Dis 2020;5:e263-70. [PMID: 33644484 DOI: 10.5114/amsad.2020.102423] [Reference Citation Analysis]
669 Kaklamanos A, Belogiannis K, Skendros P, Gorgoulis VG, Vlachoyiannopoulos PG, Tzioufas AG. COVID-19 Immunobiology: Lessons Learned, New Questions Arise. Front Immunol 2021;12:719023. [PMID: 34512643 DOI: 10.3389/fimmu.2021.719023] [Reference Citation Analysis]
670 Cardone M, Yano M, Rosenberg AS, Puig M. Lessons Learned to Date on COVID-19 Hyperinflammatory Syndrome: Considerations for Interventions to Mitigate SARS-CoV-2 Viral Infection and Detrimental Hyperinflammation. Front Immunol 2020;11:1131. [PMID: 32574265 DOI: 10.3389/fimmu.2020.01131] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 13.0] [Reference Citation Analysis]
671 Mitra S, Ling RR, Yang IX, Poon WH, Tan CS, Monagle P, Maclaren G, Ramanathan K. Severe COVID-19 and coagulopathy: A systematic review and meta-analysis. Ann Acad Med Singap 2021;50:325-35. [DOI: 10.47102/annals-acadmedsg.2020420] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 7.0] [Reference Citation Analysis]
672 Stenmark KR, Frid MG, Gerasimovskaya E, Zhang H, McCarthy MK, Thurman JM, Morrison TE. Mechanisms of SARS-CoV-2-induced lung vascular disease: potential role of complement. Pulm Circ 2021;11:20458940211015799. [PMID: 34046161 DOI: 10.1177/20458940211015799] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
673 Kasal DA, De Lorenzo A, Tibiriçá E. COVID-19 and Microvascular Disease: Pathophysiology of SARS-CoV-2 Infection With Focus on the Renin-Angiotensin System. Heart Lung Circ 2020;29:1596-602. [PMID: 32972810 DOI: 10.1016/j.hlc.2020.08.010] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
674 Seo J, Kim D, Yun N, Kim D. Coronavirus Disease 2019-Associated Coagulopathy. Microorganisms 2022;10:1556. [DOI: 10.3390/microorganisms10081556] [Reference Citation Analysis]
675 Rogani S, Calsolaro V, Franchi R, Calabrese AM, Okoye C, Monzani F. Spontaneous muscle hematoma in older patients with COVID-19: two case reports and literature review. BMC Geriatr 2020;20:539. [PMID: 33353545 DOI: 10.1186/s12877-020-01963-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
676 Chatterjee S, Sengupta T, Majumder S, Majumder R. COVID-19: a probable role of the anticoagulant Protein S in managing COVID-19-associated coagulopathy. Aging (Albany NY) 2020;12:15954-61. [PMID: 32826388 DOI: 10.18632/aging.103869] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
677 Baker D, Roberts CAK, Pryce G, Kang AS, Marta M, Reyes S, Schmierer K, Giovannoni G, Amor S. COVID-19 vaccine-readiness for anti-CD20-depleting therapy in autoimmune diseases. Clin Exp Immunol 2020;202:149-61. [PMID: 32671831 DOI: 10.1111/cei.13495] [Cited by in Crossref: 75] [Cited by in F6Publishing: 73] [Article Influence: 37.5] [Reference Citation Analysis]
678 Xiong J, Chen L, Zhang L, Bao L, Shi Y. Mesenchymal Stromal Cell-Based Therapy: A Promising Approach for Severe COVID-19. Cell Transplant 2021;30:963689721995455. [PMID: 33650894 DOI: 10.1177/0963689721995455] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
679 Thalji NK, Patel PA, Elliott M, Augoustides JG. Hematologic Consequences of the Coronavirus Crisis-Focus on Relevant Clues and Complications for the Perioperative Cardiothoracic and Vascular Community. J Cardiothorac Vasc Anesth 2020;34:3189-92. [PMID: 32565045 DOI: 10.1053/j.jvca.2020.05.032] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
680 Sinkovits G, Réti M, Müller V, Iványi Z, Gál J, Gopcsa L, Reményi P, Szathmáry B, Lakatos B, Szlávik J, Bobek I, Prohászka ZZ, Förhécz Z, Mező B, Csuka D, Hurler L, Kajdácsi E, Cervenak L, Kiszel P, Masszi T, Vályi-Nagy I, Prohászka Z. Associations between the von Willebrand Factor-ADAMTS13 Axis, Complement Activation, and COVID-19 Severity and Mortality. Thromb Haemost 2022. [PMID: 35062036 DOI: 10.1055/s-0041-1740182] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
681 De Greef A, Coulie PG, Baeck M. Pandemic chilblains: Are they SARS-CoV-2-related or not? Clin Immunol 2022;237:108984. [PMID: 35338000 DOI: 10.1016/j.clim.2022.108984] [Reference Citation Analysis]
682 [DOI: 10.1101/2020.05.30.20117929] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
683 Wozniak RJ, Nixon DF, Marston JL. Involvement of Cisgender and Transgender Individuals in Studies on the Impact of Hormonal Therapy on COVID-19. AIDS Patient Care STDS 2020;34:367-8. [PMID: 32551880 DOI: 10.1089/apc.2020.0118] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
684 Gianotti R, Zerbi P, Dodiuk-Gad RP. Clinical and histopathological study of skin dermatoses in patients affected by COVID-19 infection in the Northern part of Italy. J Dermatol Sci 2020;98:141-3. [PMID: 32381428 DOI: 10.1016/j.jdermsci.2020.04.007] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 20.0] [Reference Citation Analysis]
685 Parra-Izquierdo I, Aslan JE. Perspectives on Platelet Heterogeneity and Host Immune Response in Coronavirus Disease 2019 (COVID-19). Semin Thromb Hemost 2020;46:826-30. [PMID: 32882716 DOI: 10.1055/s-0040-1715093] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
686 Chaudhari S, Dey Pereira S, Asare-Warehene M, Naha R, Kabekkodu SP, Tsang BK, Satyamoorthy K. Comorbidities and inflammation associated with ovarian cancer and its influence on SARS-CoV-2 infection. J Ovarian Res 2021;14:39. [PMID: 33632295 DOI: 10.1186/s13048-021-00787-z] [Reference Citation Analysis]
687 Jodele S, Köhl J. Tackling COVID-19 infection through complement-targeted immunotherapy. Br J Pharmacol 2021;178:2832-48. [PMID: 32643798 DOI: 10.1111/bph.15187] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
688 Becker RC. COVID-19 update: Covid-19-associated coagulopathy. J Thromb Thrombolysis 2020;50:54-67. [PMID: 32415579 DOI: 10.1007/s11239-020-02134-3] [Cited by in Crossref: 222] [Cited by in F6Publishing: 204] [Article Influence: 111.0] [Reference Citation Analysis]
689 Verdiner RE. Is Angiotensin II Unopposed a Good Thing? Anesth Analg 2020;131:e170-1. [PMID: 32502133 DOI: 10.1213/ANE.0000000000005046] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
690 Wang C, Xie J, Zhao L, Fei X, Zhang H, Tan Y, Nie X, Zhou L, Liu Z, Ren Y, Yuan L, Zhang Y, Zhang J, Liang L, Chen X, Liu X, Wang P, Han X, Weng X, Chen Y, Yu T, Zhang X, Cai J, Chen R, Shi ZL, Bian XW. Alveolar macrophage dysfunction and cytokine storm in the pathogenesis of two severe COVID-19 patients. EBioMedicine 2020;57:102833. [PMID: 32574956 DOI: 10.1016/j.ebiom.2020.102833] [Cited by in Crossref: 114] [Cited by in F6Publishing: 117] [Article Influence: 57.0] [Reference Citation Analysis]
691 Jaggers GK, Watkins BA, Rodriguez RL. COVID-19: repositioning nutrition research for the next pandemic. Nutr Res. 2020;81:1-6. [PMID: 32795724 DOI: 10.1016/j.nutres.2020.07.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
692 Görgün S, Cindoruk Ş, Özgen E, Yadigaroğlu M, Demir MT, Yücel M, Akpınar ÇK, Güzel M. Diagnostic and Prognostic Value of Serum Endocan Levels in Patients With COVID-19. Angiology 2021;:33197211026044. [PMID: 34180269 DOI: 10.1177/00033197211026044] [Reference Citation Analysis]
693 Qi X, Keith KA, Huang JH. COVID-19 and stroke: A review. Brain Hemorrhages 2021;2:76-83. [PMID: 33225251 DOI: 10.1016/j.hest.2020.11.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
694 Patel A, Ajayi F, Ali R, Chan KH, Slim J. Dilemma of Anticoagulation Therapy in Mild or Asymptomatic COVID-19 Cases. Cureus 2021;13:e19291. [PMID: 34900472 DOI: 10.7759/cureus.19291] [Reference Citation Analysis]
695 Akhter MS, Hamali HA, Mobarki AA, Rashid H, Oldenburg J, Biswas A. SARS-CoV-2 Infection: Modulator of Pulmonary Embolism Paradigm. J Clin Med 2021;10:1064. [PMID: 33806540 DOI: 10.3390/jcm10051064] [Reference Citation Analysis]
696 Vas P, Hopkins D, Feher M, Rubino F, B Whyte M. Diabetes, obesity and COVID-19: A complex interplay. Diabetes Obes Metab 2020;22:1892-6. [PMID: 32627299 DOI: 10.1111/dom.14134] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 9.5] [Reference Citation Analysis]
697 Sharma P, Uppal NN, Wanchoo R, Shah HH, Yang Y, Parikh R, Khanin Y, Madireddy V, Larsen CP, Jhaveri KD, Bijol V; Northwell Nephrology COVID-19 Research Consortium. COVID-19-Associated Kidney Injury: A Case Series of Kidney Biopsy Findings. J Am Soc Nephrol 2020;31:1948-58. [PMID: 32660970 DOI: 10.1681/ASN.2020050699] [Cited by in Crossref: 103] [Cited by in F6Publishing: 77] [Article Influence: 51.5] [Reference Citation Analysis]
698 Cabal-Herrera AM, Mateen FJ. COVID-19 in a patient treated with eculizumab for aquaporin-4 neuromyelitis optica. J Neurol 2021. [PMID: 33904965 DOI: 10.1007/s00415-021-10578-7] [Reference Citation Analysis]
699 Frija-Masson J, Bancal C, Plantier L, Benzaquen H, Mangin L, Penaud D, Arnoult F, Flamant M, d'Ortho MP. Alteration of Diffusion Capacity After SARS-CoV-2 Infection: A Pathophysiological Approach. Front Physiol 2021;12:624062. [PMID: 33841169 DOI: 10.3389/fphys.2021.624062] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
700 Stefan A, Petkovic M, König A, Koch J, Hagemann F, Wuerstlein R, Harbeck N, Mahner S, Kaltofen T. Increased risk for thromboembolic events from combination of a gynecologic malignancy with severe acute respiratory syndrome coronavirus 2 infection: a case report. J Med Case Rep 2022;16:119. [PMID: 35313981 DOI: 10.1186/s13256-022-03340-8] [Reference Citation Analysis]
701 Bime C, Casanova NG, Nikolich-Zugich J, Knox KS, Camp SM, Garcia JGN. Strategies to DAMPen COVID-19-mediated lung and systemic inflammation and vascular injury. Transl Res 2021;232:37-48. [PMID: 33358868 DOI: 10.1016/j.trsl.2020.12.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
702 Kim DM, Kim Y, Seo JW, Lee J, Park U, Ha NY, Koh J, Park H, Lee JW, Ro HJ, Yun NR, Kim DY, Yoon SH, Na YS, Moon DS, Lim SC, Kim CM, Jeon K, Kang JG, Jang NY, Jeong H, Kim J, Cheon S, Sohn KM, Moon JY, Kym S, Han SR, Lee MS, Kim HJ, Park WY, Choi JY, Shin HW, Kim HY, Cho CH, Jeon YK, Kim YS, Cho NH. Enhanced eosinophil-mediated inflammation associated with antibody and complement-dependent pneumonic insults in critical COVID-19. Cell Rep 2021;37:109798. [PMID: 34587481 DOI: 10.1016/j.celrep.2021.109798] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 12.0] [Reference Citation Analysis]
703 Iba T, Levy JH, Levi M, Connors JM, Thachil J. Coagulopathy of Coronavirus Disease 2019. Crit Care Med 2020;48:1358-64. [PMID: 32467443 DOI: 10.1097/CCM.0000000000004458] [Cited by in Crossref: 151] [Cited by in F6Publishing: 105] [Article Influence: 75.5] [Reference Citation Analysis]
704 Zelek WM, Cole J, Ponsford MJ, Harrison RA, Schroeder BE, Webb N, Jolles S, Fegan C, Morgan M, Wise MP, Morgan BP. Complement Inhibition with the C5 Blocker LFG316 in Severe COVID-19. Am J Respir Crit Care Med 2020;202:1304-8. [PMID: 32897730 DOI: 10.1164/rccm.202007-2778LE] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
705 Plotz B, Castillo R, Melamed J, Magro C, Rosenthal P, Belmont HM. Focal small bowel thrombotic microvascular injury in COVID-19 mediated by the lectin complement pathway masquerading as lupus enteritis. Rheumatology (Oxford) 2021;60:e61-3. [PMID: 33147605 DOI: 10.1093/rheumatology/keaa627] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
706 Godino C, Scotti A, Maugeri N, Mancini N, Fominskiy E, Margonato A, Landoni G. Antithrombotic therapy in patients with COVID-19? -Rationale and Evidence. Int J Cardiol 2021;324:261-6. [PMID: 33002521 DOI: 10.1016/j.ijcard.2020.09.064] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
707 Gill J, Hebert CA, Colbert GB. COVID-19-associated atypical hemolytic uremic syndrome and use of Eculizumab therapy. J Nephrol 2021. [PMID: 34427905 DOI: 10.1007/s40620-021-01125-8] [Reference Citation Analysis]
708 Burwick RM, Dellapiana G, Newman RA, Smithson SD, Naqvi M, Williams J 3rd, Wong MS, Bautista M, Gaden A, Kazani SD, Dunn DA, Ma MH, Mitter S, Monteleone JPR, Ortiz SR, Ghandehari S, Merin N, Zakowski MI, Karumanchi SA. Complement blockade with eculizumab for treatment of severe Coronavirus Disease 2019 in pregnancy: A case series. Am J Reprod Immunol 2022;:e13559. [PMID: 35514201 DOI: 10.1111/aji.13559] [Reference Citation Analysis]
709 Hayama H, Ide S, Moroi M, Kitami Y, Bekki N, Kubota S, Uemura Y, Hara H, Kutsuna S, Ohmagari N, Hiroi Y. Elevated high-sensitivity troponin is associated with subclinical cardiac dysfunction in patients recovered from coronavirus disease 2019. Glob Health Med 2021;3:95-101. [PMID: 33937572 DOI: 10.35772/ghm.2021.01025] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
710 Ogawa F, Oi Y, Nakajima K, Matsumura R, Nakagawa T, Miyagawa T, Sakai K, Saji R, Taniguchi H, Takahashi K, Abe T, Iwashita M, Nishii M, Takeuchi I. Temporal change in Syndecan-1 as a therapeutic target and a biomarker for the severity classification of COVID-19. Thromb J 2021;19:55. [PMID: 34399775 DOI: 10.1186/s12959-021-00308-4] [Reference Citation Analysis]
711 Fang FC, Benson CA, Del Rio C, Edwards KM, Fowler VG, Fredricks DN, Limaye AP, Murray BE, Naggie S, Pappas PG, Patel R, Paterson DL, Pegues DA, Petri WA, Schooley RT. COVID-19-Lessons Learned and Questions Remaining. Clin Infect Dis 2021;72:2225-40. [PMID: 33104186 DOI: 10.1093/cid/ciaa1654] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 15.0] [Reference Citation Analysis]
712 Chebotareva N, Berns S, Berns A, Androsova T, Lebedeva M, Moiseev S. Acute kidney injury and mortality in coronavirus disease 2019: results from a cohort study of 1,280 patients. Kidney Res Clin Pract 2021;40:241-9. [PMID: 34078024 DOI: 10.23876/j.krcp.20.128] [Reference Citation Analysis]
713 Amor S, Fernández Blanco L, Baker D. Innate immunity during SARS-CoV-2: evasion strategies and activation trigger hypoxia and vascular damage. Clin Exp Immunol 2020;202:193-209. [PMID: 32978971 DOI: 10.1111/cei.13523] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 12.5] [Reference Citation Analysis]
714 Yassin A, Ghzawi A, Al-Mistarehi AH, El-Salem K, Y Benmelouka A, M Sherif A, BenhadjDahman N, AlAdamat N, Jemel A, Negida A, Abdelmonem M. Mortality rate and biomarker expression within COVID-19 patients who develop acute ischemic stroke: a systematic review and meta-analysis. Future Sci OA 2021;7:FSO713. [PMID: 34254031 DOI: 10.2144/fsoa-2021-0036] [Reference Citation Analysis]
715 Lumpuy-Castillo J, Lorenzo-Almorós A, Pello-Lázaro AM, Sánchez-Ferrer C, Egido J, Tuñón J, Peiró C, Lorenzo Ó. Cardiovascular Damage in COVID-19: Therapeutic Approaches Targeting the Renin-Angiotensin-Aldosterone System. Int J Mol Sci 2020;21:E6471. [PMID: 32899833 DOI: 10.3390/ijms21186471] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
716 Warkentin TE, Kaatz S. COVID-19 versus HIT hypercoagulability. Thromb Res 2020;196:38-51. [PMID: 32841919 DOI: 10.1016/j.thromres.2020.08.017] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
717 Allegra A, Innao V, Allegra AG, Musolino C. Coagulopathy and thromboembolic events in patients with SARS-CoV-2 infection: pathogenesis and management strategies. Ann Hematol 2020;99:1953-65. [PMID: 32671455 DOI: 10.1007/s00277-020-04182-4] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 9.5] [Reference Citation Analysis]
718 Kumar N, Zuo Y, Yalavarthi S, Hunker KL, Knight JS, Kanthi Y, Obi AT, Ganesh SK. SARS-CoV-2 Spike Protein S1-Mediated Endothelial Injury and Pro-Inflammatory State Is Amplified by Dihydrotestosterone and Prevented by Mineralocorticoid Antagonism. Viruses 2021;13:2209. [PMID: 34835015 DOI: 10.3390/v13112209] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
719 Sameni F, Hajikhani B, Yaslianifard S, Goudarzi M, Owlia P, Nasiri MJ, Shokouhi S, Bakhtiyari M, Dadashi M. COVID-19 and Skin Manifestations: An Overview of Case Reports/Case Series and Meta-Analysis of Prevalence Studies. Front Med (Lausanne) 2020;7:573188. [PMID: 33224961 DOI: 10.3389/fmed.2020.573188] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
720 Ritter JM, Wilson TM, Gary JM, Seixas JN, Martines RB, Bhatnagar J, Bollweg BC, Lee E, Estetter L, Silva-Flannery L, Bullock HA, Towner JS, Cossaboom CM, Wendling NM, Amman BR, Harvey RR, Taylor D, Rettler H, Barton Behravesh C, Zaki SR. Histopathology and localization of SARS-CoV-2 and its host cell entry receptor ACE2 in tissues from naturally infected US-farmed mink (Neovison vison). Vet Pathol 2022;:3009858221079665. [PMID: 35229669 DOI: 10.1177/03009858221079665] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
721 Thornton GD, Shetye A, Knight DS, Knott K, Artico J, Kurdi H, Yousef S, Antonakaki D, Razvi Y, Chacko L, Brown J, Patel R, Vimalesvaran K, Seraphim A, Davies R, Xue H, Kotecha T, Bell R, Manisty C, Cole GD, Moon JC, Kellman P, Fontana M, Treibel TA. Myocardial Perfusion Imaging After Severe COVID-19 Infection Demonstrates Regional Ischemia Rather Than Global Blood Flow Reduction. Front Cardiovasc Med 2021;8:764599. [PMID: 34950713 DOI: 10.3389/fcvm.2021.764599] [Reference Citation Analysis]
722 Kumar NA, Kunnakkadan U, Thomas S, Johnson JB. In the Crosshairs: RNA Viruses OR Complement? Front Immunol 2020;11:573583. [PMID: 33133089 DOI: 10.3389/fimmu.2020.573583] [Reference Citation Analysis]
723 Inal J. COVID-19 comorbidities, associated procoagulant extracellular vesicles and venous thromboembolisms: a possible link with ethnicity? Br J Haematol 2020;190:e218-20. [PMID: 32645205 DOI: 10.1111/bjh.17011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
724 Sauter JL, Baine MK, Butnor KJ, Buonocore DJ, Chang JC, Jungbluth AA, Szabolcs MJ, Morjaria S, Mount SL, Rekhtman N, Selbs E, Sheng ZM, Xiao Y, Kleiner DE, Pittaluga S, Taubenberger JK, Rapkiewicz AV, Travis WD. Insights into pathogenesis of fatal COVID-19 pneumonia from histopathology with immunohistochemical and viral RNA studies. Histopathology 2020;77:915-25. [PMID: 32614086 DOI: 10.1111/his.14201] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 21.0] [Reference Citation Analysis]
725 Dane B, Smereka P, Wain R, Kim D, S. Katz D. Hypercoagulability in Patients With Coronavirus Disease (COVID-19): Identification of Arterial and Venous Thromboembolism in the Abdomen, Pelvis, and Lower Extremities. American Journal of Roentgenology 2021;216:104-5. [DOI: 10.2214/ajr.20.23617] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 12.0] [Reference Citation Analysis]
726 Reinhart M, Metze D, Braun SA. [Skin manifestations of COVID-19 and after COVID-19 vaccination]. Hautarzt 2022. [PMID: 35477785 DOI: 10.1007/s00105-022-04991-w] [Reference Citation Analysis]
727 Andreani G, Uscello L, Montaruli B, Briozzo A, Vitale F, Tricarico M, Arnaldi L, Marengo S, Norbiato C. Acquired Factor XI Deficiency during SARS-CoV-2 Infection: Not Only Thrombosis. TH Open 2020;4:e233-5. [PMID: 32939441 DOI: 10.1055/s-0040-1714696] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
728 Vinciguerra M, Romiti S, Sangiorgi GM, Rose D, Miraldi F, Greco E. SARS-CoV-2 and Atherosclerosis: Should COVID-19 Be Recognized as a New Predisposing Cardiovascular Risk Factor? J Cardiovasc Dev Dis 2021;8:130. [PMID: 34677199 DOI: 10.3390/jcdd8100130] [Reference Citation Analysis]
729 Sh Hassan AA, Alsaleh ME, Alsaleh ME, Al Zaher FA, Almajed FA, Alkhudhair AM, Alali MM, Alzayer HA, Alolayan AJ. Budd-Chiari Syndrome: A Case Report of a Rare Presentation of COVID-19. Cureus 2021;13:e12554. [PMID: 33564546 DOI: 10.7759/cureus.12554] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
730 Fodil S, Annane D. Complement Inhibition and COVID-19: The Story so Far. Immunotargets Ther 2021;10:273-84. [PMID: 34345614 DOI: 10.2147/ITT.S284830] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
731 Posch W, Vosper J, Noureen A, Zaderer V, Witting C, Bertacchi G, Gstir R, Filipek PA, Bonn GK, Huber LA, Bellmann-Weiler R, Lass-Flörl C, Wilflingseder D. C5aR inhibition of nonimmune cells suppresses inflammation and maintains epithelial integrity in SARS-CoV-2-infected primary human airway epithelia. J Allergy Clin Immunol 2021;147:2083-2097.e6. [PMID: 33852936 DOI: 10.1016/j.jaci.2021.03.038] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
732 Soldati G, Demi M. What Is COVID 19 Teaching Us about Pulmonary Ultrasound? Diagnostics 2022;12:838. [DOI: 10.3390/diagnostics12040838] [Reference Citation Analysis]
733 Li H, Zhao Y, Zhou L, Hu J. Cutaneous, skin histopathological manifestations and relationship to COVID-19 infection patients. Dermatol Ther 2020;33:e14157. [PMID: 32770717 DOI: 10.1111/dth.14157] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
734 Xiang M, Jing H, Wang C, Novakovic VA, Shi J. Persistent Lung Injury and Prothrombotic State in Long COVID. Front Immunol 2022;13:862522. [PMID: 35464473 DOI: 10.3389/fimmu.2022.862522] [Reference Citation Analysis]
735 Saponaro F, Rutigliano G, Sestito S, Bandini L, Storti B, Bizzarri R, Zucchi R. ACE2 in the Era of SARS-CoV-2: Controversies and Novel Perspectives. Front Mol Biosci 2020;7:588618. [PMID: 33195436 DOI: 10.3389/fmolb.2020.588618] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26]</